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INTRODUCTORY WORDS 
 
Dear colleagues, 
 
It has been our great pleasure to organize this congress, as the first 
attempt to accelerate interaction between immunologists and other 
biomedical scientists, as well as between basic and clinical 
immunologists. We are all witnesses of increased specialization in 
science. At the same time, there is a growing need for integration of 
specific fields for the benefit of scientific research. We hope that this 
congress is a step forward to better integration of biomedical studies.
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Plenary lecture 
IMMUNE AGING OF SECONDARY LYMPHOID ORGANS: 
PERSPECTIVES FOR INTERVENTION 
Janko Nikolich-Žugich 
 
Department of Immunobiology and the University Arizona Center on Aging, University 
of Arizona College of Medicine-Tucson, Tucson, AZ, USA 
 
Adaptive immune system is in charge of precise defense against a highly 
diverse array of microorganisms. For defense against new infections, the 
organism deploys naïve, previously antigen-unexposed, T and B lymphocytes, 
whose antigen-specific receptors recognize, and eventually orchestrate the 
removal of, the invading microorganisms.  Naïve B, and even more so T, 
lymphocytes numerically diminish with aging. However, new data suggests 
that those that remain appear to have maintained their functional potential, 
contrary to an earlier dogma.  These findings refocused our attention upon cell-
extrinsic defects in immunity with aging. Results will be presented showing 
that thymic rejuvenation is not sufficient to improve/increase the naïve T cell 
pool in the secondary lymphoid organs. Moreover, data will be presented 
showing that aging of lymph nodes, including alteration in their architecture 
and stromal cell numbers, integrity and function, as well as changes in 
circulating, most likely soluble, factors, critically modulate both homeostasis 
and function of the aging immune system. Finally, we will present interventions 
to improve function in older LN and will discuss implications for immune 
rejuvenation in humans.  
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Invited lecture 
TARGETS OF SPONTANEOUS IMMUNOSURVEILLANCE AS 
VACCINE ANTIGENS FOR CANCER PREVENTION AND THERAPY 
Olivera J. Finn 
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 
 
Both mutated and non-mutated tumor antigens have been incorporated into 
vaccines in hope of eliciting or boosting immune responses to control tumor 
growth. One of the first non-mutated tumor antigens to be reported as a target 
of human cellular and humoral immunity is MUC1, abnormally expressed on 
all human adenocarcinomas. Preclinical and clinical studies of therapeutic 
MUC1 vaccines have been performed in breast, pancreatic, colon, ovarian, 
prostate and lung cancer.   Immune responses were elicited but they were of 
low titter (antibodies) and low frequency (T cells). Clinical responses were rare.  
Several reasons for this were elucidated over the years, the major one being the 
immunosuppressive microenvironment of advanced disease. In studying the 
expression of the tumor forms of MUC1 we discovered that abnormal 
expression occurs already on premalignant lesions, and that individuals 
diagnosed with such lesions, including colonic polyps, benign lung nodules and 
premalignant pancreatic lesions, generate immunity to abnormal MUC1. This 
led to our current work testing the MUC1 vaccine in the premalignant setting, 
in the absence of an established immunosuppressive tumor microenvironment, 
to induce strong immunity that could prevent premalignant lesions from 
progressing to cancer. We will report results from two ongoing clinical trials 
testing a preventative MUC1 vaccine composed of a 100aa peptide from the 
MUC1 tandem repeat region, the immunogenic portion of the molecule, with 
the TLR3 agonist Poly-ICLC as adjuvant, in individuals at high risk for 
developing colon cancer or lung cancer.  In this prevention setting the vaccine 
elicits strong antibody responses as well as strong immune memory, not seen 
in the therapeutic setting. Antibodies from vaccine responders were cloned and 
are being developed for antibody-based or CAR-based adoptive T cell therapy  
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Invited lecture 
TOLEROGENIC VACCINATION WITH DENDRITIC CELLS IN TYPE 1 
DIABETES 
- FROM AN IDEA TO A TRIAL - 
 
Tanja Nikolić, Vivienne Gibson, S. Laban, A.M. Joosten, J.J. Zwaginga and 
B.O. Roep 
Department of Immunohematology and Blood Transfusion, LUMC, Leiden, The 
Netherlands 
Tolerogenic dendritic cells (tolDC) have been nominated as a promising cellular 
therapy to treat autoimmune conditions. TolDC generated in vitro with vitamin D3 and 
dexamethason eliminate antigen-specific effector T-cells, promote IL-10 production 
and generate antigen-specific regulatory T-cells, which in their turn modulate 
inflammatory dendritic cells and promote tissue-specific infectious tolerance. These 
findings pointed to tolDC as a conceptually superior approach to induce antigen-
specific immunomodulation. To test tolDC in a clinical setting, we designed a study to 
evaluate the stability and safety in vivo and obtain proof-of-concept evidence of their 
immunomodulatory properties. First, we evaluated and confirmed the durability of the 
phenotype and function of clinical-grade tolDCs in vitro. The phenotype and function 
of tolDCs proved stable despite repeated stimulation with LPS, CD40-L or 
inflammatory cytokines, specified by expression of high CD52 and low CD86 
molecules. To examine whether tolDCs induce antigen-specific tolerance in vivo, 
HLA-DR4-Tg mice were treated with autologous tolDCs either unpulsed or pulsed with 
DR4-restricted proinsulin peptide (C19-A3) and monitored for adverse events. One 
week before the readout, mice were challenged by immunization with intact human 
proinsulin and autoreactive IL-10 and IFNg responses measured. Vaccination of DR4-
Tg mice with tolDCs proved safe and IL-10 production to proinsulin increased after 
treatment with C19-A3-pulsed tolDCs. Moreover, subsequent immunization of DR4-
Tg mice with proinsulin resulted in reduced IFNg production in mice treated with C19-
A3-pulsed tolDCs compared to those treated with tolDCs only. Our data show that 
monocyte modulation with VitD3 and dexamethasone generates potent and stable 
tolerogenic DCs for clinical cell-therapy. Administration of C19-A3-pulsed tolDCs in 
humanized mice is safe and shows that tolDCs inhibit autoimmunity in vivo, paving 
the way for clinical evaluation of the safety and feasibility of intradermal vaccination 
with proinsulin peptide-pulsed tolDC.  
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Invited lecture 
THE PD-1/PD-L1 IMMUNE INHIBITORY CHECKPOINT IN H. pylori- 
RELATED GASTRIC MALIGNANCIES 
E. Merve Aydin1,2, Dilan Demir1,3, Sinem Oktem-Okullu2, Sawsan S. Said1, 
Arzu Tiftikci4, Ayca Sayi Yazgan1 
1Molecular Biology-Genetics and Biotechnology Research Center, Istanbul Technical 
University, Istanbul, Turkey; 2Department of Medical Microbiology, Acibadem 
University, Istanbul, Turkey; 3Research Center for Translational Medicine, Koc 
University, Istanbul, Turkey; 4Department of Gastroenterology, Acibadem University, 
Istanbul, Turkey 
 
Gastric cancer is one of the most common cancer types worldwide. Even 
though, early recognition of disease can lead to high survival rates, it is mostly 
diagnosed in late stages. Infection with Helicobacter pylori (H. pylori) is the 
strongest known risk factor for development of gastric cancer. PD-L1 is an 
immune inhibitory checkpoint protein that is expressed in various cell types 
including antigen presenting cells and tumor cells. PDL-1 binds to PD-1 
(expressed on T-cells) and dampen T-cell activity. This event is crucial for 
peripheral tolerance and prevent excessive tissue damage. However, it has been 
suggested that upregulation of PD-L1 favors immune evasion and result in 
chronic infection with H. pylori and development of gastric cancer. Our 
laboratory focus on investigating the relationship between H. pylori and host’s 
immune cells to understand the mechanism of progression of H.pylori- induced 
gastric malignancies such as gastritis and ulcer to gastric cancer. By 
understanding this mechanism, we aim to contribute to future research on 
gastric cancer immunotherapies. We are using both mouse infection models and 
human gastric biopsy samples throughout our studies. During this presentation, 
I am going to talk about our findings related to the role of PD-1/PD-L1 
expressed on regulatory B cells in development of regulatory T cell in a murine 
setting. Also, I will discuss our data about the expression profile of PD-1 and 
PD-L1 in human gastritis, ulcer, and gastric cancer patients. Finally, the 
correlation of PD-L1 and PD-1 with H. pylori virulence factors, T-cell subset 
related cytokine expressions, and clinical outcomes will be emphasized. 
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Poster presentation 
SHORT TERM FISH OIL TREATMENT ALTERS FATTY ACID 
COMPOSITION AND CHOLESTEROL-RELATED GENE EXPRESSION 
IN MOUSE RETINA AND RETINAL PIGMENTED EPITHELIUM (RPE) 
Irena Jovanovic Macura1, Ivana Djuricic2, Marjana Brkic1,#, Desanka 
Milanovic1, Sladjana Sobajic2, Selma Kanazir1 and Sanja Ivkovic1 
1Institute for Biological research “Sinisa Stankovic”, University of Belgrade, 
Serbia; 2Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; # 
current affiliation - Center for the Promotion of Science, Belgrade, Serbia  
The imbalance in omega-6/omega-3 long chain polyunsaturated fatty acids (LC-PUFA) 
ratio can play a significant role in the development of many chronic and inflammatory 
diseases, including age related macular degeneration (AMD), the multifactorial disease 
recently linked to the hypercholesterolemic eye. Fish oil (FO) is a natural source of n-
3 long chain polyunsaturated fatty acids (LC-PUFA) and intermittent supplementation 
of high doses of FO (up to 5g/day for up to 16 weeks) is considered safe for use in 
human population and is suggested as a prophylaxis for AMD. However, proper eye 
function depends on the strictly regulated docosahexaenoic fatty acid, DHA (C22:6n3), 
one of the n-3 LC-PUFAs, and cholesterol homeostasis. As retina/RPE visual system 
has very specific, and likely different, requirements for cholesterol and DHA 
homeostasis we analyzed the effects of the FO supplementation on the lipid profile and 
the expression levels of the genes regulating cholesterol synthesis, transport and 
elimination in these structures. For the FO treatment, 3 months old B6/SJL mice were 
divided in two groups – the treated group (n=7) that was supplemented with 100 µl 
commercial fish oil (DietPharm, FidaFarm Croatia) daily via oral gavage for 21 days, 
and the control group (n=7), which received the same volume of the water as vehicle. 
The animals were sacrificed immediately after the treatment, eyes were enucleated, and 
retinas and RPEs were processed for RNA and fatty acid isolation. Lipid profile 
analysis and real time RT-PCR showed significant changes in the levels of 
eicosapentanoic (EPA) n-3 PUFA in retina and RPE, while DHA levels remain 
unlatered. Furthermore, the FO treatment significantly decreased the expression of the 
genes regulating cholesterol synthesis and transport in retina. These findings contribute 
to the better understanding of the role of FO supplementation in the retinal health and 
function, and can help improve the recommendation strategies.  
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Poster presentation 
BENFOTIAMINE DIRECTS DENDRITIC CELLS TOWARD A 
TOLEROGENIC PHENOTYPE 
Iva Božić1, Neda Đedović2, Milica Lazarević2, Đorđe Miljković2, Irena 
Lavrnja1 
1Department of Neurobiology, 2Department of Immunology, Institute for 
Biological Research "Siniša Stanković"- National Institute of Republic of 
Serbia, University of Belgrade 
 
Dendritic cells (DC) are professional antigen presenting cells that have an important 
role in inducing the immune response. Under normal conditions, DC reside in 
peripheral tissues in an immature state. However, they undergo a series of maturation 
steps in response to inflammatory stimuli. During maturation, DC up-regulate major 
histocompatibility complex (MHC) class II molecules and co-stimulatory molecules 
(CD40, CD80, CD86) for antigen presentation and increasingly secrete cytokines. 
Tolerogenic DC (tolDC) have immunoregulatory properties and are characterized by 
low expression of MHC class II and co-stimulatory molecules, with limited production 
of proinflammatory cytokines. TolDC-based immunotherapy is a promising 
perspective in the treatment of autoimmune diseases. Benfotiamine (S-
benzoylthiamine-O-monophosphate) is an S-acyl derivative of vitamin B1 with anti-
inflammatory and anti-oxidative properties. Here, we explored the potential of 
benfotiamine to induce tolerogenic phenotype of DC. DC were cultivated from 
progenitor bone marrow cells isolated from the femur of C57BL/6 mice. The cells were 
cultured for 7 days in the presence of granulocyte-macrophage colony-stimulating 
factor (20 ng/mL) with 100 ng/mL lipopolysaccharide added for the last 24 h of 
cultivation for maturation. Treatment with benfotiamine (100 µM) was performed on 
days 0, 2, 4 and 6. FACS analysis showed that benfotiamine applied during 
differentiation of DC suppressed the expression of MHC class II and CD86, while it 
did not affect the expression of CD40. The secretion of proinflammatory cytokines 
TNF, IL-1β, and IL-6 was also decreased. Morphological analysis showed that DC 
treated with benfotiamine were similar in shape and size to immature DC, despite the 
maturation stimulus that they were exposed to. The effects of benfotiamine are 
associated with its suppression of NF-κB translocation to the nucleus. Together, these 
results show that benfotiamine has the potential to direct DC toward tolDC. Studies on 
the application of benfotiamine-treated DC in animal models of autoimmunity are 
warranted.  
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ETHYL PYRUVATE STIMULATES DIFFERENTIATION OF 
REGULATORY T CELLS IN VITRO AND IN VIVO 
 
Ivan Koprivica1, Dragica Gajić1, Nada Pejnović1, Tamara Saksida1, Ivana 
Stojanović1 
 
1Department of Immunology, Institute for Biological Research "Siniša 
Stanković" - National Institute of Republic of Serbia, University of Belgrade, 
Belgrade, Serbia 
 
Ethyl pyruvate (EP) is a stable form of pyruvate that has shown potent anti-oxidant and 
anti-inflammatory properties both in vitro and in vivo and was able to ameliorate 
systemic inflammation and multiple organ dysfunctions in multiple animal models. Our 
recent study suggests that the application of EP in the mouse model of type 1 diabetes 
successfully prevents the clinical manifestation of the disease by augmenting the 
number of tolerogenic dendritic cells and regulatory T cells (Treg). Our present study 
indicates that during in vitro differentiation of CD4+ naïve cells into Treg, the addition 
of EP stimulated Treg generation. This was in line with the observed increased 
proliferation of newly differentiated Treg (Ki67+FoxP3+). Surprisingly, EP did not 
scavenge reactive oxygen species (ROS), but rather stimulated ROS production by 
Treg. In Treg, ROS is mainly generated during oxidative phosphorylation (OXPHOS) 
during which the majority of energy for the cell is produced. EP probably acted as a 
substrate in Krebs cycle because the cells produced more pyruvate dehydrogenase, 
which converts pyruvate to acetyl CoA. EP treatment also resulted in less kinase of 
pyruvate dehydrogenase, which acts as an inhibitor of Krebs cycle. As a result, there 
was an evident stimulation of OXPHOS, confirmed by increased ATP production in 
differentiated Treg. Additionally, EP exerted its stimulatory function on Treg in healthy 
C57BL/6 mice. When given either intraperitoneally or per os, EP increased Treg 
numbers within the peritoneal cavity or gut-associated lymphoid tissue, respectively. 
Seemingly, EP promoted differentiation of Treg in vivo and did not affect their 
suppressive properties (proportion of CTLA-4+, CD39+, PD-1+, IL-10+ Treg) or their 
affinity towards specific effector T helper cells (RORγT+, Tbet+ or GATA-3+ Treg). In 
conclusion, EP acts as specific metabolic fuel for Treg generation, likely because these 
cells mainly rely on OXPHOS-derived energy  
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FIRST OBSERVATION OF EXTRACELLULAR VESICLES FROM 
MUSCLE LARVAE OF Trichinella spiralis AND THEIR 
IMMUNOMODULATORY PROPERTIES 
 
Maja Kosanović1, Jelena Cvetković1, Alisa Gruden-Movsesijan1, Saša 
Vasilev1, Nataša Ilić1, Ljiljana Sofronić Milosavljević1 
 
1Institute for the Application of Nuclear Energy, INEP, University of Belgrade, 
Belgrade, Serbia 
 
Extracellular vesicles (EVs) represent newly discovered, third mode of inter-cellular 
communication, apart from direct contact and exchanging soluble molecules. They are 
membrane enclosed vesicles, released from all cells and functioning as transport 
vehicles between cells, for all types of biomolecules. EVs are involved in all 
phisyological and pathophysiolologcal processes studied so far, including functioning 
of immune system. EVs transfer bioinformation between cells of one organism but also 
between cells of different organisms as in host/parasite system. EVs were found to be 
produced by several parasites, including helminthes. However, research of helminths’ 
EVs was mostly focused on trematodes, while few data exist on nematodes’ EVs and 
none for Trichinella spiralis. Since it was found that some helmintic EVs have 
immunomodulatory properties, and having in mind that products of T. spiralis are 
known immunomodulators, the question arose if T. spiralis produce EVs as part of its 
excretory-secretory product (ES L1) and weather they have immunomodulatory 
properties. The EVs were found in ES L1. Transmission electron microscopy revealed 
round, vesicular structures of 30-80 nm in size. Those vesicles were positive for two 
out of three glycoproteins with the immunodominant epitope characteristic for muscle 
larvae of the genus Trichinella. Immunomodulatory potential of T. spiralis EVs was 
analyzed in an assay using peripheral blood mononuclear cells (PBMC). PBMC were 
stimulated with T. spiralis EVs and the results showed significantly elevated production 
of IL10 and IL6, and decresed production of IL-17, compared to control. This indicates 
that T. spiralis EVs can independently induce response similar to that induced by native 
ES L1. 
These results represent first finding of T. spiralis muscle larvae EVs and confirmation 
of their immunomodulatory potential.  
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BISPHOSPHONATED CELLULOSE NANOCRYSTALS INDUCE 
MATURATION AND ANTI-TUMOR FUNCTIONS OF HUMAN 
DENDRITIC CELLS VIA GABA-B RECEPTORS 
Marina Bekić1, Miloš Vasiljević2, Vanja Kokol3, Marijana Milanović4, Marija 
Drakul2, Dragana Vučević4, Miodrag Čolić1,2, Sergej Tomić1 
1University of Belgrade, Institute for Application of Nuclear Energy, Belgrade, 
Serbia; 2University of East Sarajevo, Medical Faculty Foča, R. Srpska, BiH; 
3University of Maribor, Faculty of Mechanical Engineering, Maribor, Slovenia; 
4University of Defence, Medical Faculty of the Military Medical Academy, Belgrade, 
Serbia 
 
Osteoclast-inhibiting agents, bisphosphonates (BP), recently emerged as potentially promising 
for the therapy of primary and metastatic bone tumors. The delivery of BP via nanomaterials 
increases their efficacy and minimizes adverse effects. Accordingly, cellulose nanocrystals 
(CNC) emerged as attractive new delivery systems with excellent physicochemical properties, 
biodegradability and biocompatibility. However, anti-tumor properties of BP-CNC conjugates, 
particularly their effects on the immune response, have not been investigated so far. Dendritic 
cells (DC) are the key regulators of anti-tumor response. Therefore, we investigated the effects 
of BP (3-AminoPropylphosphoric Acid (ApA)), either soluble or covalently attached to CNC 
(CNC-ApA, wt. 7% ApA) on the maturation and anti-tumor functions of human DC in vitro. We 
found that non-toxic doses of CNC-ApA (200 µg/ml), similarly to the effects of higher doses of 
soluble ApA (70 µg/ml), but not lower ApA doses (14 µg/ml), increased the expression of CD83, 
CD86, HLA-DR, IL1β, NLRP3, TNF-α, IL-6, IL-10 and IL-12p70, and downregulated the 
expression CD40, IL-33, ILT-3, ILT-4, PDL1 and CD73 on DC, compared to control, or DC 
treated with control CNC (w/o ApA). LPS/IFN-γ stimulation further potentiated the effects of 
higher doses of soluble ApA and CNC-ApA on DC maturation. ApA/CNC-ApA-treated DC 
increased the relative number of alloreactive Th1 and cytotoxic (Perforin+ Granzyme+) CD4 and 
CD8 T cells, while decreasing the number of Th17, Th2, Treg and Tr-1 cells, compared to 
corresponding control DCs. Some of the effects of CNC-ApA (i.e. on CD83, TNF-α, IL-6, CD40, 
IL33, ILT-3, ILT-4, CD73 expression and downregulation of Th17 and Tregs) were mediated 
via GABA-B receptor and downstream regulation of cAMP levels in DC, as they could be 
blocked by a specific GABA-B-R inhibitor, whereas other mechanisms remained unknown. 
Cumulatively, DC-mediated immunological effects, induced by a new promising BP-CNC 
nanoplatform, could be useful for the treatment of bone resorptive diseases and cancer.  
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THE CROSSTALK BETWEEN DC-SIGN, TLR2 AND TLR4 TRIGGERS 
TOLEROGENIC HUMAN DC PHENOTYPE 
Natasa Ilic,1 Jelena Cvetkovic,1 Alisa Gruden-Movsesijan,1 Sergej Tomic,1 
Ninoslav Mitic,1 Elena Pinelli,2 Ljiljana Sofronic-Milosavljevic1 
1Institute for the Application of Nuclear Energy, University of Belgrade, Belgrade, 
Serbia 
2Centre for Infectious Disease Control Netherlands, National Institute for Public 
Health and the Environment (RIVM), Bilthoven, Netherlands  
 
Human tolerogenic dendritic cells (tolDCs) possess immense potential for specific 
immunotherapy of autoimmune diseases and our research have recently revealed that 
ES L1 (Trichinella spiralis antigens) treatment of human monocyte-derived DC from 
healthy donors leads to a stable tolDCs. Underlying molecular events have not been 
discovered yet. It has been only delineated that TLR2 and TLR4 receptors recognize 
ES L1 antigens and are requisite for ES L1-induced tolerogenic status of DCs. 
Cooperation of TLRs with other PRRs may be the mechanism by which these antigens 
divert pro-inflammatory TLR signaling into anti-inflammatory. As it has been shown 
that ES L1 antigens possess sugars that could interact with DC-SIGN, this study was 
dedicated to revealing the role of this receptor on human DCs in binding ES L1 antigens 
and possible consequential modulation of TLR-signaling pathway. Interaction between 
ES L1 and DC-SIGN has been proven using recombinant DC-SIGN-Fc in ELISA and 
Western-blot. To establish the importance of this interaction for immunomodulatory 
properties of ES L1, immature human monocyte derived DCs were treated with 
blocking antibodies against DC-SIGN, TLR2 and TLR4 before ES L1 treatment. DC 
phenotype and their capacity to provoke anti-inflammatory immune response upon co-
cultivation with allogeneic T lymphocytes were assessed. Obtained results indicated 
that simultaneous blocking of the receptors hindered the phenotypic and functional 
properties of ES L1-treated DCs. Namely, ES L1-induced higher expression of CD40 
and production of TGF-β by DCs was impeded. Additionally, blocking of the receptors 
before ES L1 exposure abolished the ability of DCs to induce Th2 polarization and 
interfered with the induction of CD4+CD25hiFoxp3+ T cells in vitro.  Overall, these 
results indicate that DC-SIGN, TLR2 and TLR4 are all immensely involved in the ES 
L1’s induction of tolerogenic characteristics of human monocyte derived DCs. (Grant 
No: 173047, 175102)  
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Natasa Ilic,1 Jelena Cvetkovic,1 Alisa Gruden-Movsesijan,1 Sergej Tomic,1 
Ninoslav Mitic,1 Elena Pinelli,2 Ljiljana Sofronic-Milosavljevic1 
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Human tolerogenic dendritic cells (tolDCs) possess immense potential for specific 
immunotherapy of autoimmune diseases. Our research has recently revealed that 
treatment of human monocyte-derived DC (from healthy donors) with Trichinella 
spiralis muscle larvae ES L1 antigens leads to a stable tolDCs. This study also indicates 
that TLR2 and TLR4 receptors recognize ES L1 antigens and are requisite for ES L1-
induced tolerogenic status of DCs. However, molecular events that underline tolDCs 
formation under the influence of T. spiralis, have not been fully elucidated. It has been 
shown that ES L1 antigens possess sugars that could interact with DC-SIGN but 
possible cooperation of TLRs with this PRR was not investigated. The current study 
was dedicated to revealing the role of DC-SIGN receptor on human DCs in binding ES 
L1 antigens and possible consequential modulation of TLR-signaling pathway. 
Interaction between ES L1 and DC-SIGN has been proven using recombinant DC-
SIGN-Fc in ELISA and Western-blot. To establish the importance of this interaction 
for immunomodulatory properties of ES L1, immature human monocyte derived DCs 
were treated with blocking antibodies against DC-SIGN, TLR2 and TLR4 before ES 
L1 treatment. DC phenotype and their capacity to provoke anti-inflammatory immune 
response upon co-cultivation with allogeneic T lymphocytes were assessed. Obtained 
results indicated that simultaneous blocking of the receptors hindered the phenotypic 
and functional properties of ES L1-treated DCs. Namely, ES L1-induced higher 
expression of CD40 and production of TGF-β by DCs was impeded. Additionally, 
blocking of the receptors before ES L1 exposure abolished the ability of DCs to induce 
Th2 polarization and interfered with the induction of CD4+CD25hiFoxp3+ T cells in 
vitro.  Overall, these results indicate that DC-SIGN, TLR2 and TLR4 are all immensely 
involved in the ES L1’s induction of tolerogenic characteristics of human monocyte 
derived DCs. (Grant No: 173047, 175102)   
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TOLEROGENIC EFFECTS OF ETHYL PYRUVATE ON DENDRITIC 
CELLS – THE IMPORTANCE OF NRF2 AND NF-ΚB SIGNALING 
 
Neda Đedović1*, Đorđe Miljković1, Irena Lavrnja2 
 
1Department of Immunology, 2Department of Neurobiology, Institute for 
Biological Research "Siniša Stanković" - National Institute of Republic of 
Serbia, University of Belgrade 
 
Dendritic cells (DC) are professional antigen presenting cells that are crucial for 
initiation, propagation, but also for regulation of immune response. Tolerogenic 
dendritic cells have immuno-regulatory properties and they are a promising potential 
therapy for multiple sclerosis, as well as for other autoimmune diseases. Ethyl pyruvate 
(EP) is a redox analogue of dimethyl fumarate (Tecfidera), a drug for multiple sclerosis 
treatment. We have recently shown that EP has the ability to direct DC towards tolDC 
in both murine and human DC. In order to investigate mechanisms responsible for EP-
imposed tolerance in DC, we examined signal pathways responsible for anti-oxidative 
cell protection such as Nrf2 signalling pathway, HO-1 and NQO1 enzymes. 
Furthermore, pro-inflammatory transcription factor NF-κB was also observed. 
Additionally, change in morphology of DC was assessed via actin filaments staining. 
EP was applied on days 3 and 6 during 7 days long differentiation of C57BL/6 mouse 
bone marrow derived immature DC (iDC) or lipopolysaccharide induced mature DC 
(mDC). Afterwards, immunocitochemistry staining was performed. Results have 
shown that the maturation of DC led to reduction of the Nrf2 and HO-1 expression, 
which was successfully prevented by EP. Furthermore, the expression of NQO1 was 
higher in EP-treated iDC in comparison to untreated iDC. However, the expression in 
EP treated mDC was lower than in untreated mDC, but still higher than in iDC. Finally, 
EP-treated mDC had lower expression of NF-κB compared to EP-treated iDC. 
Moreover, these results are supported by morphological changes of DC after their 
treatment with EP. While mDC have observable dendrites, EP-treated DC have round 
shape and are much similar to iDC. In conclusion, these results clearly demonstrate that 
EP exerts its tolerogenic potential on DC through the up-regulation of anti-oxidative 
signalling pathways, as well as through the inhibition of pro-inflammatory transcription 
factor NF-κB.  
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PROSTAGLANDIN E2 POTENTIATE THE SUPPRESSIVE FUNCTIONS 
OF HUMAN MYELOID DERIVED SUPPRESSOR CELLS AND THEIR 
CAPACITY TO INDUCE IL-10- PRODUCING REGULATORY T CELLS 
 
Sergej Tomić1, Bojan Joksimović2, Marina Bekić1, Miloš Vasiljević2, 
Marijana Milovanović3, Miodrag Čolić1,2, Dragana Vučević3 
 
1Department for Immunology and Immunoparasitology, Institute for the Application 
of Nuclear Energy, University of Belgrade, Serbia  
2Medical Faculty Foca, University of East Sarajevo, Lukavica, Bosnia and 
Herzegovina 
3Medical Faculty of the Military Medical Academy, University of Defense in 
Belgrade, Serbia 
 
Myeloid-derived suppressor cells (MDSC) emerged as major factors driving the tumor 
progression and the main obstacle for successful checkpoint blockade therapy. 
Prostaglandin (PG)E2 is shown critical for the induction of MDSC and their 
suppressive functions in vivo, but it is poorly understood how it affects the capacity of 
MDSC to induce different subsets of regulatory T cells (Treg). By using a novel 
protocol for the generation of human mononuclear (M)-MDSC, we showed that PGE2 
potentiates the GM-CSF/IL-6-dependent induction of M-MDSC in vitro. PGE2 
diminished the capacity of GM-CSF/IL-6 M-MDSC to produce proinflammatory 
cytokines upon activation and augmented their capacity to produce IL-27, IL-33, and 
TGF-β. These results correlated with an increased potential of PGE2 M-MDSC to 
suppress T cell proliferation, expand alloreactive Th2 cells, and reduce the development 
of alloreactive Th17 and cytotoxic CD8 T cells. Interestingly, PGE2 M-MDSC 
displayed a lower capacity to induce TGF-β-producing FoxP3+ regulatory Tregs 
compared to GM-CSF/IL-6 M-MDSC which induced FoxP3+ Tregs via IDO-1. In 
contrast, PGE2 M-MDSC potentiated IL-10 production by CD8+T, Th2, and 
particularly CD4+FoxP3− type 1 Treg (Tr1), the latter of which depended on ILT3 and 
ILT4 expression. Cumulatively, PGE2 potentiated the suppressive phenotype and 
functions of human M-MDSC and changed the mechanisms involved in Treg induction, 
which could be important for investigating new therapeutic strategies focused on 
MDSC-related effects in tumors and autoimmune diseases with dominant Tr-1-
mediated suppression.  
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OF HUMAN DENDRITIC CELLS IN VITRO 
 
Tanja Džopalić1, Miloš Kostić1, Goran Marjanović1,2, Biljana Božić 
Nedeljković3 
 
1University of Niš, Medical Faculty, Department of Immunology, Niš, Serbia; Clinic 
for Hematology and Clinical Immunology, Clinical Center Niš, Serbia; 3 University of 
Belgrade, Faculty of Biology, Institute for physiology and biochemistry “Ivan Djaja” 
Belgrade, Serbia 
 
Galectin-1 (Gal-1) has numerous biological functions, such as function in cell 
survival/apoptosis, regulation of cell cycle, adhesion, and cell migration. The response 
of dendritic cells (DCs) to pathogenic and inflammatory stimuli is reflected through 
changes of their phenotype and functions. The aim of our study was to determine the 
effects of different concentrations of Gal-1 on monocyte-derived (Mo) DCs’ maturation 
and their ability to modulate the immune response in vitro. The study was performed 
in the culture of MoDCs in vitro. MoDCs were treated with increasing concentrations 
of Gal-1 (1, 3 and 6 μg/ml) for 48 h, upon which their phenotypic characteristics, the 
cytokine profile, and the ability to direct the immune response in the culture with 
allogeneic CD4+T cells was observed. Gal-1 in all investigated concentrations reduced 
the expression of CD80 and CD86 molecules on MoDCs compared to their expression 
on untreated MoDCs. Gal-1 at a concentration of 1 μg/ml and 6 μg/ml led to a 
significant reduction in IL-12 production, while at a concentration of 3 μg/ml it led to 
its significant increase. On the other hand, Gal-1 administered in all concentrations 
induced a significant increase the production of IL-10. Treatment of MoDC with Gal-
1 in concentrations of 3 and 6 μg/ml stimulated the production of IL-2 and IFN-γ in the 
co-culture, while the lowest Gal-1 concentration (1 μg/ml) reduced the production of 
IL-17 by CD4+T lymphocytes. This study demonstrated a two-part immunomodulatory 
effect of Gal-1 on MoDC in terms of immunostimulation and immunosuppression, 
depending on the applied concentration. Future studies require a deeper understanding 
of the role of Gal-1 in the modulation of phenotypes and MoDC functions depending 
on the applied concentration in order to better define its role as a potential adjuvant in 
the preparation of the MoDC for cell therapy. 
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GENOMIC APPROACH TO MULTIPLE SCLEROSIS 
 
Borut Peterlin1, Lovro Vidmar1, Jelena Drulović2, Ivana Novaković3, Smiljana 
Ristić4, Aleš Maver1 
 
1Clinical Institute for Genomic Medicine, Slajmerjeva 4, University Medical Centre 
Ljubljana, Ljubljana, Slovenia. 
2Clinic of Neurology, CCS, Faculty of Medicine, University of Belgrade, Belgrade, 
Serbia. 
3Faculty of Medicine, University of Belgrade, Institute of Human Genetics, 26 
Visegradska, Belgrade, Serbia. 
4Department of Biology and Medical Genetics, School of Medicine, University of 
Rijeka, Rijeka, Croatia. 
 
Despite extensive research, key aspects of multiple sclerosis etiology and 
pathogenesis remain unresolved. More than 200 genetic risk loci that have been 
identified through genome-wide association studies imply the role of many 
different immune cell types and tissues, including microglia. On the other hand, 
no convincing rare and penetrant variants have been reported to date, despite 
familial forms are well recognized. Recently, we described several rare variants 
in the NLRP1 gene, presumably conveying an increased risk for familial MS. 
Furthermore, we described the increased burden of rare genetic variation in the 
inflammasome signaling pathway suggesting its role in the etiology of MS. 
Finally, we will discuss the potential role of unfixed HERV insertions in the 
genetic predisposition to MS.
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FROM TRADITIONAL TO MODERN APPROACHES IN ANALYSIS OF 
DISEASE CAUSING GENES AND GENE VARIANTS: ROLE OF NEXT 
GENERATION SEQUENCING 
 
Ivana Novaković 
 
Neurology Clinic, Faculty of Medicine, University of Belgrade, Belgrade, Serbia 
 
In the field of inherited disorders, the first important intent is identification of 
disease causing genes and gene mutations. Traditional approach in detection of 
genes responsible for some condition includes methods of direct or reverse 
genetics, such as linkage analysis and positional cloning. Since the late 1980s, 
in this way have been discovered genes for number of monogenic disorders. In 
order to detect gene mutations several methods of direct and indirect testing 
have been developed, with Sanger sequencing as an ultimate step. Over the last 
two decades Next Generation Sequencing (NGS) changes powerfully strategies 
mentioned above. NGS comprises group of methods for effective high-
throughput DNA sequencing. Different NGS strategies could be used for whole 
genome or whole exome sequencing, or for analysis of selected gene panels 
such as “clinical exome” panel. Bionformatic analysis of obtained big data 
allows analysis of known relevant genes and detection of number of gene 
variants with in-silico prediction of its significance. In addition, NGS is a 
powerful method for the identification of new disease causing genes.  As an 
example, we describe our 5-years journey of discovering the PDGFB gene, 
encoding for beta subunit of platelet derived growth factor, as a new gene 
responsible for Idiopathic Basal Ganglia Calcification. After initial 
achievement in large international group, we identified new cases of disease 
using NGS-based methodology in our laboratory.   
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NEXT GENERATION SEQUENCING AND IMMUNOGENETICS: 
EXPERIENCE FROM CLINICAL GENETIC SERVICE OF TERTIARY 
PEDIATRIC REFERRAL CENTRE 
 
Goran Čuturilo 
 
1Faculty of Medicine, University of Belgrade, Serbia 
2Clinical genetic service, University Children’s Hospital, Belgrade, Serbia 
 
Recently, new technologies have made it possible to obtain a huge number of 
molecular data for each patient and establish diagnosis in many of them. 
Clinical genetic service at the University Children’s Hospital started to employ 
modern techniques for exome assessment from November 2014. For multiple-
gene assessment we started with solo (patient only) Mendeliome sequencing, 
followed by subsequent introducing of solo whole-exome sequencing, trio 
(patient + parents) whole-exome sequencing, and finally genome-sequencing. 
In terms of chromosomes, traditional and low-resolution analysis of a 
karyotype has been replaced with chromosomal microarray techniques. 
We present the data for pediatric patients who were referred or diagnosed with 
immunogenetic disorders, such as various types of autoimmune 
lymphoproliferative syndromes, autoinflamatory disorders, 
immunodeficinecies. We illustrate diagnostic successes of next generation 
sequencing techniques, as well as failure or doubtful results in some patients. 
In summery, next generation sequencing has made it possible to establish 
diagnosis and provide genetic counseling in a significant proportion of patients 
and families with immunogenetic disorders. 
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Genotypisation of Human Leukocyte Antigen (HLA) locus is important in 
clinical practice, especially in transplantation and transfusion medicine. In 
addition, association of HLA genotype with different autoimmune diseases is 
subject of diagnostic procedures or scientific research. The aim of our study 
was to analyze HLA genotype in a group of patients with Neuromyelitis Optica 
spectrum of disorders (NMOSD).  Genomic DNA was extracted from 
peripheral blood samples using salting out method. NGS-based HLA 
genotyping was performed using Omixon commercial kit for HLA genes A, B, 
C, DQB1 and DRB1, on Illumina MiSeq NGS platform. For data analysis we 
used Holotype Twin software by Omixon. This method allowed sequencing of 
entire coding length, including elements of the 5’ and 3’ untranslated regions 
for HLA A, B, C and DQB1, while DRB1 was analyzed from intron 1 to intron 
4. In the first run of 24 samples we obtained 9 completed HLA genotypes.  In 
these cases, all 5 analyzed genes were characterized at 8-digit level. In the 
remaining 15 samples partial HLA genotype was determined, mainly on the 6-
digit level for genes HLA A, B and DQB1, while genes HLA C and DRB1 
showed ambiguous results. Our data confirmed association of particular HLA 
DQB1 alleles with NMO observed in literature.  Further investigation of larger 
group of patients is necessary.  From technical aspect, we suggest importance 
of quality control in all steps of NGS protocol, from genomic DNA preparation, 
via HLA amplification, to library preparation and quantification. 
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The interaction between exposome, its relations to genome and  the subsequent 
modifications of the genome, reffered as epigenome, are potential pathway  for SLE 
onset and progression. Epigenetic changes could be: altered DNA methylation, histone 
modification, non coding RNAs. In SLE, hypomethylation of CD4+ T cells, and in B 
cells is demonstrated. Monozygot twins have  only 24% concordace rate with SLE. 
Particulate matter measuring 2,5 microns and smaller are associated with prevalence of 
SLE. Trace elements: uranium, lead and cadmium are capable to induce autoimmunity  
and increase a production of ANA. Silica and asbestos exposure  also promote 
autoimmunity. Exogenous estrogen administration increase a risk for SLE. The role of 
xenoestrogen, such as bisphenol A, is implicated in increasing of Ab prodution. UVA 
radiation 320-400nm act on keratinocytes and produce DNA damage.  
Organ specific biomarkers  in lupus  nephritis  are:  renal biopsy, proteinuria, ds DNA, 
C3, C4, also genetic markers: MCP-1 polymorphism, ITGAM gene , levels of ACE. 
DNA methylation biomarkers are: circulating micro RNAs,  APRIL. Biomarkers for 
NPSLE  in CSF: Il-6, Il-8, Il-10, TNF alfa, ACA, U1RNP. For cutaneous manifestations 
in SEL: antiannexin 1. 
 Infection is a common problem in patients with SLE. Infection can mimic 
exacerbations of SLE. We use conventional biomarkers for infection such as  CRP - 
most sensitive and specific marker for bacterial infections in SEL. Procalcitonin is a 
promising marker for respiratory bacterial infection, sometimes is complicated to 
differentiate between sepsis and  SLE flare. Hematuria and piuria may present a clinical 
dilemma. The expression of CD64 on the surface of PMN increases in response to 
microbial  wall components,  so  CD64 could be a useful biomarker. Also, CD27 high 
plasma cells freqency correlates with SLEDAI and some autoantibodies. 
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Cryoglobulins are serum immunoglobulins that precipitate at temperatures lower than 
370C and redissolve after rewarming. Their occurrence is most often associated with 
various infections, autoimmune and malignant disorders, or the cause of it remains 
obscure (essential cryoglobulinemia (EMC). Three basic types are recognized 
according to the clonality and type of immunoglobulins. Type I consists of monoclonal 
immunoglobulins (IG), while in Type II cryoglobulins are a mixture of monoclonal 
IgM and polyclonal IgG. Type three cryoglobulis are mixture polyclonal IG. Types II 
and III are referred to as mixed mixed cryoglobulinemias (MC). MC deposits of 
immune complexes in walls of blood vessels might lead to vasculitis of small and 
medium blood vessels, giving the histological picture of leukocytoclastic vasculitis. 
Clinically, this inflammation is manifested as arthralgias, fatigue, and lesions mainly 
in skin, kidneys and peripheral nerves, however, any organ system can be involved. 
Most of the so far reported clinical and laboratory investigations deal with mixed CG 
in chronic hepatitis C virus (HCV) infection while the data concerning essential CG 
vasculitis (CV) are scarce. Only recently, so-called noninfectious CV has attracted 
more attention of the medical community. Chronic antigenic stimulation, increased 
cytokine and growth factor (BLyS) levels and complement activation may are 
implicated in the pathogenesis of CV, etiology of which remains largely unknown.  
Cryoglobulinemia is not a unique entity in either clinical or laboratory terms. The 
amount and type of cryoglobulin, the presence of viral markers, autoantibodies, 
complement consumption, and cytokine concentrations may be important in the onset, 
development, and severity of the clinical picture of cryoglobulinemic vasculitis. 
Increased B lymphocyte proliferation may play a pathogenic role in a number of 
patients with cryoglobulinemia. It is possible to define subgroups (phenotypes) of 
patients with cryoglobulinemia who have different disease evolution and prognosis. 
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Takayasu arteritis (TA) is a rare, systemic vasculitis that predominanatly affects the aorta, its 
major branches and pulmonary arteries. While our understanding of the pathogenesis of TA has 
considerably improved during the last two decades, the exact pathogenic mechanism remains to 
be elucidated. Historically, cell-mediated autoimmunity has been strongly implicated in the 
pathogenesis of TA. Hystopathological investigations would be very useful, but in majority of 
cases we lack samples to be analyzed. Immunohistochemical studies of infiltrating cells from the 
aortic tissue of patients with TA have showed infiltration by macrophages, natural killer (NK) 
cells, neutrophils, CD4+ T cells, CD8+ T cells and γδ T cells. Based on this finding, novel 
imaging techniques such as 18F- fluorodeoxyglucose position emission tomographies (PET) 
computed tomography (CT) and PET magnetic resonance (MR) angiography allow us, not only 
to visualize inflammation by showing the hypermetabolic infiltrate, but also to better characterize 
and quantify disease activity.As we have known that certain genetic factors play an important 
role in the development of TA, we aimed to study the association between human leukocyte 
antigen (HLA) and TA susceptibility. The strong association between HLA-B*52 and TA in the 
Serbian TA cohort was found. The HLA-A*32, -B*15 and -B*57 allelic groups and 
DRB1*15:02-DQB1*05 haplotype, as susceptibility factors, and HLA-C*03, described for the 
first time in the literature as a protective allelic group in TA patients, still need to be confirmed 
in a larger study population. Searching for a non-invasive test, we have recently identified ELF, 
a biochemical test consisted of three serum biomarkers: hyaluronic acid, tissue inhibitors of 
metalloproteinases and amino-terminal propeptide of procollagen type III, as a potential 
promissing tool for disease assesment. The performance and considerable diagnostic value for 
the prediction of disease progression due to vessel wall fibrosis still remain to be explored in 
future studies. 
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A.A. born in 1991, was hospitalized at the KCS Allergology and Immunology Clinic 
on suspicion of having SEL. Four months before that, she had an infectious syndrome. 
Ten days later, she was hospitalized for shortness of breath, bilateral pleural effusion, 
lower leg swelling. The renal lesion was verified: elevated values of nitrogenous 
substances, significant proteinuria and pathological urine sediment. It was concluded 
that this was a renal weakness initially presented with hypervolemia, hypertension, and 
signs of cardiac decompensation. A kidney biopsy showed severe damage that almost 
matched the end stage kidney disease in the RPGN field. It has been decided to begin 
immunosuppressive prednisolone therapy of 1mg / kg tt. After a positive ANA titer, 
hospitalization at the Allergology and Immunology Clinic is scheduled. When she was 
admitted to the clinic, she reported headache, diplopia and vomiting. The asymmetric 
rhyme of the oculi, convergent strabismus and ptosis of the left eye were noted in the 
objective finding.  Meningeal signs were negative; CT of the endocranium was neat. 
Neurological findings suggested neurolupus. Endocranial MR and diplopia test were 
advised. In consultation with the infectologist, an LP Cryptococcus shower was done, 
the preliminary finding was positive (a lot of cryptococci were found). The patient was 
transferred to the Infectious Diseases Clinic.  
Nervous system involvement is present in 50% of patients with SEL. American 
rheumatologists have identified 19 neuropsychiatric syndromes that can be divided into 
manifestations of the central and peripheral nervous systems. In 40% of patients, CNS 
damage is due to the disease itself, in others it is due to infections, metabolic disorders, 
and drug side effects. Since these are patients belonging to the group of 
immunocompromised patients with immunodeficiency, caused by long-term use of 
corticosteroid therapy and / or cytostatics, differential opportunistic infections must 
always be considered. 
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S. stercoralis infection can be clinically silent for decades. However, in 
immunosuppressed patients, especially those on corticosteroid therapy, 
hyperinfective syndrome and disseminated strongyloidiasis can occur. 
Corticosteroid therapy is also, a risk factor for the development of active 
tuberculosis. 
We report the case of hyperinfective syndrome complicated by the development 
of bacterial meningitis and tuberculosis in a patient with polyarteritis nodosa 
treated with corticosteroids. The diagnosis of strongyloidiasis was made by 
finding of larvae and adult parasites in the samples of the upper gastrointestinal 
tract mucosa and the stool. Eradication of S. stercoralis was achieved by 
subcutaneous administration of the veterinary formulation of ivermectin. The 
clinical course was complicated by the development of tuberculous 
lymphadenitis and pulmonary tuberculosis. Despite the use of tuberculostatic 
therapy and supportive measures, a lethal outcome occurred. 
Clinical manifestations of strongyloidiasis in patients with systemic vasculitis 
often resemble an exacerbation of the underlying disease, remaining 
unrecognized for a long time. The use of immunosuppressive therapy in these 
patients increases, not only the risk of more severe forms of strongyloidiasis, 
but also the risk of developing tuberculosis. A specific interrelation between 
strongyloidiasis and tuberculosis has been suggested, possibly through the 
phenomenon of helminth-induced imunossupression.  
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We describe a case of a 20-year-old man diagnosed with hypersensitive vasculitis most 
likely caused by Treponema pallida infection. The disease began predominantly with 
changes in the lower legs, of the type of numerous disseminated palpable purpura, 
partially fused into purplish plaques with single erythematous maculae on the forearms 
with pain in the feet and right knee. Local therapy with anti-inflammatory creams and 
antihistamines did not help. One month before the onset of the changes, he was cold 
with symptoms: nasal secretions, coughing without fever, pain in the right ear, diarrhea, 
fresh blood in the stool. He took Ibuprofen from his medication. In clinical presentation, 
changes in purpura skin, in laboratory analyzes polyclonal stimulation with elevated 
IgG, IgA, ANA positivity. Other analyzes: positive calprotectin, positive VDRL, in 
later course extremely high TPHA, ACLA IgG and IgM class, positive LA, 
pathological urine sediment, erythrocyturia, hyaline cylinders, proteinuria. Based on 
the clinical presentation of skin changes of the purpura type, PH-proven small blood 
vessel vasculitis, calprotectin and its normalization to the applied corticosteroid 
therapy, renal lesions with nephrotic grade proteinuria (8.5 gr for 24 h), the diagnosis 
of Henoch-Schonlein purpura was made. The patient was treated with intensive 
corticosteroid therapy 1mg / kg TT as well as "pulse" therapies of corticosteroids and 
three "pulses" of cyclophosphamide 800 mg per month, when proteinuria was reduced 
to 3g ... and then 0.25 gr for 24 hours. On the basis of positive treponemal and non-
treponemal tests on Treponema Ag, he was diagnosed as Lues latens tarda and, in 
consultation with an infectologist and dermatovenerologist, pencillin preparations 
Benzatin pecinillin were administered according to the protocol, with a decrease in 
VDRL and TPHA parameters. He was discharged in clinical remission with Pronison 
5mg therapy, mycophenolate mofetil 2X500mg, IPP, as well as treatment advice for all 
sexual partners.
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Churg Strauss syndrome or allergic eosinophilic graulomatosis with polyanginitis is a very rare 
form of vasculitis. In this disease, there are signs of vasculitis on the skin and internal organs 
associated with asthma and increased eosinophils. The disease can be caused by a variety of 
hereditary and external factors. This syndrome usually occurs in long-standing asthma and in 
patients with familial atopic predisposition. In 1990, the American Association of 
Rheumatologists (ACR) set 6 criteria for the diagnosis of Churg Strauss sydrome (CSS): 1. 
Asthma in 97% of patients; 2. Eosinophilia> 10% in peripheral blood; 3. Paranasal sinusitis 
(90%), often nasal polyps (61%); 4. Infiltrates in the lungs that migrate or are transient (26-77%); 
5. Peripheral neuropathy; 6. Histological findings of perivascular eosinophilic infiltrates or 
granulomas, which are vasculitis of small and medium sized blood vessels, arteries and veins. A 
33-year-old patient has been treated for asthma since year 2010. 7-8 years ago, he had sinus 
surgery. In June 2018., gallbladder surgery is done. 10 days after surgery, he begins to fever and 
develop bilateral pneumonia and wound infection in which Staphylococcus foecalis is isolated. 
He continues to fever for the next 32 days regardless of antibiotic therapy and he is been 
hospitalized at the Infectious Diseases Clinic. After treatment at the Infectious Disease Clinic, 
fever has stoped, but  he was still in poor general condition. Two days after discharge from the 
Infectious Disease Clinic, the condition in terms of heart failure worsens. The patient is 
hospitalized at the Clinic for Diseases of the Heart, Blood Vessels and Rheumatism, where 
complete cardiac and laboratory tests are performed. In the laboratory, eosinophilia up to 60%, 
is observed. Immunoassay is done with ANA: negative, ENEA6 profile: negative, PANCA: neg., 
PANCA: neg. Ultrasound of the heart shows dilated cardiomyopathy EF: 18%, with severe 
insufficiency of the mitral valve, and moderate pulmonary hypertension, as well as signs of 
pericardial and pleural effusion.  Glucocorticoid therapy is administered. The pulmonologist and 
the infectologist completely rule out the disease in terms of myocarditis and possible processes 
in the lungs, and the pulomolgist confirms previously verified asthma bronchialae. A medical 
review board  of immunologists, rheumatologists, pulmonologists, infectologists, cardiologists 
concludes the diagnosis of Churg Strauss syndrome on the basis of the clinical picture and 
laboratory parameters. The findings are summarized on a cardiac surgery board indicating 
cardiac transplantation.
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Gut microbiota composition is increasingly recognized as a critical factor determining the 
efficacy of different immunotherapeutic approaches. However, it is not known how it correlates 
with a therapeutic potential of myeloid-derived suppressor cells (MDSC), key suppressors in 
various autoimmune diseases (AD). Therefore, we investigated how the potential of MDSC-
therapy to suppress symptoms of multiple sclerosis (MS) correlate with gut microbiota 
composition. Autologous MDSC generated from bone marrow cells were applied as single 
therapy to spinal cord homogenate/CFA-induced experimental autoimmune encephalomyelitis 
(EAE) in Dark Agouti (DA) rats, an animal model of MS. MDSC-therapy resulted in a significant 
attenuation of EAE symptoms over 30 days of disease monitoring. These results correlated with 
lower percentage of proinflammatory interferon-gamma and interleukin-17 producing cells and 
higher percentage of antiinflammatory IL-10 producing cells in spinal cord and spleen. The 
effects of EAE and MDSC-therapy on gut microbial composition were studied using 16S rDNA-
based metagenomic analyses of fecal samples collected prior to the induction of EAE, and at the 
peak of the disease. The induction of EAE in control group of animals, resulted in a lower 
microbiota diversity compared to healthy controls, whereas the MDSC therapy preserved the 
microbial diversity in treated animals. In addition, the induction of EAE in control group 
correlated with a higher relative abundance of Peptococcaceae, whose role in the chronic-
progressive course of MS was previously reported. Besides, the relative abundance of 
Veillonellaceae, known to produce immunosuppressive short chain fatty acid (SCFA), was 
significantly decreased in the control EAE group. In contrast, MDSC therapy resulted in the 
preservation of Veillonellaceae and elevated Ruminococcaceae, another SCFA-producing family 
and Coriobacteriaceae, which are known to produce immunosuppressive metabolites from 
phytoestrogens. Based on these results, MDSC therapy and the observed changes in microbial 
diversity could be further developed as a promising therapy for MS and other AD. 
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The gut microbiome is very important for hosts’ proper essential functions, as 
microbiota influence both near and distant organs and disruption at any level of this 
complex relation can be underlying cause for many diseases. Both intestinal bacterial 
population and their metabolic products are involved in immune system development, 
activity and maintenance of immune homeostasis. Previous findings revealed 
differences in immune reactivity in Albino Oxford (AO) and Dark Agouti (DA) rat 
strains in various diseases models (such as experimental autoimmune 
encephalomyelitis, rheumatoid arthritis, contact hypersensitivity reaction, pulmonary 
aspergillosis etc.), and in response to xenobiotics such as cadmium, warfarin, etc.  
The aim of present study was to investigate microbial composition of gut (duodenum, 
jejunum, coecum and colon) and lungs of AO and DA rats using DGGE method. 
Although similar number of bacterial species were noted in both tissue and lumen of 
duodenum, bacterial composition differ between these two strains (solely 76.2% and 
44.4% species were common in both strains tissue and lumen, respectively), while 
greater variability was noted in DA rats. Similar results were noted in jejunum. In 
contrast to duodenum and jejunum, higher number of bacterial species were detected 
in coecum (content) and colon (tissue and content) of AO rats. Around 50% of detected 
bacteria were present in both gut segments of both strains. Analysis of DGGE bands 
obtained from lung tissue revealed similar number of bacteria in both strains, but solely 
54.5% were common. Further investigations will be directed to identification of 
bacterial species and try to connect observed differences in microbial composition with 
different immune reactivity in AO and DA rats. 
Supported by the Ministry of Education, Science and Technological Development of 
the Republic of Serbia, Grants #173019 and #173039.
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One of the most toxic heavy metals is cadmium which was classified as a human 
carcinogen. Cadmium is capable of induction of numerous acute and chronic disorders. 
Several studies have shown that inflammation and oxidative stress play a key role in 
the toxicity and carcinogenicity. Some reports have shown that species belonging to 
Lactobacillus sp. present in the human gastrointestinal tract and in fermented foods 
have the ability to bind and detoxify heavy metal ions. There are evidences that 
exopolysaccharides (EPS) can be used as tools for removing heavy metal ions by 
detoxication, which prevents their absorption from the gastrointestinal tract by host 
cells.  
Lactobacillus plantarum BGAN8 showed the best cadmium binding ability, among 
others EPS producing strains from Laboratory for Molecular Microbiology collection 
(LMM collection). So, the aim of this study was to determine the role of isolated and 
purified EPS from Lactobacillus plantarum BGAN8 (EPS-AN8) in protection of 
cadmium induced damage like inflammation and oxidative stress in Caco-2 cells. 
The subtoxic dose of CdCl2 (the concentration that has killed less than 10% of Caco-2 
cells) was determined by LDH and MTT assay. Caco-2 cells were treated with subtoxic 
dose of CdCl2 and EPS-AN8. The changes in expression of target genes were 
determined by quantitative PCR, while the changes in permeability of Caco-2 cells 
were tracked by lucifer yellow assay. 
Treatment of differentiated CdCl2 treated Caco-2 cells monolayer with EPS-AN8 
alleviated inflammation and oxidative stress (decreased level of expression of mRNA 
IL-8, NQO1 genes) and also decreased level of lucifer yellow flux. In conclusion, EPS-
AN8 might be used as postbiotic in prevention and treatment of cadmium-induced 
damages.
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The major parts of the commensal microbial flora of the human gastrointestinal tract (GIT) 
belong to the lactic acid bacteria (LAB) that are frequently used as probiotics. Probiotics must 
survive passage through the upper GIT and reach its site of action alive, where they have to 
maintain their stability, viability and function. Preparation of various biopolymer-based carriers 
and microencapsulation become inevitable part of probiotics-focused researches. In this study, 
we assessed probiotic activity of Lactobacillus reuteri B2 selected from the panel of LAB 
isolated from the feces of C57BL/6 mice. L. reuteri B2 was evaluated as potential probiotic and 
its microencapsulation with alginate-based materials were performed. We hypothesized that if L. 
reuteri B2 in the free form can survive all conditions in the GIT then the usage of the appropriate 
biomaterials for microencapsulation would improve its viability and stability in GIT.  
Consequently, there has been assessed L. reuteri B2 in free and in microencapsulated form, in 
vitro, in the culture of epithelial cells. High survival rate of L. reuteri B2 at low pH (2.0-  4.0) 
and in the presence of the bile salts at concentrations up to 0.30% imply that it can survive harsh 
conditions within GIT. Likewise, L. reuteri B2 strong antimicrobial activity toward pathogen 
species on which this strain has been   assessed. Furthermore, testing of the alginate-based 
polymers revealed no negative impact on the viability of epithelial cells. Results obtained from 
this study highly encourage further research on the impact of alginate- encapsulated L. reuteri 
B2 in physiological conditions as well as for the prevention or treatment of some pathological 
states. Additionally, demonstrating extended viability of encapsulated probiotics in vivo will 
justify scaling up the encapsulation process for commercial application.  
Acknowledgment: The authors would like to acknowledge the financial support of the Ministry 
of Education, Science and Technological Development, Government of Republic of Serbia, 
projects: OI176018 and OI172049.
Friday, December 6th Session: MICROBIOTA 
 
31 
 
Poster presentation 
THE EFFECTS OF HEAT-KILLED Enterococcus faecium BGPAS1-3 ON 
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN DARK AGOUTI 
RATS 
Nikola Popović1, Milica Lazarević2, Jelena Đokić1, Katarina Veljović1, Bojan 
Jevtić2, Neda Đedović2, Đorđe Miljković2, Nataša Golić1 
1Laboratory for Molecular Microbiology, Institute of Molecular Genetics and Genetic 
Engineering, University of Belgrade, 11000 Belgrade, Serbia; 2Department of Immunology, 
Institute for Biological Research "Siniša Stanković" - National Institute of Republic of Serbia, 
University of Belgrade, 11000 Belgrade, Serbia; 
Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple 
sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS). 
Recent evidence suggests the involvement of gut microbiota dysbiosis in etiology of 
MS. Hence, the modification of gut microbiota composition could be an effective 
approach in MS prevention/treatment. The aim of this study was to evaluate the effect 
of the heat-killed cells of Enterococcus faecium BGPAS1-3 on gut microbiota 
composition and EAE development in female DA rats. The results showed that the oral 
application of the heat-killed BGPAS1-3 during 30 days alleviated the clinical 
symptoms of the disease. The beneficial effects were paralleled with less immune cells 
infiltrating the CNS, judged by histological examination, as well as their limited ability 
to produce the major inflammatory cytokines interferon-gamma and interleukin-17, as 
deduced by ELISA. The effect of heat-killed BGPAS1-3 cells on the gut microbiota 
was examined by Denaturing Gradient Gel Electrophoresis (DGGE) and Next-
Generation Sequencing (NGS) analysis. Based on DGGE analysis, Shuttleworthia 
satelles appeared only in feces sampled from control animals 30 days after EAE 
induction. Lactobacillus murinus and En. hirae were present only in feces of 
immunized animals that were treated for 30 days with heat-killed BGPAS1-3, although 
not in the control group. Additionally, the results of NGS analysis revealed that some 
members of Firmicutes, Bacteroidetes, and Proteobacteria were more prevalent in 
feces of immunized animals treated with heat-killed BGPAS1-3 than in control groups. 
The changes in gut microbiota were mirrored in lower cellularity and reduced the 
proportion of interleukin-17-producing cells in mesenteric lymph nodes. The obtained 
results indicate that oral administration of BGPAS1-3 leads to modulation of the 
autoimmune response, modification of gut microbiota composition and eventually to 
the alleviation of the disease symptoms.
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The breakthrough in microbiota analysis calls for the thorough analysis of the steady-
state antibody reactivity to different microorganisms. The location of the antibodies 
plays a key role in determining host-microorganism relationship. Here we compared 
the level of specificity of serum and salivary IgA antibodies towards different bacterial 
antigens. Enzyme-linked immunosorbent assays targeting four designated antigens – 
whole Escherichia coli cells - urinary infection clinical isolate, whole Lactobacillus 
rhamnosus LA68 cells, Escherichia coli O55:B5 lipopolysaccharide (LPS) and 
Staphylococcus aureus peptidoglycan (PGN) were performed. The tested population 
comprised 14 healthy adults with serum and saliva samples collected at the same time. 
Both total IgA and IgA subclasses were analyzed and compared. The selected dilutions 
of serum and saliva used were such that there were effectively 10 x more serum 
antibodies than salivary ones in the assay. Notwithstanding, extremely high correlations 
in salivary IgA were obtained between very distant bacterial species such as L. 
rhamnosus and E. coli, as well as towards isolated components of microorganisms (r = 
0.7-0.96), implying high cross-reactivity and/or low specificity. For serum IgA, the 
reactivity was profoundly different. Serum IgA differentiates G + from G- 
microorganisms, i.e. serum IgA towards E. coli correlated best with serum IgA towards 
LPS (0.86), and serum IgA against L. rhamnosus correlated best with the anti-PGN 
IgA2 response (0.88). 
Serum IgA response against E. coli cells consisted primarily of IgA1 response, whereas 
serum response to L. rhamnosus cells consisted primarily of IgA2 response. For 
isolated components, serum IgA against LPS was guided by IgA2 response and towards 
PNG by IgA1 response. The explanation of this phenomenon exceeds the capacity of 
this study and confirms the delicacy, specificity and orchestration of the immune 
system. 
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The characterization of molecules and mechanisms in the bases of probiotic effects of 
bacteria is necessary for their safe and efficient application in various 
pathophysiological conditions. GABA-producing Lactic Acid Bacteria, such as 
Lactobacillus brevis BGZLS10-17, isolated from dairy product, are considered as a 
valuable source of naturally produced GABA as this molecule have wide range of 
physiological effects. In that mean the aim of this study was to evaluate the effects of 
GABA containing bacterial cell-free supernatant obtained from BGZLS10-17 culture 
on intestinal epithelial barrier (differentiated Caco-2 cells monolayer) and immune cells 
(mesenteric lymph node cells, MLNC) exposed to inflammatory conditions in vitro. 
The treatment of Caco-2 with IL-1β induced the expression of mRNA for pro-
inflammatory IL-8 cytokine while decreased the expression of mRNA for tight junction 
proteins and TGF-β thus mimicking deleterious effects of inflammation on intestinal 
epithelial barrier. Importantly, BGZLS10-17 supernatant containing GABA alleviated 
these effects by attenuating IL-8 production and preserving the tight junction proteins 
and TGF-β expression in Caco-2 exposed to IL-1β. Further, we investigated the effects 
of GABA containing BGZLS10-17 supernatant on Concanavalin A-stimulated MLNC. 
We have shown that GABA containing supernatant have strong immunosuppressive 
effect by inhibiting proliferation of MLNC, the production of IFN-γ and IL-17 and the 
expression of MHCII and CD80 by these cells. At the other hand, GABA containing 
supernatant exposed strong stimulatory effect on the expression of immunosuppressive 
molecules such as Foxp3+, IL-10, TGF-β, CTLA4 and SIRPα in MLNC. Considering 
all these results, we assume that GABA-producing BGZLS10-17 could have significant 
role in the maintenance of intestinal epithelial barrier integrity and immune system 
homeostasis when used as supplement to therapy of diseases related to exacerbated 
inflammation. 
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Clinical and animal trials show that early life probiotic consumption provides 
health benefits in adult life by modulating the immune response. We tested the 
effects of early life oral consumption of the probiotic Lactobacillus rhamnosus 
on the function and phenotype of rat peritoneal cavity cells in a model of 
induced colitis. For the first month of their lives, rats were either fed with an 
aqueous probiotic bacteria suspension (LB group) or tap water (control group). 
When the rats grew to 3 months old, we studied the response of their peritoneal 
macrophages to autologous fecal bacteria stimulation in vitro, both before and 
after colitis induction (TNBS 40mg/kg of body mass in 50% ethanol). 
Compared to the controls, the peritoneal cavity cells of the LB group produced 
less nitric oxide (NO) and had an increased proportion of CD163+ cells. The 
rats in the LB group have shown milder symptoms of colitis (shorter length of 
colon under necrosis, less severe submucosal infiltration, lesser degree of 
colonic wall thickening), along with a diminished increase of peritoneal pro-
inflammatory CCR7+ cells and blunted NO production in response to 
stimulation by autologous fecal bacteria. Our results may indicate that early 
oral probiotic administration attenuates macrophage responses to fecal bacteria, 
which are the primary cause of tissue inflammation and necrosis in chemically 
induced colitis models, and that this attenuation may be involved in improving 
the health of colitic rats. (Supported by Ministry of Education, Science and 
Technological development, Republic of Serbia, Grant No 175050). 
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Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect of 
platinum-based chemotherapy and decreases the quality of life of cancer 
patients. We compared neuroprotective properties of several agents using an in 
vitro model of terminally differentiated human cells NT2-N derived from cell 
line NT2/D1. Sodium azide and an active metabolite of amifostine (WR1065) 
increase cell viability in simultaneous treatment with cisplatin. In addition, 
WR1065 protects the non-dividing neurons by decreasing cisplatin caused 
oxidative stress and apoptosis. Accumulation of Pt in cisplatin-treated cells was 
heterogeneous, but the frequency and concentration of Pt in cells were lowered 
in the presence of WR1065 as shown by X-ray fluorescence microscopy 
(XFM). Transition metals accumulation accompanied Pt increase in cells; this 
effect was equally diminished in the presence of WR1065. To analyze possible 
chemical modulation of Pt-DNA bonds, we examined the platinum LIII near 
edge spectrum by X-ray absorption spectroscopy. The spectrum found in 
cisplatin-DNA samples is altered differently by the addition of either WR1065 
or sodium azide. Importantly, a similar change in Pt edge spectra was noted in 
cells treated with cisplatin and WR1065. Therefore, amifostine should be 
reconsidered as a candidate for treatments that reduce or prevent CIPN. 
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6-hydroxydopamine (6-OHDA) is one of the most common neurotoxins used to induce 
experimental model of Parkinson’s disease (PD) both in vivo and in vitro. Neurotoxic 
action of 6-OHDA is mediated by oxidative stress and apoptotic cell death which leads 
to neurodegeneration and neuroinflammation. Natural disaccharide trehalose exhibits 
powerful neuroprotective effect in certain brain injury models. In this study, we 
investigated the neuroprotective and the antioxidative effects of trehalose against 6-
OHDA induced neurotoxity in human neuroblastoma SH-SY5Y cells. The ability of 
trehalose to improve cell viability and to reduce neuronal death was assessed by 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), crystal violet, 
lactate dehydrogenase assay, AnnexinV-FITC/propidium iodide staining and cell cycle 
analysis. The production of reactive oxygen species (ROS) was analyzed by flow 
cytometry using redox-sensitive dyes dihydrorhodamine 123 (DHR) and MitoSOX 
Red. MTT and LDH assays demonstrated that trehalose pretreatment in a time-
dependent manner significantly improved cell viability and reduced 6-OHDA induced 
neurotoxic effect. Annexin V-FITC and propidium iodide double staining and cell 
cycle analysis indicated that trehalose reduced 6-OHDA-induced apoptosis also in a 
time dependent manner. Flow cytometric analysis of DHR and MitoSOX stained cells 
confirmed that trehalose pretreatment significantly reduced oxidative stress and 
production of superoxide anion radical in 6-OHDA exposed cells. These results 
indicate that trehalose suppresses the formation of ROS and further protects from 6-
OHDA induced neuronal death and suggest further investigation on trehalose as a 
potential treatment in oxidative neuronal injury such as Parkinson’s disease. 
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We here investigated protective potential of nanoparticles graphene quantum dots 
(GQD) against neurotoxicity of sodium nitroprusside (SNP), NO-donor and 
antihypertensive drug widely used in studies of nitrosative stress-induced 
neurotoxicity. GQD prevented SNP-induced apoptosis, caspase activation and 
mitochondrial depolarization in SH-SY5Y neuroblastoma cells. GQD decreased SNP 
generated nitrite accumulation in supernatants, as well as NO/ONOO- concentrations 
in cells and cell-free medium. However, ONOO- and NO scavengers only slightly 
suppressed SNP neurotoxicity. Moreover, light exhausted SNP, incapable of producing 
NO, was toxic to SH-SY5Y cells, while GQD strongly reduced its neurotoxicity, 
suggesting that defensive effect of GQD far exceeded their NO scavenging activity. 
FeSO4 increased death of SH-SY5Y cells, while iron chelators decreased toxicity of 
iron-containing SNP. GQD neutralized SNP generated reactive oxygen species (ROS) 
production, particularly O2•− and •OH in both cells and cell-free condition. 
Neurotoxicity of SNP was suppressed in the presence of unspecific antioxidants, 
scavengers of •OH and lipid hydroperoxyl radicals, while it was increased with •OH 
generating superoxide dismutase (SOD). Intracellular localization of GQD was 
confirmed by transmission electron microscopy (TEM), while extensive washing of 
cells preincubated with GQD, only partly reduced their protective activity, suggesting 
that GQD exerted neuroprotective effect both intra- and extracellularly. Taken together, 
these results suggested that GQD protected neuroblastoma cells by neutralizing reactive 
nitrogen species (RNS) and ROS, predominantly •OH formed in Fenton reaction 
catalyzed by iron derived from SNP. Therefore, GQD might be promising choice for 
treatment of ROS/RNS-mediated neurodegenerative diseases. 
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Our previous results showed that the administration of methanolic oregano extract 
(MOE) to C57BL/6 mice treated with multiple low doses of streptozotocin (MLSD) for 
diabetes induction, reduced diabetes incidence and preserved normal insulin secretion. 
MOE acts as an antioxidant and immunomodulatory and in an anti-apoptotic manner 
resulting in the protection of mice from diabetes development. Here we studied MOE 
effects on antioxidant defense enzymes activity (superoxide dismutase (SOD), 
catalsase (CAT), glutatione peroxidase (GPx) and glutathione reuctase (GR)) in the 
liver of 8-12 weeks old male C57BL/6 mice treated with MLDS (40 mg/kg per day, 
intraperitoneally for five consecutive days; Sigma-Aldrich). MOE was administered for 
ten consecutive days by intraperitoneal injections at a dose of 5 mg/kg per day, starting 
from the day of MLDS induction (‘prophylactic’ regimen). MOE was also administered 
to healthy mice for 10 days, and antioxidant enzymes were evaluated 14 days from the 
beginning of the experiment. The control mice received the vehicle (PBS + dimethyl 
sulfoxide (DMSO)). Results showed that MLDS treatment induced total SOD activity 
elevation and a decrease of GPx activity suggesting the state of oxidative stress. MOE 
abolished MLDS effect on SOD activity, but was ineffective concerning GPx activity. 
Since MOE has potent in vitro antioxidant activity measured by DPPH scavenge test, 
it seems that its protective effect comes from radical scavenging activity. However, 
there is more than one compound responsible for the beneficial effect of MOE. 
Therefore, its protective action has to be considered as a multitasking on both cellular 
and tissue level. 
 
Friday, December 6th Session: INFLAMM/INFECT 
 
39 
 
Poster presentation 
POLYMORPHISMS IN GLUTATHIONE S-TRANSFERASE T AND M GENES 
MAY SERVE AS DETERMINANTS OF RISK IN APICAL PERIODONTITIS 
Aleksandar Jakovljevic1, Nadja Nikolic2, Jelena Carkic2, Miroslav Andric3, Maja 
Miletic1, Katarina Beljic-Ivanovic4, Jelena Milasin2 
1Department of Human Genetics, 2Laboratory for Basic Research, 3Department of Oral 
Surgery, 4Department of Restorative Odontology and Endodontics, School of Dental 
Medicine, University of Belgrade, Serbia 
 
Apical periodontitis (AP) represents an inflammatory process in periapical tissues 
characterized, among other, by the presence of oxidative stress. Glutathione S-
transferases are important antioxidant enzymes involved in the detoxification of 
endogenous or exogenous compounds such as reactive oxygen species (ROS). Deletion 
polymorphisms in glutathione S-transferase genes, leading to decreased enzymatic 
activity, have not been previously associated with apical periodontitis. Therefore, this 
study aimed to investigate glutathione S-transferase theta 1 and mu 1 (GSTT1 and 
GSTM1) polymorphisms as determinants of risk in apical periodontitis. One hundred 
and twenty AP lesions were collected following standard apicoectomy. Control group 
consisted of 60 healthy pulp tissues harvested after third molar extraction. Genotyping 
for GSTM1 and GSTT1 deletion polymorphisms was performed by real‐time PCR and 
melting curve analysis. Allele and genotypic frequencies, Hardy–Weinberg equilibrium 
(HWE) were calculated using the SPSS statistical software. Logistic regression analysis 
was used to calculate odds ratio (OR) and 95% confidence interval (CI). There was no 
evidence of deviation from HWE for any of the investigated polymorphisms within the 
groups (p>0.05). GSTM1 was deleted in 89 periapical lesions (74.2%) and in 31 
controls (51.7%). The presence of GSTM1 null genotype led to an over 2.5-fold risk 
increase for the development of chronic apical periodontitis (OR = 2.69, 95% CI = 1.40-
5.15, P = 0.003). GSTT1 gene was deleted in 72 periapical lesions (60%) and in only 2 
controls (3.3%). GSTT1 null genotype significantly affected the risk for the 
development of apical periodontitis (P < 0.001), leading to an over 40-fold increase 
(OR = 43.5, 95% CI = 10.14-186.59). Beside other factors, heredity may contribute to 
variable predisposition to AP pathogenesis. The present study has demonstrated that 
deletion polymorphisms in GSTT and GSTM increase the susceptibility for 
development of apical periodontitis. 
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The HCV is a major cause of chronic liver cirrhosis and hepatocellular carcinoma. 
While acute infection is usually asymptomatic and can be spontaneously cleared, 
approximately 50-80% of patients progress to chronic infection. The WHO estimates 
that 71 million people worldwide have chronic infection. Although, DAA (direct-acting 
antiviral) therapy is effective in around 95% of patients, universal access to diagnosis 
and treatment is very limited. Dissecting the nature of the immune response during 
HCV infection will aid vaccine development. HCV utilises different host factors to 
facilitate its cell entry, replication and propagation. Atypical PKCs (Protein Kinase C) 
direct the establishment of epithelia-specific junctional structures. These structures are 
composed of proteins such as claudin-1 and occludin, which are host factors required 
for HCV cell entry. Interferons are central to the regulation of the antiviral immune 
response with IFNα being the most abundant IFN released by numerous cell types 
following viral infection. In this study we have demonstrated that the atypical PKC 
isoform, PKC-ζ, is localised within the plasma membrane and at the cell:cell junctions 
of the Huh7 hepatocarcinoma cell line. PKC-ζ colocalises with adherens-junction and 
tight-junction proteins including claudin-1 and occludin. Inhibition of PKC-ζ activity, 
using a pseudosupstrate inhibitor, induced the relocation of PKC-ζ, claudin-1 and 
occludin to the cytosol and the disruption of cell:cell contacts. Furthermore, inhibition 
of PKC-ζ activity reduced the ability of HCV to infect Huh7 cells as demonstrated 
using a HCV in vitro cell culture system (HCVcc). We also demonstrated that IFNα 
induced the redistribution of PKC-ζ and directed a dynamic remodelling of cell:cell 
contacts through the translocation of PKC-ζ from the plasma membrane domain to the 
cytosol. Our findings reveal that PKC-ζ is a vital host cell factor required by HCV to 
enter and infect hepatocytes and identifies a novel antiviral mechanism employed by 
IFNα. 
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There is growing evidence supporting the hypothesis that immune hyperactivation and 
dysregulated cytokine production are involved in depression. Overexpression of 
inflammatory cytokines is associated with bad prognosis in major depressive disorder, 
whilst many recent studies show positive modulatory role of anti-inflammatory 
cytokines, such as IL-10 in psychiatric disorders. Moreover, converging experimental 
data suggest important role of endocannabinoids in depressive disorders. Aim of this 
study was to examine the effects of URB597. Male and female Wistar rats were 
exposed to the 6 weeks of chronic unpredictable stress (CUS) and treated 
intraperitoneally with either 0.3 mg/kg/day of URB597 or vehicle in the last 2 weeks 
of stress protocol. IL-6 plasma levels and IL-10 levels in spleen were examined using 
Elabscience ELISA kits. Animals of both genders which were subjected to the CUS 
developed significant spleen hypertrophy. URB597 prevented spleen hypertrophy in 
male, but not in female animals. Both male and female rats showed elevated plasma 
levels of IL-6 caused by CUS which were not affected by URB 597 treatment. In 
contrast, animals subjected to the CUS showed lower levels of IL-10 in spleen 
compared to the control animals. URB597 increased levels of IL-10 in males, but not 
in females. Our results suggest that URB597 may have potentially beneficial anti-
inflammatory effect in depression-induced inflammation through regulation of IL-10. 
However, this effect is sex-dependent and present only in males. 
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Efficacy of the immune response to vaccine depends on genetic background, sex and 
age of the recipient. However, mechanisms underlying this phenomenon have not been 
elucidated, yet. The study investigated influence of sex and age on serum IgG response 
to seasonal trivalent inactivated split inﬂuenza vaccine (TIV) in BALB/c and C57BL/6 
mice, and mechanisms underlying this response. Total serum IgG responses to 
influenza virus type A strains declined with aging, in a strain-specific manner. 
Consequently, strain differences (greater IgG responses in BALB/c mice) observed in 
young mice (three-month-old) were abrogated in old (eighteen-month-old) ones. 
However, irrespective of strain and age, females developed stronger influenza type A-
specific IgG responses than males. Despite age-related decrease in influenza B-specific 
serum IgG response, it was comparable between old BALB/c and C57BL/6 mice. The 
strain/sex-specific differences in age-related changes in the magnitudes of IgG 
responses to TIV correlated with those in number of germinal centre (GC) B 
splenocytes. These differences were related to those in B splenocyte and CD4+ 
splenocyte proliferation in culture upon restimulation with influenza viruses from TIV. 
The magnitudes of IgG responses also correlated to T follicular regulatory (Tfr)/T 
follicular helper and Tfr/GC B splenocyte ratios across all groups of mice. Aging, 
irrespective of influenza virus-specificity, affected serum IgG2a(c)/IgG1 ratios 
(reflecting IFN-γ/IL-4 production level ratio) in male BALB/c and female C57BL/6 
mice, respectively. Thus, although in young mice of both strains these ratios were 
comparable between sexes, in old females they were shifted towards IgG1 when 
compared with age-matched males. Consistently, the IFN-γ/IL-4 production level ratios 
in splenocyte cultures stimulated with influenza viruses from old females of both strains 
were shifted towards IL-4 compared with that in age-matched male cultures. The study 
stimulates further research to formulate sex-specific strategies to improve efficacy of 
influenza vaccine in elderly. (Funding: project 175050, MNTR RS)
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Immunomodulatory functions of periodontal ligament stem cells (PD-SCs) in the 
context of granulocytes (GRA) activity regulation have not been examined so far. 
Therefore, the aim of this study was to investigate how proinflammatory factors, 
significant for periodontal disease progression, modulate interactions between PD-SCs 
and GRA.  
As bacterial agents strongly activate innate immunity at the beginning of inflammatory 
reaction, first we analyzed potential ability of PD-SCs treated with lipopolysaccharide 
(LPS, E. Coli) to attract GRA through endothelial barrier. After 2h of incubation, by 
using transwell co-culture system, PD-SCs significantly reduced transendothelial 
migration (TEM) of GRA in vitro, while 72h pre-treatment with LPS (1000 ng/ml) did 
not affect this property of PD-SCs. Along with TEM, we examined the effect of PD-
SCs and their conditioned medium (CM) on GRA respiratory burst in vitro based on 
NBT reduction test. We showed that PD-SCs have potential to inhibit respiratory burst 
of GRA (both stimulated and unstimulated) after direct co-culture, while the effect of 
proinflammatory factors varied. Namely, no changes of PD-SCs action were detected 
after LPS (1000 ng/ml) and IL-17 (50 or 100 ng/ml) treatment, while TNF-α (1, 10 or 
20 ng/ml) amplified inhibitory functions of PD-SCs. Unlike direct co-culture tests, 
results related to the effects of CM on GRA (both stimulated and unstimulated) 
respiratory burst point out the inhibitory action of CM of PD-SCs pre-treated with TNF-
α (10 or 20 ng/ml). On the other hand, CM derived from control PD-SCs and PD-SCs 
treated with IL-17 or LPS did not change GRA activity.  
Considering the differences observed in direct co-culture and CM effects, these results 
indicate the existence of complex mechanisms in PD-SCs/GRA crosstalk. Moreover, 
the importance of the soluble factors present in microenvironment should be 
highlighted regarding their contribution in shaping the functional activity of PD-SCs as 
local regulators in inflammatory process.  
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The gut microbiota is necessary to establish an effective immune response, but also 
related to the onset of local and systemic inflammatory diseases of bonne tissue. Genus 
Lactobacillus is one of the main bacterial inhabitants of digestive tract, and we 
analysed, with in-house ELISA, titter and avidity of serum IgM, IgG, and IgA 
antibodies reactive with whole Lactobacillus plantarum and Lactobacillus reuteri, of 
25 periodontal disease (PD) patients without any systematic disease, 26 rheumatoid 
arthritis (RA) patients, and of 21 healthy people. In healthy people we found no 
correlation between titters of different immunoglobulin isotypes reactive with 
Lactobacillus spp. Moderate correlation between IgG and IgA titters was detected in 
PD and RA. Only in RA, the correlation between IgG and IgM, and IgA and IgM titters 
was found. No difference between the groups in titters and avidity of anti-Lactobacillus 
IgG and IgA was found. However, both titter and avidity of IgM antibodies reactive 
with any of two Lactobacillus species was lower in RA then in PD and in healthy 
people. We also observed that serum antibodies “discriminated” two Lactobacillus 
species. Thus, in healthy people and in PD patients titter and avidity of IgG to L. reuteri 
were of significantly lower values than those to L. plantarum. Besides, high correlation 
between titters of IgG antibodies against L. plantarum and L. reuteri was found in all 
groups, high correlation between titters of IgA antibodies to two Lactobacillus sp. was 
detected in PD and RA, and of IgM antibodies only in RA. The results showed that the 
serum anti-Lactobacillus antibodies reactivity in PD and RA patients differed of the 
reactivity observed in healthy people. This might reflect a disturbed immunoglobulin 
reactivity caused by disease-related hyper stimulation and/or a disorder in the gut 
microbiome level. The significance of the results remains to be elucidated. 
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Immune response to certain pathogens in calf bronchopneumonia is mediated by IgG 
antibody and immune complexes which they form. Whether these immune complexes 
will be effective in eliminating the pathogen or will initiate pathological response, 
depends on their size. In this study we investigated the size of circulating immune 
complexes (CIC) in three-month old calves with bronchopneumonia caused by 
Pasteurella multocida, using photon correlation spectroscopy (PCS). PCS is a method 
used for a detection of aggregates in therapeutic antibodies preparations, but also for 
detection and characterisation of CIC in humans and experimental animals. Heat 
aggregated IgG represent an in vitro analogue of CIC, and we first analysed if the heat 
aggregated calf serum IgG can be detected by PCS. Before the heating, in calf serum 
protein fraction enriched with IgG we observed only particles of 10 nm in diameter 
(diameter of native bovine IgG). After the heating, only large aggregates having 
diameter of 532 nm were detected. The result confirmed that calf CIC can be estimated 
by means of PCS. Using PCS, in a pooled, PEG-precipitated, CIC sample of healthy 
calves, six types of particles different in diameter were found, and among them particles 
with diameters of 220 nm and 615 nm were dominant. In a pooled CIC sample of 
diseased calves four types of particles were identified. Particles with diameters of 165 
nm and 1281 nm were dominant, and were approximately two (615 nm vs 1281 nm) 
and six times (220 nm vs 1281 nm) larger than the leading CIC particles of healthy 
calves. The measurement of electrokinetic potential confirmed that CIC of diseased 
calves were more stable than CIC of healthy calves. Whether the revealed increase in 
size and stability of CIC in calves with bacterial bronchopneumonia is of significance 
for their functionality remains to be analysed. 
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DECREASE IN BLOOD GLUCOSE LEVELS DUE TO VIRAL 
INFECTION PROMOTES INNATE-IMMUNE ANTI-VIRAL RESPONSE 
 
Marko Šestan1, Ante Benić1, Felix M Wensveen1 and Bojan Polić1 
 
1Department of Histology and Embryology, Faculty of Medicine, University of 
Rijeka, Rijeka, Croatia 
 
Viral infection has a major impact on systemic metabolism. We have recently 
shown that viral infection impacts endocrine regulation of systemic blood 
glucose levels (Šestan et al., Immunity 2018). However, it is not known how 
strength of infection reflects on blood sugar levels during infection, and if these 
changes are beneficial to the host. Here we investigated how different viral 
loads impact regulation of blood glucose levels. We showed that infection of 
mice with high, but non-lethal titers of mCMV or LCMV causes transient 
relative hypoglycemia. Low blood glucose levels were beneficial to the host as 
enforced hyperglycemia during infection resulted in significant increase in viral 
titers in peripheral organs. With LCMV, relative hypoglycemia was the result 
of IFNγ secretion by γδT cells, as δ deficient mice, and mice treated with anti-
IFNγ antibodies did not develop this condition. Using mice without expression 
of IFNγ receptor on myocytes, we showed that IFNγ causes insulin resistance 
in muscle, which causes compensatory hyperinsulinemia. This, in turn, impairs 
glycogen utilization as a source of blood glucose, resulting in low blood glucose 
levels. In vitro, we could show that low glucose concentrations in medium 
causes an increase in cellular stress, which made cells less receptive for viral 
replication and reduced viral titers. In summary, we found that infection with 
high, non-lethal titers of virus causes relative hypoglycemia. This causes 
systemic cellular stress, which makes the organism less receptive for viral 
replication. Thus, we speculate that reduced blood sugar levels during infection 
are part of body's natural response to infection. 
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APPLIED OMICS: INSIGHTS INTO THE PATHOGENESIS OF 
MULTIPLE SCLEROSIS 
 
Maja Jagodić 
 
Department of Clinical Neuroscience, Center for Molecular Medicine, 
Karolinska Institutet, Stockholm, Sweden 
 
Multiple Sclerosis (MS) is a chronic inflammatory disease characterized by 
autoimmune destruction of myelin and neurons in the central nervous system. 
Today, MS is one of the leading causes of neurological disability in young 
adults. Current treatments act broadly on the immune system and they are 
effective in controlling the inflammatory stage of disease while there are no 
treatments that prevent sustained neuronal loss and disease progression. 
Although the cause of MS remains unknown, vast epidemiological data 
establish MS as a complex disease influenced by genetic and environmental 
factors. Epigenetic mechanisms, such as DNA methylation, orchestrate activity 
of the genome in response to environmental cues and may provide better 
understanding of disease pathogenesis. One of the main challenges with 
studying diseases such as MS is the limited access to the target tissue - the 
brain. Recent progress in development of methods to survey epigenetic 
modifications, and from them infer genome activity, opened up possibilities to 
study brain tissue and mechanisms that underlie neuronal loss in MS patients. 
To understand the mechanisms of disease development and progression, we are 
utilizing unique clinical cohorts in combination with state-of-the-art methods 
to measure DNA methylation and transcription in discrete cell types, followed 
by functional studies in experimental models in-vitro and in-vivo.
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NUTRIGENOMICS AND INFLAMMATION 
 
Rosita Gabbianelli, Cinzia Nasuti, Donatella Fedeli, Laura Bordoni 
 
Unit of Molecular Biology, School of Pharmacy, University of Camerino, 
62032 Camerino (MC), Italy. 
 
Diet is one of the main factors that can impact gene expression and gut 
microbiota diversity and it provides the functional groups required for 
epigenome modulation.  
Starting from early life, the exposome (e.g. diet, xenobiotics, drugs, etc.) is 
responsible for specific epigenetics marks.  A maternal high fat diet and food 
pesticide exposure during the pre- and post-natal period of live can promote 
inflammatory responses in offspring that may influence organ development 
promoting a healthy/unhealthy phenotype in adulthood.  High protein and 
carbohydrate (e.g. fructose, glucose) intake in adult age can play a key role in 
the development of chronic low-grade systemic inflammation. Of particular 
concern is that epigenetic marks of diseases may be inherited, hence they can 
mediate epigenetic inheritance of diseases.  
In this context, nutrigenomics mediated by bioactive compounds and a 
balanced nutrient intake can actively control inflammation and maintain the 
cellular redox homeostasis. 
A summary of data on how and when nutrigenomics can modulate 
inflammatory responses through healthy dietary choices to prevent the main 
inflammatory-related metabolic diseases occurring across life will be 
presented. 
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THE IMMUNOMODULATORY EFFECTS OF POLYPHENOL RICH 
JUICE CONSUMPTION ON GENE EXPRESSION IN SUBJECTS AT CVD 
RISK 
Aleksandra Stankovic1, Ljiljana Stojkovic1, Manja Zec2 
1Laboratory for Radiobiology and Molecular Genetics, “Vinča” Institute of Nuclear 
Sciences, University of Belgrade, Belgrade 11000, Serbia 
2Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical 
Research, University of Belgrade, Belgrade 11000, Serbia 
 
Anthocyanins (ANTs) belonging to the flavonoids subclass of polyphenols, related to 
the prevention of the development of chronic diseases. The chronic inflammation is 
common in many complex diseases: metabolic syndrome, diabetes and cardiovascular 
diseases. In vitro and in vivo experiments in animals showed modulating effects of 
ANTs on cardiovascular risk factors such as central obesity, dyslipidemia, 
hyperglycemia and hypertension, which occurs simultaneously in cardio-metabolic 
disorders. Aim of the study was to delineate the effects of polyphenol-rich Aronia 
melanocarpa juice, daily consumption, on the transcriptome of PBMC (which have 
been used as common target in nutrition studies to reflect changes in metabolic 
inflammation) in subjects at moderate CVD risk (defined as the presence of at least one 
of the following: increased BMI, central obesity, high normal blood pressure or 
dyslipidemia). The present research is designed as a sub-study of the original three-
arm, crossover, randomized, double-blind, placebo-controlled study 
(ClinicalTrials.gov as NCT02800967). Three 4weeks treatments were: original Aronia 
juice (high dose of total polyphenol, 11771.09 mg gallic acid equivalents (GAE)/L); 
Aronia juice-based beverage (low dose of polyphenol, 2942.77 mg GAE/L); and 
placebo beverage. The microarray analysis was performed at two time points (before 
and after each treatment). Enrichment analysis of DEGs will be presented. The analysis 
revealed 10 Hallmark gene sets significantly enriched and upregulated after original 
Aronia juice consumption. Top 3 enriched gene sets were TNFA signaling via NFKB, 
apoptosis and inflammatory response, which is in line with findings of the current 
enrichment analysis of DEGs. The overlapping and non-overlapping significantly 
enriched biological terms among treatments were defined. In conclusion, daily Aronia 
juice consumption significantly affected transcriptome in subjects at moderate CVD 
risk after both, short-term and long-term treatments. Validation analysis of 
differentially expressed genes is in progress. 
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T CELLS AND STRESS - NOVEL REGULATORS OF OBESITY 
DEVELOPMENT 
Ivana Nikolić, Luis Leiva-Vega, Alfonso Mora, Aránzazu Pintor Chocano, 
María Elena Rodríguez Andrés, Magdalena Leiva, María Crespo-Ruiz, Marta 
Pulgarín-Alfaro, Marta León, Aikaterini Tsilingiri, Pilar Martin, Guadalupe 
Sabio 
1Myocardial Pathophysiology Area, Centro Nacional de Investigaciones 
Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain 
 
Obesity is currently a serious epidemic health problem associated with other metabolic 
disorders. The hallmark of obesity is inflammation, especially in adipose tissue (WAT), 
liver, pancreas and blood. Pro-obesogenic immune response is driven by pro-
inflammatory M1 macrophages, cytokines, Th1 and Th17 cells and reduced response 
of anti-inflammatory Th2 and regulatory T cells (Treg), especially in WAT. In addition, 
obesity promotes senescence of memory T cells and depletion of CD4+ cells protects 
against weight gain. p38 kinases (p38α, p38β, p38γ, p38δ), an important kinase family 
implicated in the transduction of stress signals into the cell, could be the key regulator 
of obesity development. Activated by kinases MKK3 and MKK6, p38s promote 
Th1/Th17 response and negatively regulate Treg cell induction. To clarify the role of 
p38s pathway in Treg and memory T cell development, and its role in obesity, we 
generated mice lacking MKK3/6 in CD4+ cells (MKK3/6CD4-KO). Our data showed that 
these mice have reduced number of CD4+ T cells, upregulated Treg cells in blood and 
reduced frequency of memory T cells with aging. After feeding an HFD, MKK3/6CD4-
KO mice had lower body weight and glucose level in blood. Furthermore, mice lacking 
MKK3/6 in CD4+ cells had higher energy expenditure, higher brown adipose tissue 
thermogenesis and less ectopic fat accumulation in liver. Our results suggest that mice 
lacking MKK3/6 in CD4+ T cells are protected against diet-induced obesity and T2D 
by improving their whole body metabolism. Further study will help us to decipher the 
molecular mechanism responsible for observed protective phenotype. These findings 
will allow us to create novel, cell specific therapeutics approaches to efficiently fight 
obesity and its related diseases. 
Grants: EFSD Rising Star Fellowship, EFSD/Lilly Young Investigator Award, 
EFSD/Lilly Research Fellowship Programme, CNIC IPP FP7 Marie Curie Programme 
(PCOFUND-2012-600396), ERC 260464, EFSD/Lilly European Diabetes Research 
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IS METAFLAMMATION A USUAL SUSPECT  
FOR FRUCTOSE-INDUCED METABOLIC DISTURBANCES? 
Nataša Veličković, Danijela Vojnović Milutinović, Jelena Brkljačić, Ana Teofilović, 
Biljana Bursać, Marina Nikolić, Ljupka Gligorovska, Sanja Kovačević, Gordana Matić, 
Ana Djordjevic 
Department of Biochemistry, Institute for Biological Research “Siniša Stanković”, 
University of Belgrade, Belgrade, Serbia 
Fructose overconsumption, especially in the form of sweetened beverages, has been 
linked to development of obesity, insulin resistance, dyslipidemia and type 2 diabetes. 
In rodents, high-fructose diet leads to hypertriglyceridemia, ectopic fat deposition and 
insulin resistance. Metabolically triggered inflammation (metaflammation) is now 
recognized as a link between nutrient signals and insulin resistance and considered as 
usual suspect for metabolic disturbances. Metaflammation usually evolve from visceral 
adipose tissue, progresses to liver and brain strucures, and results in peripheral insulin 
resistance, lipid accumulation and oxidative stress. Hence, the aim of our study was to 
investigate metaflammation as a trigger for fructose-induced metabolic disturbances. 
Experiments were performed on male Wistar rats fed with different concentrations of 
liquid fructose (10, 20 and 60%) during 9 weeks. Physiological and biochemical 
parameters, hepatic and brain inflammation, indicators of peripheral and systemic 
insulin resistance, as well as hepatic lipogenesis and oxidative stress were examined. 
The results demonstrated that fructose-enriched diet generally led to increased 
proinflamatory cytokines in the liver, hippocampus and hypothalamus, and to 
stimulated activation of proinflamatory kinases NFκB and JNK, while it did not change 
the expression of inflammasome component NLRP3, toll-like receptor 4 or anti-
inflammatory cytokines in the liver. The observed metabolic inflammation was 
accompanied with impaired glucose tolerance after 10 and 20% fructose-enriched diet, 
while decreased hepatic insulin sensitivity, hypetriglyceridemia and increased 
expression of hepatic lipogenic genes were observed after all fructose diets. The 
treatment of fructose-fed rats with chronic unpredictable stress annulled the effects of 
fructose on hepatic and hypothalamic inflammation and glucose tolerance, but did not 
alter fructose-induced effects on lipogenesis and insulin signaling. The results suggest 
that fructose-induced metaflammation and systemic insulin resistance are closely 
interconnected, while the link between inflammation and other metabolic disturbances 
could still be a matter of debate.  
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PROPHYLACTIC TREATMENT BY BANANA LECTIN INFLUENCES THE 
IMMUNE RESPONSE IN THE PEAK OF EXPERIMENTAL COLITIS 
Radmila Miljković1, Ivana Lukić1, Emilija Marinković1, Ana Kovačević1, Mina 
Popović2, Zorana Lopandić3, Marija Gavrović-Jankulović3, Marijana Stojanović1 
1Department of Research and Development, Institute of Immunology, Virology, 
Vaccines and Sera – Torlak, Belgrade, Serbia 
Department of Ecology and Techoeconomic, Institute of Chemistry, Technology and 
Metallurgy, University of Belgrade, Belgrade, Serbia 
Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Belgrade, 
Serbia 
Banana is highly abundant in everyday nutrition and it is recommended to be a part of 
the diet with patients suffering from inflammatory bowel diseases. A mannose-specific 
banana lectin (BanLec) is reported to be a potent immunomodulator. Our aim was to 
explore the prophylactic impact of BanLec in a murine model of colitis. A recombinant 
BanLec (rBanLec) that possesses structural and functional characteristics similar to 
naturally occurring counterparts was used in the research. Colitis was induced (day 0) 
in C57BL/6 mice by 2,4,6-trinitrobenzene sulfonic acid (TNBS; 3.5 mg/ml TNBS / 
50% ethanol, 100 μl intrarectal). 24h prior to the induction of colitis, mice were treated 
(100 μl, intrarectal) by 0.1 μg/ml (rBL0.1), 1 μg/ml (rBL1) and 10 μg/ml (rBL10) 
rBanLec/PBS. Mice subjected to colitis induction without rBanLec pretreatment (PC) 
were referent. The impact of rBanLec pretreatment was assessed at the peak of the 
disease (day 2). Body weight loss was taken as a main parameter for estimation of 
disease severity. A significant reduction in disease severity was noticed in rBL0.1 
group and it correlated with lower leukocyte infiltrations in the colon. Nevertheless, 
inflammation-related parameters (MPO activity, production of NO, IL-12 and TNFα) 
were significantly lower in colons of rBL0.1 group compared to rBL1, rBL10 and PC 
groups. Levels of regulatory cytokines (IL-10, TGFβ) were the highest in the colons of 
rBL0.1 group. Local activities of antioxidant enzymes (CAT, SOD, GST) were also 
significantly increased in rBanLec-pretreated groups, especially in rBL0.1 group.  
Presented results show that local stimulation by low dose of rBanLec prior to colitis 
induction reduces the severity of the disease. Observed positive impact resulted from 
the stimulation of local regulatory and antioxidant mechanisms that alleviate harmful 
proinflammatory response. (Supported by Ministry of Education, Science and 
Technological Development Republic of Serbia, Grant no. 172049)
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INFLAMMATION AND INSULIN SENSITIVITY IN THE LIVER OF 
FRUCTOSE-FED Mif DEFICIENT MICE  
 
Ljupka Gligorovska1, Ana Teofilović1, Nataša Veličković1, Danijela Vojnović 
Milutinović1, Sanja Kovačević1, Gordana Matić1 and Ana Djordjevic1 
 
1Institute for Biological Research "Siniša Stanković"- National Institute of 
Republic of Serbia, University of Belgrade, Serbia 
 
Introduction: The macrophage migration inhibitory factor (MIF) is a key pro-
inflammatory mediator involved in the regulation of energy metabolism and metabolic 
inﬂammation in the liver. Fructose overconsumption has been previously associated 
with development of low-grade inflammation characterized by elevated production of 
pro-inflammatory cytokines and activation of mitogen-activated protein kinase 
(MAPK) signaling pathway. The inflammatory response can disrupt insulin signaling 
and genetic deletion of Mif may contribute to the development of systemic insulin 
resistance, as well. The aim: The aim of the present study was to elucidate combined 
effects of Mif deficiency and fructose-enriched diet on metabolic inflammation and 
insulin sensitivity in the liver of male mice. Methods: Wild type (WT) and Mif deficient 
(MIF−/−) C57Bl/6J mice were used to analyze the effects of 9-week 20% fructose-
enriched diet on indicators of insulin sensitivity and markers of metabolic inflammation 
(tumor necrosis factor α (TNFα), interleukin (IL)-1β and IL-6). Deregulation of Akt 
signaling pathway was used as hallmark of hepatic insulin resistance. Also, the protein 
levels of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase 1 (JNK) 
and p38 were analyzed. Results: Mif deficient animals exibited elevated expression of 
IL-1β and IL-6 in the liver, regardless of the diet regime, while hepatic TNFα was 
unchanged in all animals. On the other hand, both total and phosphorylated ERK and 
JNK protein levels were decreased in all fructose-fed mice. In the same animals, 
impaired hepatic insulin signaling, revealed by decreased pAkt and total Akt protein 
levels, was observed. Conclusion: Although, Mif deficiency led to upregulation of pro-
inflammatory cytokines, fructose diet did not aggravate this effect. On the other hand, 
insulin signalling was diminished by fructose feding independently of Mif deficiency. 
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AN ANTI-DIABETIC DRUG, DIPEPTIDYL PEPTIDASE 4–INHIBITOR 
INDUCE TOLEROGENIC ILT4-EXPRESSING HUMAN DENDRITIC 
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Marija Drakul1, Marina Bekić2,3, Miloš Vasiljević1, Dragana Vučević3, Sergej 
Tomić2,3, Miodrag Čolić1,2,3 
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Dipeptidyl peptidase (DPP)-4 inhibitor belong to a class of anti-hyperglycemic agents 
indicated for patients with type-2 diabetes. In addition to glucose-lowering effects, 
emerging data suggests that DPP4 inhibitors could display anti-inflammatory effects as 
well, but the molecular and immunological mechanisms of these actions are 
insufficiently investigated. Using a model of human monocyte-derived dendritic cells 
(MoDC), which are the key immune regulatory cells we investigated how non-toxic 
concentrations of Sitagliptin (250 µg/ml) affect DC properties, morphology, 
differentiation and maturation potential, as well as the capacity to modulate T cell-
mediated immune response in vitro. We found an inhibited DC differentiation, 
according to CD14/CD1a co-expression analysis, after the differentiation of MoDC in 
the presence of sitagliptin. These results correlated with a weak maturation capacity of 
sitagliptin-treated MoDC upon stimulation with LPS/IFN-γ and their lower capacity to 
stimulate T cell proliferation in co-culture, compared to control MoDC. Moreover, 
sitagliptin-treated MoDC displayed a higher expression of immunoglobulin like-
transcript (ILT) 4 tolerogenic marker and produced significantly more TGF-β. In co-
culture with T cells, sitagliptin-treated MoDC potentiated Th2 polarization and induced 
a higher percentage of CD4+CD25highFoxp3+TGF-β+ regulatory T cells, compared to 
corresponding control MoDC. Interestingly, CD4+CD25highFoxp3+ Tregs induced by 
sitagliptin-MoDC also displayed a high expression of CD127, suggesting their memory 
Treg phenotype. Our results suggest for the first time that DPP4 inhibitor can induce 
tolerogenic properties in DCs, which could explain some of the anti-inflammatory 
actions observed for DPP-4 inhibitors. Besides glucose lowering effects, these 
tolerogenic properties DPP-4 inhibitors, could be beneficial for prevention of 
microvascular and macrovascular complications in diabetic patients, but also in the 
therapy of inflammatory diseases. 
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THE EFFECTS OF FISH OIL INTAKE ON SOME IMMUNOLOGICAL 
AND ANTIOXIDATIVE PARAMETERS IN DM2 PATIENTS 
Tamara Popovic1, Rasic Zorica2, Borozan Suncica3, Marija Takic1, Marija 
Glibetic1 
1Institute for medical research University of Belgrade 
2University Clinical Center Zemun  
3Faculty of Veterinary Medicine 
 
High density lipoprotein (HDL)-cholesterol and has been linked to vascular disease and 
diabetes. HDL also has antioxidative, anti-inﬂammatory, and antithrombotic properties. 
HDL-associated PON1 is primarily responsible for the properties of HDL in retarding 
the oxidation of LDL. The objective of this study was to determine the effect of fish oil 
consumption on antioxidative capacity of HDL-cholesterol by measuring erythrocyte 
activity of antioxidant enzymes [catalase (CAT), superoxide dismutase (SOD), 
glutathione peroxidase (GSH-Px) and PON1], parameter of oxidative stress, also 
measuring fasting blood lipids, glucose, insulin, creatinine, high sensitivity C-reactive 
protein (hsCRP) and HbA1c.  
Twenty patients (12 females, 8 males, mean age 53±6) received daily 4g natural fish 
oil (1.2g n-3 fatty acids; 20:5n-3 [EPA] and 22:6 n-3 [DHA]) during 12 weeks. 
The blood samples were taken before and at the end of the twelve weeks n-3 PUFAs 
intervention period. The fasting blood lipids, glucose, insulin, creatinine, high 
sensitivity C-reactive protein (hsCRP) and HbA1c were assessed from the same blood 
samples with a conventional autoanalyzer. Blood samples were taken after 12h of 
overnight fasting. Serum CRP levels were measured using a highsensitivity CRP (hs-
CRP) assay. The assay was able to detect a minimum hs-CRP concentration of 0.175 
mg·L -1.  
After supplementation with n-3 PUFAs HbA1c was improved, and not significant 
improve in glucose level, HOMA-IR and HOMA-beta. The level of HDL-C improved 
with borderline significance, by 19% (p ˂0.05). There was no significant improvement 
of hsCRP level after intervention, although there was a trend to decreased 17.5% 
(p=0.20) compared to baseline levels. The level of SOD improved significantly, 
increased by 23.5% (p=0.04). We demonstrated signiﬁcant improvement in PON1 
activity (p=0.01), it was increased by ~ 105 %, as well as HDL-C corrected PON1 
activity or PON/HDL-C ratio, increased by ~ 95 % (p=0.01). 
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AUTOIMMUNITY AND AUTOINFLAMMATION IN PRIMARY 
IMMUNODEFICIENCY 
Mario Abinun 
Emeritus Consultant in Paediatric Immunology, Great North Children's Hospital  
Associate Lecturer, Translational and Clinical Research Institute, Faculty of Medical 
Sciences, Newcastle University, Newcastle upon Tyne, UK  
Besides conventional primary immunodeficiency disorders (PID) characterized by 
increased susceptibility to various infectious agents, the current classification of 
monogenic inborn errors of immunity (IEI) includes an increasing number of diseases 
of immune dysregulation characterized by autoimmunity, autoinflammation, allergy 
and malignancy (Picard C et al, 2018). Next generation sequencing techniques used for 
identifying mutations in genes involved in the innate and adaptive immunity played a 
major role in this progress. Both gain-of-function (GOF) and loss-of-function (LOF) 
mutations causing a number of novel monogenic autoimmune and autoinflammatory 
disorders have been recently reported (e.g. STAT1 and STAT3 GOF, CTLA4 
haploinsufficiency, LRBA deficiency, PIK3CD and PIK3R1 GOF, otulin deficiency, 
RIPK1 deficiency, etc.).  
As a number of the genes affected by GOF mutations also harbor LOF alleles, these 
‘experiments of nature’ lead to a vast diversity of both the immunological and clinical 
phenotypes, mirroring the diversity and pleiotropy of the underlying genotypes. 
Clinical features are extremely variable, and can include systemic inflammation (fever 
and raised inflammatory markers), joint (arthralgia, inflammatory arthropathy) and skin 
involvement (vasculitis, vasculopathy, eczema, granulomas, blisters, panniculitis), 
interstitial lung disease, lymphadenopathy, hepato- and splenomegaly, inflammatory 
bowel disease (early onset severe enteropathy, colitis), organ specific autoimmunity 
(cytopenias, endocrinopathies), and presence of autoantibodies.  
I will review the option of specific targeted therapies (such as JAK- and P110delta-
signaling inhibition, etc.), developed in parallel to and as a result of better 
understanding of the underlying pathophysiology (Forbes LR et al, 2018), as well as 
our experience with allogeneic haematopoietic stem cell transplantation for the most 
severely affected patients, which are often resistant to these ‘precision’ therapies 
(Slatter MA et al, 2016; Nademi Z et al, 2017; Leiding JW et al, 2018; Greco R et al, 
2019). 
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PRIMARY IMMUNE DEFICIENCY AND CANDIDIASIS FROM BENCH 
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Desa Lilić 
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Institute of Cellular Medicine, Newcastle University, United Kingdom 
Candida is an opportunistic yeast causing infection in permissive circumstances, either 
secondary to recognized causes (e.g. tissue maceration) or due to immune gene 
mutations leading to Primary Immune Deficiencies (PIDs). Chronic Mucocutaneous 
Candidiasis (CMC) is persistent Candida infection of skin and mucous membranes, 
due to impairment of the STAT3/interleukin-17 pathway as a consequence of primary 
genetic defects of the immune system.  
CMC may present 1) as part of broader immune defects (e.g. SCID), when it is 
accompanied by an array of other infections; 2) as part of defined syndromes (e.g. 
Hyper IgE - HIES); or as isolated disease (CMC disease - CMCD, see below). In 2011, 
in CMCD patients, we (N Engl J Med) and others (J Exp Med) identified a STAT1 
gain-of-function (GOF) genetic mutation leading to downregulation of the 
STAT3/interleukin 17 pathway, found in >50% of all CMCD patients. The other major 
group of CMCD patients present with the Autoimmune Polyendocriopathy Syndrome 
type 1 (APS1) due to a genetic defect of the Autoimmune Regulator (AIRE) gene 
resulting in defective thymic clearance of autoimmune T cells, where we and others 
identified (JEM 2011) autoantibodies to IL-17 leading to CMC.  
In a recent collaborative review of 276 patients (Blood 2016) we reported that GOF-
STAT1 CMCD is a life-limiting condition with serious infectious, autoimmune and 
malignant complications. Diagnosis of GOF-STAT1 CMCD requires confirmation of 
pathogenic STAT1 mutations resulting in STAT1 hyperactivity (hyparphosphorylation 
& increased gene transcription). In APS1, anti-IL-17 antibodies have sensitivity and 
specificity of >98% mostly eliminating the need for complicated genetic confirmation. 
Unfortunately, these tests are still mostly available only in research laboratories. 
Defining the pathogenesis of GOF-STAT1 and APS1 CMCD has enabled new, bold 
therapeutic approaches including JAK-STAT inhibitors, anti-cytokine antibodies and 
bone marrow transplantation. PIDs are paramount in elucidating immune system 
function in both health and disease.  
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PRIMARY IMMUNODEFICIENCY DISEASES WITH DEFICIENT 
ANTIBODY PRODUCTION IN CHILDREN 
 
Srđan Pašić1 
 
1Mother and Child Health Institute, Belgrade, Serbia   
 
Primary immunodeficiency diseases (PID) represent a group of inherited disorders of 
immune system with unusual susceptibility to various infections. Among PID, 
disorders of deficient antibody production are the most common.  
In 1950, Ogden Bruton recognized X-linked agammaglobulinemia (XLA) in a 9-year-
old boy with recurrent pneumococcal infectons. Later on, it was found that XLA is due 
to mutations of Bruton tyrosin kinase (btk), an enzyme which is important for 
development of mature B-cells in bone marrow. The children with XLA suffer from 
repeated respiratory infections with incapsulated bacteria. Repeated infections lead to 
bronchiectasis and chronic lung diseases.  Intravenous immunoglobulin treatment, 
which was introduced in 80’, is highly effective in preventing recurrent bacterial 
infections in these patients.  
Common variable immunodeficiency (CVID) represents a group of heterogeneous 
immune disorders characterized by defect in antibody production. An incidence range 
from 25,000-50,000. It may develop as early as 2 years of age, with peak incidence in 
the third decade of life. In contrast to XLA, CVID is frequently associated with 
autoimmune disorders such as autoimmune cytopenias, autoimmune hepatitis, 
thyreoditis, rheumatoid arthritis, etc. Also, patients with CVID may develop malignant 
lymphomas. These patient also suffer from recurrent infections, and regular IVIG 
supstitution is necessary in prevention.  
Selective IgA deficiency (sIgAD) is the most common PID in humans. It occurs with a 
frequency of 1:700-18,000 in different populations. Patients sIgAD may be healthy or 
present with recurrent infections. Also, allergic and autoimmune diseases can be 
associated with sIgAD. If associated with subclass IgG deficiency, development of 
bronchiectasis is consequence of repeated infections. These patients require IVIG 
replacement therapy. 
In conclusion, PID with deficit of antibody production are common. IVIG replacement 
therapy is of vital importance preventing infections and chronic lung disease. Also, 
treatment with antibiotics is important in acute infections. In CVID, treatment of 
autoimmune phenomena requires the use of immunosuppressive drugs. 
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THE MANY FACES OF HEREDITARY ANGIOEDEMA 
Slađana Andrejević 
Clinic of Allergy and Immunology, Clinical Center of Serbia, Belgrade, Serbia 
School of Medicine, University of Belgrade, Serbia 
 
Patients with hereditary angioedema (HAE) have episodic swellings that can 
affect any part of the body. Most episodes result in reversible disability lasting 
1–5 days. Studies in the early 1960s established that the fundamental defect in 
HAE was a deficiency of C1 inhibitor (C1INH). In the case of type I HAE, 
C1INH protein levels are low, whereas type II HAE is associated with reduced 
C1INH function due to a dysfunctional protein. Subsequent studies proved that 
type I and type II HAE resulted from mutations in the gene encoding C1INH, 
SERPING1. Until now more than 450 different mutations of SERPING1 gene 
have been reported. In 2000, two groups independently described families with 
HAE in which the affected subjects had entirely normal C1INH levels and 
function. When initially described, HAE with normal C1INH levels was called 
type III HAE, but it has become increasingly clear that type III does not 
represent a single type of HAE. In 2006 it was discovered that some families 
with HAE with normal C1INH levels had mutations in exon 9 of the 
coagulation factor XII (F12) gene that were shown to cause enhanced 
susceptibility of the contact system to become activated. Yet, only 20% of 
patients with HAE with normal C1INH levels in Europe have a F12 mutation. 
In 2018 a novel mutation in the angiopoietin 1 gene (ANGPT1) was identified 
in an Italian family with HAE. Another group has recently discovered a 
mutation in the plasminogen gene identifying a fourth type of HAE with normal 
C1INH levels. The most recent finding is kininogen 1 gene mutation that 
change N-terminal site of bradykinin. Our understanding of the basic biology 
of angioedema has dramatically expanded over recent years. Moreover, new 
insights into the pathophysiology of angioedema enabled therapies that 
changed the life of patients with HAE. 
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COMMON VARIABLE IMMUNODEFICIENCY: 18-YEAR FOLLOW-UP 
OF PATIENTS IN CLINICAL CENTER OF SERBIA 
 
Radovan Mijanovic1.2 
1Clinic of Allergy and Immunology, Clinical Center of Serbia, Belgrade, Serbia 
2Faculty of Medicine, University of Belgrade, Belgrade, Serbia 
 
Introduction: Common variable immunodeficiency (CVID) is heterogeneous syndrome 
characterized by hypogammaglobulinemia, defective antibody production, recurrent 
bacterial infections and presence of various immune disorders.   
Material and Methods: The demographics, immunologic parameters, medical 
complications, pulmonary function tests and mortality statistics from 51 patients with 
CVID followed during 18 years (1998-2016; median 11±10,03) in Clinic of allergy and 
immunology, Clinical Center of Serbia, Belgrade, Serbia were analyzed in this study. 
Results: The average age at diagnosis of CVID patients was 33 (10-68) years and the 
median delay in diagnosis was 6 (0-31) years. At the time of diagnosis median 
immunoglobulin (Ig) G level was 2.09, IgA: 0.2 and IgM 0.22 g/L. The commonest 
non-infectious complications were chronic lung disease in 52.9%, splenomegaly in 
47.0%, bronchiectasis in 35.3%, hepatomegaly in31.4%, lymphadenopathy in 31.4% 
patients. Pernicious anemia was diagnosed in 16%, cytopenias in 13.7%, enteropathy 
in 11.8%, granuloma in 9.8% and lymphoma in 5.9% patients. The most frequent 
clinical manifestations prior to diagnosis of CVID were pneumonias in 85.1%, sinusitis 
in 68.6% and bronchitis in 47.1% patients. Infections were most often caused by S. 
pneumoniae, H. influenzae, Pseudomonas a. and Giardia lamblia. Males and females 
were affected equally by CVID, but in our group females were found to be older (53.5 
vs. 41 years; p= 0.034) than males. 5-years survival rate in CVID patients was 91.4%. 
Mortality of this group of patients during 18 years follow-up was 25.5%. The most 
common causes of death were sepsis and respiratory failure. Reduced survival was 
associated with the delay in the diagnosis, initial high serum IgM levels and damaged 
lung function. 
Conclusion: This is the first study of adult patients with CVID in Serbia that determined 
the spectrum of clinical manifestations, demographic and immunological 
characteristics, prognostic markers and disease outcome. 
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THE ASSOCIATION BETWEEN SNP RS3212227 IN IL12B GENE AND 
COMMON VARIABLE IMMUNODEFICIENCY IN SERBIAN 
POPULATION 
Vladimir Perovic1, Dijana Perovic2, Dusan Popadic1, R. Mijanovic3, B. 
Bonaci-Nikolic3 
 
1Institute of Microbiology and Immunology, Faculty of Medicine University of 
Belgrade 
2Institute of Human Genetics, Faculty of Medicine University of Belgrade 
3Clinic of Allergy and Clinical Immunology, Clinical Center of Serbia 
 
Introduction: Common variable immunodeficiency disease (CVID) is a primary 
immunodeficiency characterized by impaired production of antibodies and increased 
susceptibility to infections. The variety in clinical presentation and genetic 
heterogeneity among patients with CVID represents considerable diagnostic challenge. 
The increasing body of evidence showed that genetic variants of cytokine genes may 
be involved in dysfunctional immune response in CVID. Genes IL12A and IL12B are 
encoding proinflammatory cytokine IL-12 which regulate cellular and humoral 
immunity. Considering important role of IL-12 in immune response, we investigated 
potential association between single nucleotide polymorphism (SNP) in IL12B 
+1188A>C (rs3212227) and CVID pathogenesis. 
Materials and Methods: This study included 35 CVID patients and 250 healthy controls. 
Genotyping for IL12B +1188A>C was performed using TaqMan® genotyping SNP 
assays. 
Results: Analysis revealed significant difference in allele and genotype distribution of 
polymorphism rs3212227 between controls and patients with CVID. In patients there 
was increased frequency of C allele (p=0,002) with odds ratio (OR) 2.32 and 95% 
confidence interval (95%CI) 1.35-3.99. Also, the frequency of CA genotype was 
significantly increased in patients (p=0.01; OR=2.50 95%CI=1.22-5.11), while AA 
genotype was more frequent in controls (p=0.02; OR=0.33, 95%CI=0.16-0.68). 
Conclusions:  This study indicates that polymorphisms in gene coding IL12B could 
have role in CVID susceptibility but our finding has to be confirmed in larger cohorts.
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INFLAMMATORY NEURODEGENERATION IN MULTIPLE 
SCLEROSIS 
 
Diego Centonze 
 
1Laboratory of Synaptic Imunopathology, Tor Vergata University, Rome, Italy 
2Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy 
 
Neurons in the central nervous system are organized in functional units 
interconnected to form complex networks. Acute and chronic brain damage 
disrupts brain connectivity producing neurological signs and/or symptoms. In 
several neurological diseases, particularly in Multiple Sclerosis (MS), 
structural imaging studies cannot always demonstrate a clear association 
between lesion site and clinical disability, originating the "clinico-radiological 
paradox." The discrepancy between structural damage and disability can be 
explained by a complex network perspective. Both brain networks architecture 
and synaptic plasticity may play important roles in modulating brain networks 
efficiency after brain damage. In particular, long-term potentiation (LTP) may 
occur in surviving neurons to compensate network disconnection. In MS, 
inflammatory cytokines dramatically interfere with synaptic transmission and 
plasticity. Importantly, in addition to acute and chronic structural damage, 
inflammation could contribute to reduce brain networks efficiency in MS 
leading to worse clinical recovery after a relapse and worse disease progression. 
This evidence suggests that removing inflammation should represent the main 
therapeutic target in MS. Moreover, as synaptic plasticity is particularly altered 
by inflammation, specific strategies aimed at promoting LTP mechanisms 
could be effective for enhancing clinical recovery. Better knowledge of features 
inducing neuronal degeneration and brain disconnection in MS is crucial to 
design specific strategies to promote recovery with increasingly tailored 
approach. 
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NEUROFILAMENT LIGHT CHAIN LEVELS AND OLIGOCLONAL IgG 
BANDS - POTENTIAL BIOMARKERS IN MULTIPLE SCLEROSIS 
 
Jelena Drulović 
Clinic of Neurology, Clinical Center of Serbia, Faculty of medicine, University 
of Belgrade, Belgrade, Serbia 
 
Multiple sclerosis (MS) is a disabling disorder of the central nervous system 
characterised by immune-mediated demyelination and neurodegeneration. 
Significant effort has been made during the last decades to identify biomarkers 
for MS that may improve disease diagnosis and predict disease progression and 
activity. Neurofilaments (Nf) are structural elements of neurons, composed of 
three Nf chains (light, medium and heavy), which are released in the 
extracellular space following neuronal death. Therefore, Nf are considered a 
candidate biomarker of ongoing neurodegeneration. It has been demonstrated 
that serum Nf light chain correlates with concurrent and future clinical and MRI 
measures of disease activity and severity. High serum neurofilament light chain 
levels are associated with both brain and spinal cord volume loss. Cerebrospinal 
fluid (CSF) IgG oligoclonal bands are one of the crucial findings for 
establishing the diagnosis of MS, according to the new 2017 criteria. 
Additionally, they are known to play prognostic roles in patients with clinically 
isolated syndrome (CIS), and patients with positive oligoclonal bands are at 
higher risk for MS independently of other covariates present at the time of the 
CIS event. Also, in patients with radiologically isolated syndrome (RIS), 
oligoclonal bands have been demonstrated to be independent predictors of later 
conversion to CIS and MS. Similar to high CSF Nf light chain levels, the 
presence of oligoclonal bands was shown to be associated with shorter time to 
CIS and MS compared to individuals without oligoclonal bands. Evidence that 
serum and CSF Nf light chain levels and oligoclonal IgG bands may serve as 
diagnostic, prognostic and monitoring biomarkers in MS is progressively 
increasing. 
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THE GUT-BRAIN AXIS IN CNS AUTOIMMUNITY 
 
Gurumoorthy Krishnamoorthy 
 
Research group Neuroinflammation and mucosal Immunology, Max Planck 
Institute of Biochemistry, Martinsried, Germany 
 
Autoimmunity results from a combined influence of genetic and environmental 
factors. Emerging evidence in the experimental models of autoimmunity 
suggests an important contribution of gut microbiota in the disease 
development. However, how and which gut microbial species are involved in 
triggering processes is poorly understood. In this presentation, I will present 
evidence for the role of gut microbiota in mouse models of Multiple Sclerosis, 
an autoimmune disease of the central nervous system. Microbial organisms 
may trigger the activation of CNS-specific, auto-aggressive lymphocytes either 
through molecular mimicry or via bystander activation. This presentation will 
also highlight the approaches we are taking to translate these findings to MS 
patients. 
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NEUROIMMUNOLOGY OF ZBTB20 TRANSGENIC MICE 
 
Aleksandar Markovski, Iliyan Manoylov, Andrey Tchorbanov 
 
Laboratory of Experimental Immunology, Department of Immunology, Institute 
of Microbiology, Academy of Sciences, Sofia, Bulgaria 
 
Zinc ﬁnger- and BTB domain-containing protein 20 (ZBTB20) is a member of 
the BTB/POZ family of nuclear DNA-binding proteins and functions as a 
transcriptional repressor. In the immune system, ZBTB20 promotes plasma cell 
differentiation and longevity and regulates antibody response towards different 
stimuli.  
Astrocytes are glial cells in the CNS (central neural system), responsible for the 
maintenance of the blood–brain barrier (BBB) integrity and form a boundary, 
that restricts entry of metabolites and peripheral immune cells into the CNS. 
ZBTB20 regulates astrocytogenesis in the developing brain and we 
hypothesize, that its’ knockout may lead to abnormal BBB formation. This 
might have an impact on the organism and lead to autoimmune 
neuroinflammatory conditions. The purpose of this study is to examine the 
distribution, mitotic and secretory activity of immune cells in different 
compartments of the body in a transgenic mouse strain of 129/Sv ZBTB20 +/+, 
+/- and -/-  in comparison to other mouse strains. 
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THE ROLE OF IgG IN PATHOPHYSIOLOGY OF AMYOTROPHIC 
LATERAL SCLEROSIS 
 
Dunja Bijelić1, Katarina Milićević1, Irena Živković2, Zorica Stević3, Milena 
Milošević1, Pavle Andjus1 
1Center for Laser Microscopy, Faculty of Biology, University of Belgrade, Studentski 
trg 3, 11000 Belgrade, Serbia 
2Immunology Research Centre “Branislav Jankovic ”, Institute “Torlak”, Vojvode 
Stepe 458,11158 Belgrade, Serbia 
3Clinic of Neurology, School of Medicine, University of Belgrade, Dr Subotića 
starijeg 6, 11000 Belgrade, Serbia 
Amyotrophic lateral sclerosis (ALS) is an adult-onset disease, characterized principally 
by progressive degeneration of upper and lower motoneurons. Since numerous studies 
described perturbed processes in other cell types as well, the disease is considered 
multifactorial and multi-systemic. The role of the immune system in ALS pathology is 
still obscure, especially in the early stages, but with the disease progression, strong 
neuroinflammation is evident. Over the years, different groups reported antibodies 
reactive to various motoneuronal structures, and recent study suggested that prolonged 
and sustained intraperitoneal injection of ALS patients’ sera induced the experimental 
motor neuron disease model in mice. Glycosylation patterns of ALS IgG and their 
potential use as biomarkers are also currently in focus. Some of the early work done by 
our group demonstrated that in cultured rat hippocampal neurons ALS IgG suppressed 
KCl-induced [Ca2+]i  rise through P/Q- type calcium channels, and later on, that they 
increased the frequency of spontaneous excitatory postsynaptic currents. Thereafter, as 
our focus shifted to astrocytes, we demonstrated that ALS IgG increased the mobility 
of endosomes and lysosomes and induced a transient increase of intracellular calcium 
in cultured rat cortical astrocytes. Our current research aims at deeper understanding of 
functional activity of ALS IgG on the one hand and the patophysiological changes they 
induce in cultured neurons and astrocytes on the other. We now have evidence that 
astrocytes also release glutamate upon treatment with ALS IgG. In experiments with 
neuronal cultures it became apparent that ALS IgG directly affect spontaneous 
synchronized calcium activity, an effect that is missing when such calcium activity is 
not present (in premature neurons) or is abolished by blockers. Our research indicates 
probably a non- Fc receptor-mediated IgG effect, even though the experiments with 
fragmented IgG do not exclude the importance of Fc region for their pathological 
functionality. 
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CYTOKINE GENE POLYMORPHISMS IN PATIENTS WITH CHRONIC 
INFLAMMATORY DEMYELINATING POLYNEUROPATHY 
 
Emina Milošević1, Verica Paunović1 Irena Vuković1, Stojan Perić2, Ivana 
Basta2, Ivo Božović2, Aleksa Palibrk2, Mirjana Arsenijević2, Ivana Berisavac2, 
Zorica Stević2, Vladimir Trajković1 
 
1Institute of Microbiology and Immunology, Faculty of Medicine, University of 
Belgrade 
2 Clinic of Neurology, Clinical Centre of Serbia, Faculty of Medicine, University of 
Belgrade 
 
Chronic inflammatory demyelinating polyneuropathy (CIDP) is debilitating 
neurological disorder caused by inadequate immune response against self-proteins 
present in peripheral nerves. It is the most common chronic form of immune-mediated 
neuropathies. Although rare, it bears considerable socio-economic burden. 
Mechanisms underlining the pathogenesis of this heterogeneous group of diseases 
include loss of immunological tolerance to myelin or axonal components, but how these 
diseases are triggered and why immune system reacts against these self-antigens is 
poorly understood. 
We assessed if functional single nucleotide polymorphisms (SNPs) in the genes 
encoding IL-10 (rs1800871, rs3024505), TNF (rs1800629, rs361525), IL-12B 
(rs3212227) and IL-23R (rs11209026) associate with the occurrence of CIDP in 89 
patients compared to 486 healthy controls by qPCR TaqMan assays. 
We found higher proportion of allele C for SNP in the IL10 promotor -819 C/T 
(rs1800871) in patients with CIDP (p<0.05). Distribution of genotypes for this SNP 
was similar in diseased and healthy people.  For other investigated SNPs frequencies 
of alleles and genotypes were similar in CIDP cohort compared to healthy. 
Studies of SNPs in CIDP are scares and this is the first study on SNPs in cytokines in 
these patients. Potentially it would be useful to correlate these polymorphisms with 
actual cytokine production and clinical course and outcomes of patients with CIDP.    
Supported by Ministry of Education, Science, and Technological Development, 
Republic of Serbia, Grant No. 41025 and 175038 
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EXPRESSION OF ECTO-5' NUCLEOTIDASE ON AMOEBOID MICROGLIA 
DURING NEURODEGENERATION INDUCED BY TRIMETHYLTIN 
INDICATES ITS ROLE IN PHAGOCYTOSIS 
Ivana Grković1, Milorad Dragić1,2, Nataša Mitrović1, Marina Zarić1, Marija Adžić1, 
Nadežda Nedeljković2 
1Department of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sceinces, 
University of Belgrade, Belgrade, Serbia.  
2Department for General Physiology and Biophysics, Faculty of Biology, University of 
Belgrade, Belgrade, Serbia 
Microglial cells invade the brain as amoeboid precursors and acquire a highly ramified 
morphology in the adult brain. Also, these glial cells express all essential components of 
purinergic signaling system, including ecto–enzymes, which plays a major role in the regulation 
of phagocytosis in activated microglia during different neuropathologies. Ecto-5'-nucleotidase 
(CD73) is a part of ecto-enzyme chain which sequentially degrades extracellular ATP to 
immunosuppressive adenosine, but expression of the enzyme in different morphological stages 
of activated microglia is unknown. Activation of resident microglia is one of the components in 
the progression of trimethyltin (TMT)-induced neurodegeneration. Three week after bilaterally 
ovariectomy, Wistar rats were treated with a single dose of TMT (8 mg/kg, i.p) and sacrificed 2-
, 4-, 7- and 21 days post-treatment. A combination of histological methods was used to determine 
activity and expression of CD73 in the hippocampal microglia of TMT treated animals. 
Microglial cells of mixed morphology gradually populated CA1 and hillar/pCA3 hippocampal 
sub-regions. Four days post-treatment microglia changed morphology from resting to 
bushy/amoeboid type as a result of TMT-induced neurodegeneration Activation of microglia 
during investigated timeframe was reflected as a huge increase in the cell number and the full 
repertoire of microglial shapes and forms, including unusual bushy and long, rod-shaped 
microglia. AMPase histochemistry and CD73-ir indicated reduction of staining in synaptic 
regions 2-d post-treatment, and after that, increase of specific labeled glial cells that infiltrated 
neuronal layers. From that time-point CD73 nicely depicted processes of bushy microglia, while 
amoeboid type completely colocalized with CD73. At day 21 post-treatment, numerous 
CD73+/IBA1+ amoeboid/phagocytic cells were noticed. Degree of CD73 expression correlates 
with morphological stage of microglial cells, suggesting the specific role of CD73 in 
amoeboid/phagocytic microglia. Taken together, these data show that CD73 plays a prominent 
role in controlling adenosine levels and thereby microglial phagocytosis. 
Supported by the Ministry of Education, Science and Technological development, Republic of 
Serbia, Grants III41014 and OI173044 
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PROPRANOLOL REDUCED SEVERITY OF EAE BY INCREASING THE 
EXPRESSION OF Nrf2 IN MICROGLIA 
Ivan Pilipović1, Ivana Prijić1, Zorica Stojić-Vukanić2, Gordana Leposavić3 
 Immunology Research Centre “Branislav Janković”, Institute of Virology, Vaccines and Sera 
“Torlak”, 458 Vojvode Stepe, 11221 Belgrade, Serbia 
2Department of Microbiology and Immunology, University of Belgrade-Faculty of Pharmacy, 
450 Vojvode Stepe, 11221 Belgrade, Serbia 
3Department of Pathobiology, University of Belgrade-Faculty of Pharmacy, 450 Vojvode Stepe, 
11221 Belgrade, Serbia 
 
Sympathetic dysfunction was proposed to participate in development of multiple sclerosis and 
its animal model, experimental autoimmune encephalomyelitis (EAE). This may be linked with 
findings indicating that noradrenaline, the key sympathetic end-point mediator, through β-
adrenoceptor exerts immunomodulatory action. Considering importance of the target tissue for 
the clinical outcome of EAE, the study investigated the effects of propranolol, a non-selective β-
adrenoceptor blocker, on the disease severity in Dark Agouti rats. Administration of propranolol 
over the effector phase of EAE substantially moderated neurological symptoms of the disease. 
This correlated with the increased proportion of spinal cord microglia expressing CX3CR1, the 
crucial neuroinflammation-limiting molecule, and upregulated expression of Nrf2, the key 
CX3CR1 downstream target gene. Additionally, in spinal cord of propranolol-administered rats 
the expression of heme-oxigenase 1, Nrf2 target gene, was upregulated. Consequently, microglia 
from propranolol-administered rats, exhibited increased proportion of IL-10–expressing cells, 
but decreased those of IL-1β– and IL-23–expressing ones. Propranolol also downregulated the 
IL-6 and MCP-1/CCL2 expression in spinal cord. Furthermore, propranolol affecting 
CXCR1/Nrf2 signaling pathway enhanced microglial phagocytic/endocytic capacity and surface 
expression of anti-inflammatory CD163/CD83 markers. Results from in vitro pharmacological 
study examining influence of noradrenaline/propranolol on functional properties of microglia 
showed that microglia synthesize noradrenaline, which, in turn, through β-adrenoceptor, 
downregulated their Nrf2 expression, in a CX3CR1-independent manner. In accordance with 
microglial shift towards a more anti-inflammatory profile, in spinal cord of propranolol-
administered rats was found: i) decreased infiltration with blood-borne myeloid and CD4+ T 
cells, and ii) reduced CD4+ T-cell reactivation/proliferation and differentiation into highly 
pathogenic IL-17+ cells co-producing IFN-γ and GM-CSF. The study suggests a 
neuroinflammation-promoting role for central noradrenaline in EAE, via β-adrenoceptor–
mediated modulation of microglial Nrf2 expression. Thus, it points out to a putative target for 
future translational pharmacological research to optimize multiple sclerosis therapy. Funding: 
MPNTR RS (grant number 175050).
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CAN BIDERICTIONAL MODULATION OF ALPHA5 GABAA 
RECEPTORS RESULT IN BIDERICTIONAL CHANGES OF BEHAVIOR 
IN 5xFAD MOUSE MODEL OF ALZHEIMER’S DISEASE? 
 
Jovana Aranđelović1, Anja Santrač1, Bojan Batinić1, James Cook2, Miroslav 
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Alzheimer’s disease (AD) poses a major concern due to decline in cognition, mood and 
neurological status. As GABAergic transmission in brains of AD patients is impaired, 
we assessed the behavioral consequences of positive and negative allosteric modulation 
of GABAA receptors, elicited by MP–III–022 as PAM, and PWZ–029 as NAM, in 
5xFAD mouse model of AD. Six–month old female 5xFAD transgenic (Tg) and non–
transgenic (wildtype, Wt) littermates were treated with PWZ–029 (P), MP–III–022 (M) 
or solvent (S) for 10 days i.p. prior to behavioral testing (groups: WtS, n=16; WtP, 
n=15; WtM, n=15; TgS, n=11; TgP, n=12; TgM, n=10). The behavioral battery 
comprised of elevated plus maze (EPM), open field test (OF) and novel object 
recognition test (NORT). In EPM, genotype had an impact on percent of open arm 
entries (%OE) and percent of open arm time (%OT); transgenic mice had higher values 
for both parameters. MP–III–022 decreased CE and increased %OE in TgM compared 
to WtM, and also increased CE in WtM compared to WtS. PWZ–029 increased %OE 
and %OT in TgP compared to WtP. In OF, percent of peripheral distance was higher in 
TgM than in TgS. In NORT for long–term memory (24h), overall genotype impact was 
significant in time spent with old and new objects, with decreased values in transgenic 
mice. In TgM and WtS, number of entries into zone with new object was increased in 
comparison with entries into zone with old object. The old object was explored less by 
TgM compared to TgP and WtM groups. In Wt animals, PWZ–029 increased 
exploration time of the new compared to old object. Both, PAM and NAM decreased 
anxiety parameters in transgenic animals. On the other hand, only PAM could facilitate 
long–term memory in transgenic animals. 
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Introduction: Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating and 
neurodegenerative disease of the central nervous system. Long-term outcome has been 
changed since 1993 when the interferon-beta (INF-β) was approved. The aim: The aims 
of the study were to determine the annual relapse rate in patients treated with INF-β in 
comparison with untreated patients; to estimate time to reach sustained functional 
neurological disability expressed in EDSS score 4.0 and 6.0, respectively in these two 
cohorts, and then estimating the time to secondary progressive multiple sclerosis 
(SP)MS. Patients and methods: In prospective cohort study, 236 patients treated with 
INF-β were included, and also a control group of 183 untreated with relapsing-remitting 
MS. Patients were observed initially for 7 years, and from this original cohort of 
patients, 10-year follow-up was available for 233 treated patients and 131 untreated. 
Median follow-up time was 9.7 years. Results: Treatment with INF-β statistically 
significantly delayed time for reaching all three outcomes (SP, EDSS score 4.0 and 
EDSS score 6.0). The time for reaching SP in the cohort of treated patients was 9.7 
years, and in untreated 7.8 years since baseline. The time for reaching EDSS score 4.0 
in the treated patients was 8.7 years from the baseline, and in untreated 7.1 years. Also, 
the time for reaching EDSS score 6.0 was extended; in the treated patients 9.8 years 
since baseline, and for untreated 8.8 years. INF-β was associated with a statistically 
significantly lower risk of developing SP in comparison with the cohort of untreated 
patients (HR=0.22), and also, there was a significant difference in the achievement 
EDSS score 4.0 and 6.0 (p<0.001), in a benefit of treated patients (HR=0.40 and 
HR=0.27, retrospectively). Conclusion: Treatment with INF-β has a statistically 
significant benefit on all three outcomes, and this therapy may also have a statistically 
significant effect on the long-term outcome in patients with MS. 
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THE ANALYSIS OF LABORATORY DATA FROM PATIENTS WITH 
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The aim of this study was to analyze laboratory data from patients with neuromyelitis 
optica spectrum disorder (NMOSD). 
Demographic, clinical, and laboratory data, such as, first performed: routine 
cerebrospinal fluid findings, serum anti-aquaporin 4 (AQP4), antibodies against other 
serum autoantibodies, were evaluated in 74 Caucasian NMOSD patients, from the 
Clinic of Neurology, CCS, Belgrade, who fulfilled the 2015 diagnostic criteria. Serum 
AQP4 IgG (NMO-IgG) was tested using a commercial cell-based indirect 
immunofluorescence assay (Euroimmun AG). The result was considered to be positive 
if tested positive at the dilution of 1:10. In addition, antibodies against myelin-
oligodendrocyte (MOG-IgG) in serum were tested in a subset of 47 randomly selected 
NMOSD patients for whom enough sample volume was available, using a live cell-
based assay. Antibodies against myelin-oligodendrocyte (MOG-IgG) in serum were 
tested in a subset of 47 NMOSD patients. Analysis of results showed that 89.2% of 
patients were tested NMO-IgG positive by our method. Median NMO-IgG titer was 
1:640 (range, 0-1:40960). In addition, in the subgroup of 47 NMSD patients who were 
tested for MOG-IgG, 2 out of 7 patients tested to be NMO-IgG negative by the live cell 
based assay we found MOG-IgG to be positive. The analysis of first ever performed 
routine CSF findings showed a median CSF protein level of 0.45g/L (range, 0.28-2.23 
g/L), median CSF cell count of 3.5/µL (range, 0-378 mononuclear cells/µL; CSF cell 
phenotype: lymphocytes, granulocytes, macrophages) and the presence of intrathecal 
synthesis of CSF oligoclonal IgG bands in 16 out of 66 (24.2%) patients in whom CSF 
analysis was performed. 
In conclusion, laboratory findings have a significant role in the differential diagnosis 
of NMOSD. Additionally, it has to be emphasized that the high proportion of anti-
AQP4 antibodies in our patients, implicate absolute necessity of determination of anti-
AQP4 antibodies status   for diagnostic purposes in NMOSD. 
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Aims: Food restriction (FR) is well known as an environmental intervention 
efficient in delaying aging and age-related disorders. Important role in the 
regulation of food intake plays the gut-brain dopamine (DA) axis. Dopamine is 
a neurotransmitter involved in regulation of brain’s rewarding and pleasure 
centers, who’s signaling is indispensable to survival and maintenance of eating 
patterns. Reversely, reduced food intake affects DA circuits and behaviors 
controlled by DA, including anxiety. Herein we investigated mechanisms 
through which FR affects anxiety and the role of dopaminergic system in this 
process. Methods: 60% FR of various onset and duration (FR1, FR2 and FR3) 
was implemented as a feeding regime for aging male Wistar rats. Open field 
test and light-dark box were used to investigate effects of age and food 
restriction on anxiety-like behavior. Western blot and PCR were used to 
determine the changes at the transcriptional and translational level. Results: 
Open field test showed an increased general activity of animals under FR1 in 
comparison to the controls, while FR2 and FR3 seemed to have deleterious 
effect on anxiety level. Light-dark box confirmed deleterious effect of FR2 and 
FR3 regimens.  Changes detected on behavioral level were accompanied with 
the specific changes in the level of dopaminergic receptors. Conclusions: Our 
results showed that food restriction is not universally beneficial, but depends 
on age when implemented. We showed that FR-induced effects can vary from 
anxiolytic to anxiogenic, while the components of DA circuits in the brain show 
region-specific response to FR.  
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Numerous beneficial effects of food restriction (FR) on aging and age-related 
pathologies are well documented. Neuroprotective effects of both daily calorie 
reduction (CR) and intermittent feeding (IF) were also described in animal models, 
reflected by reduced levels of proinflammatory cytokines, reactive oxygen species, and 
increased insulin sensitivity. In the present study, the effects of IF were examined in 
5XFAD transgenic mice, a commonly used transgenic mouse model of Alzheimer's 
disease (AD). Intermittent feeding regimen was introduced to transgenic female mice 
at the age of 2 months and the effects on amyloid-β (Aβ) accumulation, gliosis, synaptic 
plasticity, and blood-brain barrier breakdown were analyzed in cortical tissue of 6-
month-old animals. Surprisingly, significant increase of inflammation in the cortex of 
5XFAD fed EOD mice was observed, reflected by the expression of microglial and 
astrocytic markers. This increase in reactivity and/or proliferation of glial cells was 
accompanied by an increase in proinflammatory cytokine TNF-α, p38 MAPK and 
EAAT2, and a decrease in GAD67. NMDA receptor subunit 2B, related to glutamate 
excitotoxicity, was increased in the cortex of 5XFAD-EOD mice indicating additional 
alterations in glutamatergic signaling. Furthermore, 4 months of EOD feeding regimen 
had led to synaptic plasticity proteins reduction and neuronal injury in 5XFAD mice. 
However, EOD feeding regimen did not affect Aβ load and blood-brain barrier 
permeability in the cortex of 5XFAD mice. Collectively, the present data demonstrate 
that EOD feeding regimen exacerbates Alzheimer’s disease-like neurodegenerative and 
neuroinflammatory changes irrespective of Aβ pathology in 5XFAD mice. 
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Introduction – Ecto-5ˈ nucleotidase/cluster of differentiation 73 (CD73) is a membrane 
enzyme with active site facing extracellular compartment. It is the last and rate-limiting 
enzyme of the purine catabolic pathway, catalyzing dephosporylation of extracellular 
adenosine 5ˈ-monophosphate to adenosine. Adenosine is potent homeostatic regulator 
in central nervous system (CNS) involved in numerous processes such as control of cell 
growth, cellular differentiation and an important regulator of inflammatory response. 
Neuroinflammation is defined as an inflammatory process within CNS. This 
inflammation is mediated by various cytokines, chemokines, reactive oxygen species 
and secondary messengers. The duration and degree of neuroinflammation depends on 
the context, duration and course of the primary insult. One of the validated models for 
obtaining a hippocampal neurodegeneration followed by neuroinflammation and 
gliosis is trimethyltin (TMT) intoxication. Therefore, we used TMT-intoxicated 
animals to study temporal expression of CD73 and main pro- and anti-inflammatory 
cytokines.  
Material and methods - Two-month-old female Wistar rats were bilaterally 
ovariectomized. Three week after surgery they were treated with single i.p. dose of 
TMT (8 mg/kg) and sacrificed 7 and 21 day posttreatment. Brains were isolated using 
TRI-reagent and processed for real-time PCR analysis. Results – Seven days after 
intoxication, there was a significant increase in IL-6, TNF-α and iNOS but also in CD73 
expression, while 21 days after exposure increase in relative gene expression was 
notices in IL-1β, IL-6, IL-10 and iNOS followed by continuous increase in CD73 
expression. Conclusion – Temporal expression of pro- and anti-inflammatory cytokines 
clearly revealed and active and ongoing neuroinflammation. Increase in CD73 
expression in examined timeframe could be put in perspective of its anti-inflammatory 
role. Since adenosine represents a potent regulator of inflammation and CD73 is its 
main generator, significance of its increase could lead to resolution of 
neuroinflammatory events caused by TMT-induced neurodegeneration. 
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Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with 
no cure at present, characterized by degeneration of motor neurons in the spinal cord, 
brainstem and cortex, paralysis and muscle waisting. Proposed mechanisms of ALS 
pathophysiology and progression include neuroinflammation, oxidative stress, 
mitochondrial and endoplasmic reticulum dysfunction, protein aggregation, impaired 
axonal transport, intracellular ion misbalance and glutamate excitotoxicity. The aim of 
the present study was to identify differentially expressed genes (DEGs) in the spinal 
cord of non-transgenic (control) rats and in pre-symptomatic and symptomatic ALS 
SOD1G93A transgenic rats, using microarray analysis. A total of 166 deregulated 
mRNAs have been identified and a list of the significantly modulated genes has been 
annotated by means of gene ontology. The main pathways revealed include chemokine 
and B cell receptor signaling pathways, complement and coagulation cascade and 
cytokine-cytokine receptor interactions. Immune defense and inflammatory response 
genes were the mostly upregulated in our ALS model. In general, the following genes 
were upregulated: tumor necrosis factor alpha induced protein 6 (TNFAIP6) 9 fold, and 
apolipoprotein B mRNA editing enzyme catalytic polypeptide 1 (APOBEC1) 7 fold, 
while the complement component 1 and 3 (C1, C3), transforming growth factor beta 1 
(TGFB1) and its receptor (TGFBR1), as well as FYN binding protein (FYB) and B cell 
linker (BLNK) were upregulated more than 2 times. In order to confirm the 
transcriptome data, expression levels of several genes (APOBEC1, FYB, BLNK) were 
also determined by real-time PCR and the results were matching. Our findings provide 
evidence of the genes playing a role in ALS chronic inflammation. 
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Flaxseed (FS, Linum usitatissimum) poses well-known health benefits due to its high 
concentrations of ω-3 fatty acid: α-linolenic acid (ALA), short chain polyunsaturated fatty acids, 
fibers, proteins, antioxidants and phytoestrogens. An increasing number of postmenopausal 
women start to take FS as phytoestrogen-rich foods to prevent the risk of breast cancer, 
osteoporosis and some menopausal symptoms. However, role of FS in regulation of 
neuroinflammation is less understood. Microglial cells are resident immune cells of the central 
nervous system (CNS) which respond rapidly to the injury by shortening and thickening of 
processes and adoption of amoeboid morphology, migrate to the site of injury, and clear cellular 
debris. Extracellular ATP/ADP and P2 receptors are essential for the microglial activation. Thus, 
we examined the ability of repeated flaxseed oil (FSO, 1 ml/kg, s.c.) pretreatment to modulate 
activation of microglia in the hippocampus of ovariectomized female rats (OVX) induced by 
trimethyltin intoxication (TMT, 8mg/kg, i.p.). Seven days post-TMT intoxication enhanced total 
ADPase staining intensity and immunoreactivity of microglia-specific protein IBA-1 increased.  
Microglial activation has been manifested as significant increase in number of microglial cells, 
due to migration and/or proliferation of resident microglia. Observed IBA-1+ cells displayed 
heterogeneous morphologies which gradually populated CA1 and hillar/pCA3 hippocampal sub-
regions. We observed: ramified, hyper-ramified, bushy, amoeboid, and rod microglial 
phenotypes. Some of these phenotypes like hyper-ramified and bushy have been referred to as 
primed and reactive/activated, respectively. Repeated FSO pretreatment prevented overall 
increase in ecto-ADPase activity and IBA-1-ir cells observed after TMT. At phenotypic level 
microglial population exhibited ramified but also occasional hyper-ramifide phemotype with 
enlarged cell bodies in CA1 region, while in hillar/pCA3 region clusters of these cells were 
observed. Collectively, our findings suggest a novel FSO-mediated neuroprotective effect via 
modulation of microglia activation stage in the brain. Acknoledgement. Study was supported by 
MPNTR, Republic of Serbia, grants OI 173044 and III 41014.
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Guillain-Barré syndrome (GBS) is an immune-mediated neuropathy caused by 
inadequate immune response against peripheral nerve proteins. Though rare, GBS bears 
a large socio-economic burden, since it requires an expensive immunotherapy and may 
cause a long-term disability. The underlying cause of immune system reaction against 
self antigens in GBS is unknown. Maintenance of tolerance depends on immune cell 
homeostasis which includes autophagy - autodigestion/recycling of organelles and 
macromolecules. Although autophagy is altered in animal models of GBS and drugs 
targeting autophagy are clinically approved, available, safe and less expensive than the 
conventional therapy, there are no data about autophagy in human GBS. Therefore, our 
primary objective is to correlate the expression of authophagy markers/regulators in 
immune cells with clinical and immunological parameters of GBS patients. To date, we 
have analyzed the expression of eighteen genes involved in autophagy regulation and 
cytokines related to the disease (IFN-γ, IL-1 and IL-10) in peripheral blood 
mononuclear cells (PBMC) from nineteen GBS patients, therapy naïve, and twenty 
non-diseased control subjects. The RT-qPCR analysis revealed that PBMC of GBS 
patients had statistically significantly higher mRNA expression of GABARAP, ATG7, 
ATG5, ATG7, VPS34 and TFEB, proteins involved in autophagy regulation, as well as 
IL-10, a well-known anti-inflammatory cytokine. The mRNA levels of other 
investigated autophagy-regulating genes and cytokines did not significantly differ 
between the two groups. However, the GABARAP, ATG7, ATG5, ATG7, VPS34, 
TFEB and IL-10 mRNA expression did not correlate with age, severity of disease or 
other clinical parameters. These results indicate autophagy may have an impact on GBS 
pathogenesis or disease propagation, however further in-depth research is required to 
reveal its role in GBS. 
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Adverse effects of non-occupational exposure to cadmium (Cd) are increasingly 
acknowledged. Using a rat model of oral Cd exposure in drinking water we have shown 
that skin is a target for this metal. Due to contribution of individual variability to the 
intensity of cadmium toxicity, dermatotoxicity of two environmentally relevant Cd 
doses (5 and 50 ppm) was examined in individuals of two rat strains, Albino Oxford 
(AO) and Dark Agouti (DA), which differ in response to chemicals. A dose-dependent 
accumulation of Cd in the skin/epidermal cells was noted in both strains, and although 
there were no strain differences in the Cd accumulation, the degree of skin response to 
the metal differed. Signs of skin damage were evident in both strains, but response to 
injury was more pronounced in DA. Individuals of DA rats responded by an increase 
in the levels of antioxidant defense enzymes in the skin already at lower dose, in 
contrast to AO (which reacted to higher dose solely), implying higher sensitivity of DA 
strain to Cd-induced toxicity.  Epidermal cells from both strains developed stress 
response, however increased GSH, and higher metallothionein/MT-1 and MT-2 
mRNA, Nrf2 protein, apoptosis, Ahr and Cyp genes in AO, depicting this strain`s 
ability to better defend against Cd insult. Epidermal cells` IL-1β, TNF and IL-6 
response was induced by Cd in DA, while pro-inflammatory cytokine production was 
unchanged in AO (though increased following stimulation with S. epidermidis), with 
increased IL-10 as a possible underlying mechanism. T cells from non-exposed rats 
produce more IFN-γ and IL-17 in co-culture with epidermal cell from Cd–exposed DA 
rats what strengthens the view that this strain is more prone to metal’s dermatotoxicity. 
These data give a new insight into repercussion of genetic variability to toxicity of 
cadmium acquired by the skin via gut, bearing relevance for variations in the link 
between dietary cadmium and inflammation-based skin pathologies. 
Supported by the Ministry of Education, Science and Technological Development of 
the Republic of Serbia, Grant #173039. 
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Cadmium (Cd) is a heavy metal widely spread in the environment and significant water 
and food contaminant. This metal exerts toxic effects in various tissues thus 
representing great threat to human health, and our previous study showed that oral 
consumption of Cd (in water for 30 days) increased the metal deposition and exerted 
immunomodulatory effects in lung leukocytes. Although the most studied mechanisms 
of Cd toxicity include oxidative stress and inflammation, recent studies have indicated 
that this metal can activate aryl hydrocarbon receptor (AHR) and exert effects on AHR-
regulated genes (i.e. CYPs). AHR represents a link between environmental toxicants 
and immune response as high receptor expression is noted in immune cells and barrier 
tissues, thus the aim of presented study was to investigate if activation of AhR by Cd 
is associated with metals’ immunomodulatory effects. Treatment of lung leukocytes 
with Cd in vitro (non-toxic doses) caused an increase in mRNA levels for AHR, 
CYP1B1 and CYP1A1, but co-treatment with metal and AHR antagonist CH223191 
indicated that higher Cd doses (5 and 10 µM) can activate CYPs directly while a lower 
dose (1 µM) exerted effects on CYPs expression through activation of AHR. Low Cd 
dose induced increased production of IL-6 and decreased TNF and IL-1β by lung 
leukocytes, compared to controls. Gene expression data revealed unchanged mRNA for 
IL-6, decreased TNF, but increased IL-1β. Lower IL-1β protein level despite increased 
mRNA, was a consequence of decreased mRNA for NLRP3, a component of 
inflammasome that is involved in processing of pro-IL-1β in IL-1β. All noted effects 
were abolished in the presence of CH223191. Data obtained indicate that 
immunomodulatory effects of low Cd dose are mediated through AHR activation. 
Supported by the Ministry of Education, Science and Technological Development of 
the Republic of Serbia, Grant #173039. 
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Volume regulated anionic current (VRAC) controls regulatory decrease in cellular 
volume. It is mediated by LRRC8A-E channel proteins, present ubiquitously in 
chordate lineage. Besides VRAC being involved in basic cellular functions, it is 
considered especially important for lymphocyte and macrophage physiology, the 
notion exemplified by the fact that the only known human LRRC8 mutation, identified 
from a patient with agammaglobulinemia, exerts a dominant negative effect on T- and 
B-cell development in mice. VRAC channel permeates Cl- and other anionic species 
(bicarbonates, sulphates, nitrates) as well as large organic osmolites (glutamate, 
aspartate, taurine, ATP); it’s activity requires ATP binding from intracellular side; it 
can be activated or modulated by G proteins, ROS, reduction of intracellular ionic 
strength, AKT and RAS kinase, among other things. Here, we present patch-clamp 
analysis of a VRAC-like current from unexpected source, the membrane from 
filamentous fungi Phycomyces blakesleeanus, that we named ORIC. We have 
previously shown that ORIC has following VRAC properties: activation by 
hypoosmotic stimulus; ion selectivity and ion channel permeation sequence; 
biophysical properties of voltage dependent inactivation and activation; activation by 
GTPγS. Continuing our characterization of ORIC, here we show that, same as reported 
for VRAC by others, ORIC is ATP-dependent, as well as blocked by ATP from 
extracellular side. Namely, ORIC run-down is prevented by inclusion of ATP or non-
hydrolysable ATP analog in the patch pipette; flavonoids genistein and quercetine 
reduce ORIC; ATP (500 µM) on the extracellular side blocks ORIC. The studying of 
ORIC in our fungal model system, has a unique advantage, as ORIC represents the 
naturally occurring osmotically activated current, with all regulatory elements intact, 
while conveniently isolated for observation, since ORIC is the most dominant current 
under hypoosmotic conditions. The extent of functional and, possibly structural, 
similarity between ORIC and VRAC needs yet to be determined. 
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Chronic inflammation is found in a great proportion of chronic kidney disease 
patients on hemodialysis. As some food are benefical for human health, 
possibly because of their anti-inflammatory effects, we studied effects of 
dietary consumption of milled sesame/pumpkin/flax seed mixture on 
inflammatory markers in patients on hemodialysis. Thirty hemodialysis 
patients consumed 30g of milled sesame/pumpkin/flax (6g/6g/18g, 
respectably) added to their habitual diet for 12 weeks. Their levels of TNF-
alpha, hs-CRP and IL-6 were determined at baseline and after treatment. The 
mean level of TNF-alpha was 1.86±0.90 mU/L, for IL-6 2.63±1.45 pg/ml and 
hs-CRP 6.26±4.12 mg/L. After treatment, levels of inflammatory markers 
TNF-alpha, hs-CRP and IL-6 were significantly decreased compared to 
baseline values (p<0.001, for all parameters). Results of this study indicate that 
seed mixture sesame/pumpkin/flax added to habitual diet could improve 
inflammatory status of chronic kidney disease patients on hemodialysis as all 
studied markers of inflammation were significantly decreased after treatment. 
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Trophoblast cells represent specific placental cells which invade into uterine tissue to 
establish and maintain a successful pregnancy. Along the invasive pathway of 
differentiation trophoblast comes into close contact with various maternal cell types 
including decidual stromal cells and various immune cells. Multiple factors produced 
by both trophoblast and maternal cells regulate trophoblast invasion process, including 
IL-1β, IL-6, IL-8, LIF, EGF, HGF and many others.  
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that 
participates in both inate and adoptive immunity. It is abundantly present at the feto-
maternal interface, and expressed by trophoblast and maternal cells. We have 
previously shown that this cytokine regulates trophoblast cell invasion and that it might 
participate in trophoblast response to infection. Data from the literature implicate MIF 
as an upstream regulator of proinflamatory cytokines. For that reason, a possibility that 
MIF could regulate the expression of cytokines known to participate in trophoblast 
invasion was investigated here. HTR-8/SVneo cells were used as the model for 
extravillous trophoblast. The expression of endogenous trophoblast MIF was attenuated 
by specific small interfering RNAs (siRNA) for 72h. MIF activity was also blocked in 
a separate treatment group by a small chemical inhibitor ISO-1. The expression of 
cytokines was assessed at mRNA level by qPCR and at the protein level by flow 
cytometry. The results obtained show that IL-8 is significantly reduced after silencing 
of mRNA or blocking of MIF activity by ISO-1. 
It can be concluded that MIF regulates IL-8 expression in HTR-8/SVneo cell line, 
which may be important for trophoblast invasion and/or response to infection. 
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The major parts of the commensal microbial flora of the human gastrointestinal tract (GIT) 
belong to the lactic acid bacteria (LAB) that are frequently used as probiotics. Probiotics must 
survive passage through the upper GIT and reach its site of action alive, where they have to 
maintain their stability, viability and function. Preparation of various biopolymer-based carriers 
and microencapsulation become inevitable part of probiotics-focused researches. In this study, 
we assessed probiotic activity of Lactobacillus reuteri B2 selected from the panel of LAB 
isolated from the feces of C57BL/6 mice. L. reuteri B2 was evaluated as potential probiotic and 
its microencapsulation with alginate-based materials were performed. We hypothesized that if L. 
reuteri B2 in the free form can survive all conditions in the GIT then the usage of the appropriate 
biomaterials for microencapsulation would improve its viability and stability in GIT. 
Consequently, there has been assessed L. reuteri B2 in free and in microencapsulated form, in 
vitro, in the culture of epithelial cells. High survival rate of L. reuteri B2 at low pH (2.0- 4.0) and 
in the presence of the bile salts at concentrations up to 0.30% imply that it can survive harsh 
conditions within GIT. Likewise, L. reuteri B2 strong antimicrobial activity toward pathogen 
species on which this strain has been assessed. Furthermore, testing of the alginate-based 
polymers revealed no negative impact on the viability of epithelial cells. Results obtained from 
this study highly encourage further research on the impact of alginate-encapsulated L. reuteri B2 
in physiological conditions as well as for the prevention or treatment of some pathological states. 
Additionally, demonstrating extended viability of encapsulated probiotics in vivo will justify 
scaling up the encapsulation process for commercial application. Acknowledgment: The authors 
would like to acknowledge the financial support of the Ministry of Education, Science and 
Technological Development, Government of Republic of Serbia, projects: OI 176018 and 
OI172049. 
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The study showed sexual dimorphism in the kinetics of thymic involution in Dark 
Agouti rats, so in 24-month-old males prominent thymic fibro-adipose degeneration 
was found, whereas fibrous changes dominated in thymi of age-matched females. This 
dimorphism reflected sex-specific constellation of age-related alterations in the 
expression of the key proadipogenic factors (xanthine oxidase-induced PPARγ, 
STAT3, the transcription factor controlling PPARγ downstream adipocyte-
differentiation-related gene expression, and IL-6) and TGF-β, the key pro-fibrinogenic 
factor. The age-related epithelial-mesenchymal transition in thymi of Dark Agouti rats 
was accompanied by decline in thymopoiesis mirrored in decrease in the frequency of 
the most mature CD4+CD8-/CD4-CD8+ TCRαβhigh thymocytes and CD4+ and CD8+ 
recent thymic emigrants in peripheral blood (PB). This was more prominent in males 
than in females. Irrespective of sex, differentiation/maturation “block” leading to 
accumulation of the least mature CD45RC+CD2-CD4-CD8- thymocytes, accompanied 
by decline in the frequency of descendant double positive (DP) TCRαβ- ones was 
observed with aging. This was followed by opposing changes in the efficacy of 
positive/negative selection in males and females, which was related to sex-specific 
alterations in thymic expression of Nur77, a nuclear receptor involved in negative 
selection, and surface density of CD90 (negative regulator of thymocyte-selection 
threshold) on thymocytes undergoing selection. Moreover, compared with old females, 
in age-matched males CD4+CD8-/CD4-CD8+ TCRαβhigh thymocyte ratio was shifted 
towards the latter. However, CD4+/CD8+ ratio in PB was skewed towards CD8+ T 
cells in both sexes. Irrespective of sex, with aging the frequency of 
CD4+CD25+Foxp3+ thymocytes diminished, but that of CD4+CD25+Foxp3+ T 
regulatory cells (Tregs) in PB increased, most likely due to enhanced expansion of 
“induced” Tregs. Collectively, the study i) indicates necessity of sex-specific 
approaches in designing thymus-rejuvenating strategies and ii) warns that changes in 
the PB T-cell compartment do not necessarily reflect sex-based differences in T-cell 
generation in thymus. (Funding: project 175050 MNTR RS) 
Saturday, December 7th Session: MISCELLANEOUS 
86 
 
Poster presentation 
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Siniša Djurašević1, Maja Stojković2, Ljiljana Bogdanović2, Ilijana Grigorov3, 
Desanka Bogojević3, Nebojša Jasnić1, Predrag Vujović1, Tamara Dakić1, Zoran 
Todorović2,4 and Jelena Djordjević1 
1University of Belgrade, Faculty of Biology, Belgrade, Serbia; 2University of 
Belgrade, School of Medicine, Belgrade, Serbia; 3University of Belgrade, Institute for 
Biological Research "Siniša Stanković"– National Institute of Republic of Serbia, 
Belgrade, Serbia; 4University of Belgrade, University Medical Centre “Bežanijska 
kosa”, Belgrade, Serbia 
Acute renal ischemia/reperfusion (I/R) is a temporary restriction of kidney blood 
supply, followed by blood flow restoration and re-oxygenation. During I/R, decreased 
oxygen supply disturbs ion transport, intracellular ATP, calcium and pH levels, and 
numerous signalling pathways. Upon reperfusion, a restoration of oxygen level rises a 
reactive oxygen species generation, cytokines and chemokines release from activated 
tissue-resident macrophages, and infiltration of pro-inflammatory neutrophils into 
ischemic tissues. All these changes result in cell swelling and rupturing, and consequent 
necrotic or apoptotic cell death. Meldonium is an anti-ischemic drug clinically used to 
treat myocardial and cerebral ischemia, which acts by shifting energy production from 
fatty acid oxidation to glycolysis. We investigated the effects of a 4-week meldonium 
pre-treatment with 300 mg/kg b.m./day of rats subjected to a well-established 
experimental model of renal I/R, with ischemia lasting for 45 minutes, followed by 4 
hours of reperfusion. The degree of apoptosis and necrosis was evaluated by measuring 
renal pro-apoptotic Bax and anti-apoptotic Bcl-2 ratio, serum and kidney levels of 
necrotic marker - high mobility group box 1 protein (HMGB1), together with the 
kidney histology analysis. Our results showed that apoptotic and necrotic cell death 
occur simultaneously under I/R conditions, judging by the renal Bax/Bcl2 ratio rise 
(2.7-fold), increase in serum (22%) and renal (30%) levels of HMGB1, as well as severe 
tubular necrosis with dilatation of the tubular structure, cast formation, tubular lumina 
dilatation, brush border reduction, and loss in some renal areas cells. Meldonium pre-
treatment reduced the elevated Bax/Bcl2 ratio by 35%, as well as the serum and renal 
HMGB1 levels by 20% and notably diminished histological evidence of renal I/R 
necrotic injury, especially regarding tubular structures. These findings proved that 
meldonium protects renal cells against I/R-induced necrosis and apoptosis. 
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for Pulmology, Clinical Center of Serbia, Belgrade, Serbia; 4Faculty of Medicine, 
University of Belgrade, Belgrade, Serbia; 5Municipal Institute for Lung Diseases and 
Tuberculosis, Belgrade, Serbia 
 
Chronic obstructive pulmonary disease (COPD) is characterized by decreased air flow 
in the airways leading to shortness of breath, coughing and wheezing. Inflammation 
and oxidative stress play an important role in the pathophysiology of COPD. One of 
the primary goals of therapy is to reduce the number and frequency of exacerbations. 
Inhaled corticosteroids and phosphodiesterase inhibitors are used in addition to 
bronchodilators in patients with high rates of exacerbations. However, the use of 
inhaled corticosteroids can cause pneumonia. Mucolytics play an important role in the 
prevention of exacerbations. The goal of this work was to analyze immune parameters 
at the onset of disease/exacerbation and upon one month of supplementation with N-
Acetyl cysteine (NAC) or propomucil (NAC with propolis) in age matched acute 
bronchitis patients and COPD patients. Cytokines: IL-17, IL-6, and IL-8, were analyzed 
from patients’ plasma with commercial ELISA kits. IgG sialylation was assessed in 
ELISA with Protein G for IgG capture and SNA I – a lectin specific for sialic acid 
attached to terminal galactose with α-2,6 glycosidic bond. We were not able to detect 
significant differences in plasma cytokine levels irrespective of the patient group or 
treatment. No difference was found in IgG sialylation upon treatment. However, COPD 
patients had significantly lower level of IgG sialylation compared to acute bronchitis 
patients. The obtained results indicate that the influence of NAC on the immune system, 
with or without propolis can not be evaluated by assessing plasma cytokine levels, as 
the effects might be localized. While there were no differences in sialylation related to 
treatment, the obtained lower level of IgG sialylation is an indicator of increased level 
of chronic inflammation present in COPD patients, which is in accordance with 
literature data. As no differences were noted in this group within one month this likely 
represents a permanent state. 
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Val158Met CATECHOL O-METHYL TRANSFERASE POLYMORPHISM AND 
INCREASED PROINFLAMMATORY CYTOKINE GENE EXPRESSION AS 
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Tamara Sljivancanin Jakovljevic1, Olivera Kontic-Vucinic2, 3, Nadja Nikolic4, Jelena 
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Introduction: Poor placentation leads to different pathophysiological mechanisms that contribute 
to preeclampsia development. Single nucleotide gene polymorphism (Val158Met) for catechol 
O-methyl transferase (COMT) is related to inadequate spiral artery remodeling during 
placentation. Endothelial dysfunction may be caused by disturbed immunology response and 
increased production of proinflammatory cytokines. Aims: To determine genotypes and alleles 
frequencies for Val158Met COMT polymorphism and proinflammatory cytokines relative gene 
expression in preeclampsia and control group, and to analyze potential relationship between these 
parameters. Materials and methods: Case-control study included 50 preeclampsia patients and 50 
healthy pregnant women. Groups were matched for age, parity, gravidity, singleton pregnancy 
and gestational age at sampling. Polymerase Chain Reaction/Restriction Fragment Length 
Polymorphism technique was used to determine polymorphism in COMT gene. Real time 
Polymerase Chain Reaction was used to determine relative gene expression of proinflammatory 
cytokines. Appropriate statistical tests were applied for data analysis. 
Results: Homozygous mutation for Val158Met COMT gene polymorphism was more frequent 
in the study than in the control group (P=0.002) and carried a 3.7-fold risk increase for 
preeclampsia. Variant allele (A) was related to significantly higher risk for development of this 
hypertensive disorder. Relative mRNA expression of tumor necrosis factor (TNF)-α and 
interleukin (IL)-1β was significantly higher in preeclampsia than in healthy pregnant women 
(P=0.006 and P=0.005, respectively). Analysis of all examined patients revealed higher TNF-α 
expression in the presence of COMT polymorphism (P=0.012). Conclusions: Val158Met COMT 
gene polymorphism represents a risk factor for preeclampsia development. Preeclampsia was 
associated with higher expression of TNF-α and IL-1β. Decreased COMT activity is related to 
marked inflammatory response during pregnancy. Key words: Pre-Eclampsia; Catechol O-
Methyltransferase; Polymorphism, Genetic; Tumor Necrosis Factor-alpha; Interleukin-1beta; 
Interleukin-6; inflammation. 
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Tatjana Sarenac Vulovica and Nemanja Zdravkovicb 
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Background: Pseudoexfoliation syndrome (XFS) is an age-related systemic 
disorder with ocular manifestations. Pseudoexfoliation is the most common 
cause of pseudoexfoliation glaucoma (XFG) development. The aim of this 
study is to reveal the participation of regulatory cytokines within the process of 
pseudoexfoliation (PEX) production and accumulation. 
Methods: Our study included 160 patients referred to cataract surgery with 
early and late stage of XFS or XFG. Humour and serum levels of cytokines 
TGF-β, PDGF, EGF, IGF, IL-8 and ITAC were measured in a sample with high 
sensitivity enzyme-linked immunoabsorbent assay (ELISA) kit. 
Results: Our results indicate that profibrotic action induced by increasing TGF-
β and PDGF locally activates fibrous tissue production in the early XFS with 
prolonged effect of PDGF (late XFS) and finally (XFG stage) it is dominantly 
controlled by EGF and IGF. ITAC overrides angiogenetic effects of IL-8 in 
XFG. Conclusions: Based on our findings the local chronic inflammation in the 
eye is accompanied by the action of different profibrotic cytokines (TGF-β, 
PDGF, EGF, IGF and IL-8). Accumulated PEX material in all parts of the eye 
and decreased blood flow cause XFG development without vasculogenesis and 
angiogenesis due to the increased level of ITAC (humor aqueous and sera) in 
XFG, despite to local oxidative stress.  
Supported by: Serbian Ministry of Education, Science and Technological 
Development (Grant No. ИИИ41007) and Faculty of Medical Sciences, 
University of Kragujevac, Serbia (Grant No. JP 05/19). 
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Milica Jovanović Krivokuća, Ivana Stefanoska, Aleksandra Vilotić, Žanka 
Bojić-Trbojević, Ljiljana Vićovac 
 
Institute for the Application of Nuclear Energy - INEP, University of 
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Galectins (gals) are β-galactoside binding proteins abundantly expressed at the 
feto-maternal interface and implicated in various processes during embryo 
implantation and placentation. Extravillous trophoblast cells express gal-1, gal-
3 and gal-8. Our group has recently shown that gal-3 acts as a modulator of 
trophoblast invasion in vitro. This study aimed to investigate whether 
trophoblast gal-3 could act as a modulator of cytokines which are known to 
participate in trophoblast invasion.  
In this study extravillous trophoblast cell line HTR-8/SVneo was used. 
Expression of gal-3 was attenuated using specific small interfering RNAs 
(siRNAs), and the silencing efficiency was assessed by qPCR and Western blot. 
The expression of cytokines known to regulate trophoblast invasion IL-1β, IL-
6 and IL-8 was studied at mRNA level by qPCR and at the protein level by flow 
cytometry. The data show that the expression profiles in gal-3 silenced cells 
differ at both mRNA and protein level.  
These results indicate that endogenous trophoblast gal-3 could act as a regulator 
of cytokine expression in HTR-8/SVneo cells, which could further reflect on 
trophoblast invasive capacity and other trophoblast cell functions. 
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Sepsis results in a deluge of both pro- and anti-inflammatory cytokines leading 
to lymphopenia and chronic immunoparalysis.  The pathogenesis of sepsis is 
complex and variable, depending on the pathogen load and virulence, host 
comorbidity, genetic and epigenetic factors, environment, and the amount of 
time passed after the onset of the infection, with distinct phases of the 
immunological responses defined at local and systemic levels. Sepsis induced 
long-lasting immunoparalysis is, in part, defined by impaired CD4 and CD8 αβ 
T cell responses in the post-septic environment. The dysfunction in T cell 
immunity affects naïve T cell compartment (primary T cell responses) as well 
as infection- or vaccine-induced effector and memory T cell responses leading 
to increased susceptibility to secondary bacterial and viral infections and tumor 
development.  While the sepsis-induced severe and transient lymphopenia is a 
contributory factor to diminished T cell immunity, T cell-intrinsic and -
extrinsic factors/mechanisms also contribute to impaired T cell function. I will 
discuss the current knowledge obtained on novel experimental models of how 
sepsis quantitatively and qualitatively impairs T cell immunity and discuss 
potential avenues to boost the recovery of T cell compartment in host’s 
surviving sepsis. 
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IMPACT OF INFECTION ON HEMATOPOIESIS AND LYMPHOCYTE 
HOMEOSTASIS 
Dragana Janković 
1Immunoparasitology Unit, Laboratory of Parasitic Diseases, 
National Institute for Allergy and Infectious Diseases,  
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Aberrant differentiation of progenitor cells in the hematopoietic system is 
known to severely impact host immune responsiveness. The infection-induced 
decrease in function of primary lymphoid organs has been postulated to be a 
mechanism promoting pathogen virulence. Nevertheless, whether changes in 
primary lymphoid organs, together with “peripheral-tolerance” in secondary 
lymphoid organs and tissues, contribute to immunosuppression following a 
pathogen challenge is poorly understood. Our recent findings revealed that 
systemic infectious agents, such as T. gondii, can induce an 
immunocompromised state with quantitative and qualitative deficiency in naïve 
T cells associated with long-term thymic atrophy. Moreover, toxoplasma 
infection triggers transient bone marrow hypoplasia. When accumulated during 
the lifetime of the host, such events, even when occurring at low magnitude, 
could be a contributing factor in immunological senescence. 
Hematopoiesis is regulated by mesenchymal stromal cells in bone marrow. The 
same niche provides not only lineage-instructive differentiation signals but also 
supports homing of memory T lymphocytes and plasma cells. Pattern 
recognition receptors on mesenchymal cells have been implicated in sensing 
microbiota and maintaining steady-state hematopoiesis. We showed that in vivo 
administration of NOD1 ligand to germ-free mice restored the numbers of 
hematopoietic stem cells and precursors in bone marrow as well as serum 
concentrations of hematopoietic cytokines to the levels displayed by specific 
pathogen free control animals. Based on these findings we propose that sensing 
microbiota by mesenchymal cells serves as an important pathway underlying 
the requirement for microbiota in the maintenance of steady-state 
hematopoiesis. 
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Boris Turk1,2 
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Endolysosomal system contains over 50 hydrolases, including a number of 
proteases, which have a major role in numerous processes, in addition to 
intracellular protein turnover. Among these proteases, the most abundant are 
cysteine cathepsins.  In human genome there are 11 cysteine cathepsins, and 
although structurally similar, they do not have the same roles. Several of them 
are also associated with MHC II-mediated antigen presentation, prohormone 
processing and bone resorption. In a number of inflammation-associated 
diseases, including cancer, arthritis and atherosclerosis, they have been found 
to be secreted in the extracellular milieu. Early in vitro work suggested that 
their primary extracellular role is the degradation of the extracellular matrix. 
Several of cathepsins were suggested to be involved, but the major roles seem 
to have cathepsins B, K, S and L. In addition, there is increasing evidence that 
the cathepsins are, through the cleavage of different extracellular or membrane 
proteins, including various CAMs, CD44, EGFR and plexins involved in the 
regulation of many other processes, such as regulation of Ras GTPase activity. 
In addition, because of their high disease-related overexpression, they were 
found to be excellent targets for minimally invasive diagnostic imaging, 
primarily in cancer. Understanding and studying their specificity and 
identification of their physiological substrates are therefore of major 
importance for understanding their signaling pathways linked with disease 
progression and will be further discussed, as well as development of diagnostic 
imaging tools targeting cathepsins. 
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In modern allergology the term “allergen” is used for single allergenic molecules 
(proteins, glyco- and/or lipo-proteins) from an allergen source, for example, house dust 
mites or peanut, to name only a few. So far, extract-based in vitro- and in vivo-diagnosis 
was often proven to be insufficient regarding sensitivity and specificity, which is 
mainly due to the lack of certain allergens in diagnostic extracts. This is also relevant 
for treatment extracts since the lack of relevant allergens is associated with treatment 
failure. The identification of single allergens, their characterization and recombinant 
production is essential to improve allergy diagnostic tests (component-resolved 
diagnostics) as well as treatment options. Some single allergens are integral part of 
diagnostics already. In order to identify further / new allergens, proteomic methods are 
applied, such as SDS-PAGE with subsequent one- and two dimensional 
immunoblotting, several chromatography methods, N-terminal sequencing, mass 
spectrometry, and - depending on the allergen – peptide mass fingerprinting. In 
addition, the combination of these methods with peptide ligand libraries was shown to 
be most valuable. Allergenicity is defined by IgE-binding capacity for which sera from 
well-characterized patients should be used. The protein characterization is followed by 
epitope analysis which subsequently can be applied in microarray-based diagnostics 
tests. In addition, single allergens shown to be missing in the extract have already been 
used to spike extracts used for diagnostic tests, making the extract-based test more 
sensitive and specific. IgE-detection methods, be it on a protein-, be it on an epitope 
(peptide)-level, however, only document the patient’s sensitization. They do not prove 
the true allergy (clinically relevant sensitization). Recently, we succeeded in optimizing 
the combination of molecular allergology and a cellular allergy diagnostic test that in 
the case of peanut allergy allows the discrimination between sensitized (asymptomatic) 
and allergic patients. 
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PROTEINS AND PRO-ALLERGENIC CYTOKINES BY THE MAJOR 
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Kiwifruit is considered as a highly nutritive fruit in the human diet, thanks to its strong 
antioxidant capacity and high content of vitamin C (1). Besides health-promoting 
properties, kiwifruit is regarded as one of the most common causes of fruit allergies, 
especially in the last two decades (2). Actinidin (Act d 1), a cysteine protease isolated 
from kiwifruit has been recognized and used as a marker allergen for sensitization to 
this food source (3). The gastrointestinal barrier is the first line of defense against 
potentially harmful antigens that normally occurred in food. Epithelial cells in the 
gastrointestinal tract have an important role in the maintenance of the homeostasis and 
actively contribute to the development of food allergy (4). Very little is known about 
the molecular mechanisms underlying the disintegration of the intestinal epithelial 
barrier by actinidin. The aim of this study was to explore the effects of kiwifruit allergen 
Act d 1 on intestinal permeability, tight junction (TJ) proteins as well as pro-allergenic 
cytokines gene expression in the different parts of mice intestine (proximal, distal and 
colon). Orally administered Act d 1 increased intestinal permeability. This effect was 
accompanied by a change in the mRNA expression pattern of TJ proteins and innate 
pro-allergenic cytokines IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) 
compared to the control. Act d 1, based on its proteolytic activity, affects mRNA 
expression of tight junction proteins and pro-allergenic cytokines in vivo. The obtained 
results connect the proteolytic activity of Act d 1 protease with epithelial barrier 
dysregulation and shed new light on the understanding of the sensitization process.  
This research was supported by the Ministry of Education, Science and Technological 
Development of the Republic of Serbia, Grant No. 172049. Andrijana Nešić performed 
STSM at the Institute for Risk Assessment Sciences, University of Utrecht, 
Netherlands, which was supported by the COST Action FA1402. 
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Division of Cancer Biomolecular Therapy, Institute of Medical Science, The 
University of Tokyo, Minato-ku, Tokyo, Japan; 4Department of Cancer Drug 
Discovery and Development, Osaka International Cancer Center, Chuo-ku, Osaka, 
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Despite of its clinical success, majority of cancer patients remain unresponsive 
to currently available checkpoint inhibitors, leaving the quest for finding new 
modulators of tumor-specific immunity open. To understand the time-scale 
position of specific immune response during tumor control, we established a 
bioluminescence imaging model to monitor the interplay between 
immunogenic tumor and tumor-antigen specific immunity. By using B16-
OVA-Luc2 cells, we monitored the timeframe of tumor immune control and 
escape in the mice immunized with a model tumor antigen ovalbumin (OVA-
mice). The antitumor immune response in OVA-mice was found to be critically 
dependent on IFN-γ and CD8+ T cells and the tumor escape was strongly 
correlated with reduced clonality and loss of proliferative capacity of OVA-
specific CD8+ T cells within tumor microenvironment. Such tumor-antigen 
specific T cell dysfunction was not associated with the expression of exhaustion 
/ dysfunction markers such as PD-1, LAG3, TIM3 and KLRG-1. Instead, we 
found that the reduction of cell surface expression of NKG2D on OVA-specific 
CD8+ T cells, together with the altered transcription factor expression that 
control T cell differentiation and function, are coinciding with the tumor escape 
from immune control. Our findings suggest NKG2D as a marker of active 
tumor antigen-specific CD8+ T cells and potentially involved in controlling 
their functionality. 
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Type 1 diabetes (T1D) is T-cell dependent immune-mediated disease, in which 
the insulin-producing pancreatic beta cells are destroyed. T1D progresses 
through asymptomatic stages characterized by the appearance of 
autoantibodies, then dysglycemia and finally hyperglycemia and overt disease. 
These immunological and metabolic features can identify persons at high risk 
for T1D. Disease development reflects a failure of immune tolerance 
mechanisms that control autoreactive T cells with proinflammatory cytokine 
profiles. In that context, both CD4 +  helper and CD8 + cytotoxic T cells exert 
important role in T1D development. Thus, CD4+ T cells are required for 
activation of CD8+ T cells, then activated effector T cells infiltrate the pancreas 
and while CD4+T cells contribute to beta cell death through macrophage 
activation, CD8+ T cells directly kill beta cells in an antigen-dependent 
manner. When immunotherapy of T1D is concerned, previous studies 
suggested that anti-CD3 monoclonal antibodies (mAbs) may affect immune 
responses by induction of T regulatory cells (Tregs), the release of inhibitory 
cytokines, or depleting effector T cells. Treatment with anti-CD3 mAbs in 
patients with recent-onset T1D reduces the loss of beta-cell function, even as 
long as 7 years after diagnosis. Moreover, modulation of T cell function by anti-
CD3 mAbs, delays the progression to T1D for 2 years in subjects at high risk 
for T1D.  In that context, high-risk individuals who are progressing to T1D 
more slowly have increased frequency of CD8+ T cells, and express markers 
of T cell exhaustion and nonresponsiveness, TIGIT and KLRG1. These 
findings have directed novel therapeutic approaches in T1D and high risk 
individuals to the resetting the balance between Tregs and T effector cells.  
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Aim: Self-specific B and T lymphocytes play main roles in pathogenesis of 
autoimmunity and their selective elimination is a legitimate goal in the efforts to control 
disease progression. The complexity of autoimmunity is characterized by autoreactive 
T cell activation and the generation of IgG auto-antibodies specific to self-antigens - 
dsDNA, histones, nucleosomes, GAD65. Inhibitory B cell surface co-receptors such as 
FcγRIIb, CR1 and CD22 negatively regulate BCR signaling and engagement of these 
molecules inhibit B cell activation. One of the mechanisms for specific B cell 
suppression is the cross-linking of the surface immunoglobulins with the inhibitory 
receptors by IgG-peptide-containing immune complexes. We hypothesize that it may 
be possible to down-modulate the activity of autoreactive T and B cells in lupus- or 
diabetes-prone mice as well as in humanized NSG lupus and diabetes mouse models 
by treating them with protein engineered molecules, which co-crosslink the BCR and 
inhibitory receptors.  Methods: Protein chimeric molecules construction; MRL, NOD 
and humanized Immunodeficient NSG mouse models. The suppressive activities of the 
engineered molecules were tested in vitro and in vivo. The levels of auto-antibodies and 
cytokines in the mice sera as well as the apoptosis, the number of IgG-producing plasma 
cells and kidney injuries were quantified by ELISA, FACS, ELISpot, protein array and 
Histology. Results: By protein engineering we constructed several chimeric molecules 
by coupling different self-mimicking peptides to an anti-mouse FcγRIIb or anti-human 
CR1-binding monoclonal antibody. The administration of these chimeric molecules to 
autoimmune-prone or to humanized NSG mice, transferred with PBMC from 
autoimmune patients resulted in the reduction of the levels of IgG auto-antibodies, of 
the albumin and glucose serum levels, and in prevention of the glomerulonephritis 
development. Conclusion: Engineered chimeric molecules for targeting of antigens to 
the inhibitory receptors on self-reactive B cells are a tool for directed immune response 
modulation.  
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Milica Lazarević3, Bojan Jevtić3, Sofija Glamočlija1, Aleksandra Todorović1, 
Saša Vasilev1, Dušica Stojanović2, Dragana Vučević4, Ljiljana Sofronić-
Milosavljević1 
1Institute for the Application of Nuclear Energy-INEP, University of Belgrade, 
Banatska 31b, 11080 Belgrade, Serbia 
2Faculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, 11000 
Belgrade, Serbia 
3Institute for Biological Research “Siniša Stanković”, University of Belgrade, Despota 
Stefana 142, 11000 Belgrade, Serbia 
4Institute for Medical Research, Military Medical Academy 
 
More than a decade ago we have made our first contribution to Hygiene hypothesis by 
discovering that infection with Trichinella spiralis could dampen or even prevent the 
development of experimental autoimmune encephalomyelitis (EAE), an animal model 
of human autoimmune disease multiple sclerosis. T. spiralis exerts its impact on the 
host immune system through excretory-secretory muscle larvae (ES L1) products. 
Among the mechanisms underlying observed immunomodulation, anti-
inflammatory/regulatory mechanisms are the most significant. The application of T. 
spiralis ES L1 products through intraperitoneal injection or via tolerogenic dendritic 
cells (ES L1 TolDCs) proved to be successful in EAE amelioration, but some 
limitations regarding their possible application in humans were imposed. In aim to 
create novel therapeutic approach for multiple sclerosis, the new delivery system for 
ES L1 products was designed, made of biodegradable nano-fibers. This allowed usage 
of much smaller amounts of ES L1 during application (compared to above mentioned 
paths). The subcutaneous implantation procedure for ES L1-nanocarrier implies 
performance of a small surgical intervention ones before the induction of 
relapse/remitting form of EAE in DA rats. The results obtained on the systemic as well 
as on the target tissue level indicated a substantial potential of treatment with ES L1-
nanocarrier to restrain disease development and progression in animal model, and 
provided insight in mechanisms crucial for soothing inflammation and restoring 
immune homeostasis. (Grant No: 173047, 175102). 
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Messina, Italy 
3TherapyX, Buffalo, USA; 4Institute of Histology and Embryology, School of Medicine, 
University of Belgrade, Belgrade, Serbia; 5Department of Biomedical and Biotechnological 
Sciences, University of Catania, Catania, Italy 
Type 1 diabetes (T1D) is an autoimmune disease in which a strong inflammatory 
response causes the death of pancreatic β-cells. Attempts to induce anti-
inflammatory/regulatory immune mechanisms that would attenuate disease progression 
have shown little or no beneficial effects. We introduced microparticles (MPs) loaded 
with Transforming Growth Factor β (TGF-β) and All-Trans Retinoic Acid (ATRA), 
both known stimulators of T regulatory cell (Treg) differentiation and stabilization. 
Male C57BL/6 mice were treated with multiple low doses of streptozotocin to induce 
T1D, and orally treated with vehicle, empty MPs, or ATRA- and TGF-β-loaded MPs 
for 10 days (every other day). T1D incidence and immune cell infiltration into the 
pancreatic islets were lower in ATRA/TGF-β-MPs-treated mice. In Peyer’s patches 
(PP), ATRA/TGF-β MPs up-regulated tolerogenic dendritic cells (tolDC). 
Additionally, IL-1β expression was reduced in PP, as was the ratio of iNOS/Arginase 
expression, reflecting a less inflammatory environment. This was accompanied by 
reduced proportion of Th1 and Th17 cells and up-regulation of Treg. IL-17 expression 
within CD4+ T cells from PP was also lower and was accompanied by down-regulation 
in the expression of RORγt, a key transcription factor of IL-17. In the pancreatic lymph 
nodes (PLN), the situation was similar to PP regarding the down-regulation of Th1 
cells. Additionally, in response to ATRA/TGF-β MPs treatment, the proliferation of T 
effector cells was reduced in PLN, while Treg proliferated more. The presence of 
CTLA-4+PD1+ and CD39+IL-10+ Treg populations was also increased, indicating 
higher suppressive activity. In conclusion, ATRA and TGF-β released from MPs 
successfully ameliorated T1D by potentiating tolDC and Treg and inhibition of Th1 
cell differentiation in gut-associated lymphoid tissue and the draining lymph nodes, 
thus blocking the entrance of immune cells into the pancreatic islets and protecting β-
cells from further destruction. 
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EXOGENOUS IL-33 PREVENTS MLD-STZ INDUCTION OF DIABETES AND 
ATTENUATE INSULITIS IN PREDIABETIC NOD MICE 
Jovicic Nemanja1,2, Pavlovic Sladjana1, Petrovic Ivica1,3, Ljujic Biljana1,4, Miletic Kovacevic 
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Kragujevac; 2Department of Histology and embryology, Faculty of Medical Sciences, University of 
Kragujevac; 3Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac; 
4Department of Genetics, Faculty of Medical Sciences, University of Kragujevac; 5Department of 
Immunology, Institute for Biological Research "Sinisa Stankovic,", University of Belgrade 
Background and aims: Type 1 diabetes is an autoimmune disease caused by the immune-
mediated destruction of pancreatic β-cells. Prevention of type 1 diabetes requires early 
intervention in the autoimmune process. CD4+Foxp3+ Tregs participate as one of the most 
important cell types in limiting the autoimmune process. We have previously shown that IL-33R 
(ST2) deletion enhanced susceptibility to multiple low dose streptozotocin (MLD-STZ) induced 
diabetes. Aim: The aim of this study was to investigate the preventive and therapeutic effect of 
IL-33 in MLD-STZ induced diabetes and to delineate the mechanisms of its influence on 
autoimmune attack. Material and metods: For the induction of diabetes C57BL/6 mice were 
treated with five doses of 40 mg/kg STZ, and 0.4μg rIL-33 was administrated per mouse, four 
times, every second day from the day of disease induction. 16 weeks old NOD mice were treated 
with 6 injections of 0,4μg/mouse IL-33 (every second day). Glycemia, glycosuria and HbA1c 
levels were measured after diabetes induction and histological and immunohistochemical 
parametars in pancreatic islets were evaluated on day 28. Cellular make up of the pancreatic 
lymph nodes and islets were evaluated by flow cytometry. Results: IL-33 given simultaneously 
with the application of STZ completely prevented the development of hyperglycemia, glycosuria 
and attenuated islet mononuclear cells infiltration. IL-33 treatment enhanced the bias toward Th2 
immune response and increased the frequency and number of ST2+ Tregs. This was accompanied 
by higher number of IL-13 and IL-5 producing CD4+ T cells and increased presence of 
ST2+Foxp3+ Tregs in pancreatic lymph nodes and islets. Using IL-33 also promotes islet 
infiltration with M2 macrophages. IL-33 given 6 and 12 days after diabetes induction partially 
attenuates clinical signs and influx of inflammatory cells in the islets and had therapeutic effect. 
Conclusion: We provide evidence that exogenous IL-33 completely prevents the development of 
T cell mediated inflammation in pancreatic islets and consecutive development of diabetes in 
C57BL/6 mice by facilitating the induction Treg cells. To extend this finding for possible 
relevance in spontaneous diabetes, we showed that IL-33 attenuate insulitis in prediabetic NOD 
mice. This work was supported by a grant from the Serbian Ministry of Science and Education 
(projects no.175069 and 175071), research grant from University of Kragujevac, Faculty of 
Medical Sciences, Serbia (project no. JP 12/17) to SP and grant from Swiss National Science 
Foundation (project no. IZ73Z0_152407) to ML. 
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Bojan Jevtic1, Tamara Saksida1, Dragica Gajic1, Ivan Koprivica1, Verica Paunovic2, 
Ivana Stojanovic1, Nada Pejnovic1 
1Institute for Biological Research “Sinisa Stankovic”, University of Belgrade, Serbia 
2Institute for Microbiology and Immunology, School of Medicine, University of 
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Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the imbalance 
between the CD4 or CD8 T effector (Teff) cells and the FoxP3+CD4 T regulatory cells 
(Tregs) that leads to pancreatic beta-cells destruction causing insulin deficiency. 
Environmental factors, diet and microbiome are associated with the recent rise in T1D 
incidence. Intestinal immune cells must maintain a tolerogenic response in the gut that 
involves the development of Tregs. Recent data show that IL-2-producing type 3 innate 
lymphoid cells ILC3s (IL-2+ILC3) in the small intestine are essential for maintaining 
FoxP3+ Tregs and oral tolerance to dietary antigens and reveal the previously unknown 
direct communication between ILC3s and Treg cells in the gut. We investigated the 
frequencies of small intestine lamina propria IL-2+ILC3s and FoxP3+ Tregs during 
transition from prediabetes to diabetes in young and old female NOD mice. 20 weeks 
old, diabetic NOD mice had higher frequencies of LinnegCD45+RORγt+CD127+ ILC3s 
in small intestine lamina propria compared to 4 weeks of age-young NOD mice. 
However, the frequencies of IL-2-producing ILC3s and CD4+CD25hiFoxP3+ Tregs 
were significantly lower in diabetic NOD mice compared to young, prediabetic mice. 
We next investigated how microbiota change before diabetes induction is reflected on 
Treg and ILC3 populations. Male C57BL/6 mice were treated with broad spectrum 
antibiotics (ABX) for 14 days and then T1D was induced by multiple low doses of 
streptozotocin (STZ). Ex vivo cell analyses was done on day 10 after the first STZ 
injection. The significantly higher incidence of T1D observed in ABX-treated mice 
correlated with significantly lower frequencies of IL-2-producing ILC3s and 
FoxP3+Tregs in small intestine lamina propria compared to mice treated with STZ only. 
The obtained findings show that the decrease of tolerogenic ILC3s and FoxP3+Tregs in 
small intestine is associated with the progression and higher incidence of T1D. 
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Gabriela Boneva1, Nikolina Mihaylova1, József Prechl2, Stefka Delimitreva3, 
Andrey Tchorbanov1 
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Of Sciences, Sofia, Bulgaria; 2Immunology Research Group, Hungarian Academy Of 
Sciences, Budapest, Hungary; 3Department Of Biology, Medical University – Sofia, Sofia, 
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Introduction: Systemic Lupus Erythematosus (SLE) is an autoimmune systemic disease 
characterized by the appearance of autoantibodies directed against nuclear, cytoplasmic and 
cell- surface antigens. The fact that women are predisposed to SLE and the symptoms are 
exacerbated during active reproductive years and pregnancy emphasizes the importance of 
female hormones in the progression of autoimmunity. Hence, on account of the common 
reproductive complications, it is urgent to address the question how SLE can influence female 
fertility and vice versa. Mouse models of SLE are suitable tools for studying in details the 
interactions of different systems in the context of the present disease. Purpose: To follow the 
effect of SLE manifestations on the production and development of mouse oocytes. Method: 
Lupus-like symptoms were induced through intraperitoneal injection of hydrocarbon oil 
pristane in non-autoimmune Balb/C mice. The experimental animals were characterized using 
flow cytometry, ELISpot and ELISA. The collected oocytes were analyzed based on chromatin, 
tubulin and actin structures using Hoechst 33258, FITC-labeled alpha-tubulin antibody and 
rhodamine-labeled phalloidin, respectively. Results: A single i.p. injection of pristane led to the 
production of different autoantibodies accompanied by massive glomerular depositions of IgG-
containing immune complexes in the kidneys, and proteinuria. The total number of obtained 
metaphase oocytes from lupus mice was significantly lower compared to healthy controls. The 
maturation rate, i.e. the proportion of eggs reaching metaphase II, was also lower for lupus mice 
compared to control animals. In addition, oocytes from lupus mice presented specific 
abnormalities, including long chromosomes, disorganized spindle and missing actin cap. 
Discussion: Pristane-induced mouse model of lupus exhibited impairments of the reproductive 
system which may result due to disease activity, autoantibodies or damage in molecular 
mechanisms through the process of reproduction. The model will be further developed and the 
direct effect of female hormones on disease outcome will be studied in details. 
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IgG GLYCOSYLATION IN ACHR-AB AND MUSK-AB MYASTHENIA 
GRAVIS IDENTIFIED BY LECTIN AFFINITY ELECTROPHORESIS 
Ljiljana Hajduković1, Dragana Lavrnić2 
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Myasthenia gravis (MG) is a disease with disorder of transmission at the neuromuscular 
junction, characterized by weakness and fatigability of the skeletal muscle. The most 
frequent is acquired autoimmune form, with acetylcholine receptor autoantibodies 
(AchRAb) or muscle-specific tyrosine kinase autoantibodies (MuSKAb). 
Measurements of antibodies enable greater certainity and speed during the diagnostic 
procedure. The carbohydrate moiety of human serum IgG shows high structural 
multiplicity, particularly associated with various inflamatory, malignant and 
autoimmune diseases. However, there are not much literature data about IgG 
glycosylation in MG, and no one based on lectin interaction. The aim of the present 
work was examination of IgG glycosylation in sera of patients with two type of 
myastenia (AchRAb and MuSKAb positive) using lectin affinity electrophoresis with 
mannose-specific lectin ConA in the first dimension and monospecific anti-human IgG 
antibodies in second dimension. Control sera were tested in the same way. AchRAb 
and MuSKAb were determined using radioimmunoassay (RIA), and positive sera were 
further examined. Two-dimensional electrophoresis of MG sera without lectin resulted 
in the pattern very similar to controls. This was not the case with sera from RA patients 
whith massive IgG precipitate or myeloma sera with characteristic monoclonal fraction, 
obtained in our previous research. However, lectin ConA in the first dimension made 
difference, binding IgG in MG sera with higher affinity (determined by retardation 
coeficient) compared to control sera. Those results indicated better exposure of the 
three-mannose core, due to fewer terminal galactose residues  in IgG oligosaccharide 
chains in MG, compared to control. 
Our results are in accordance with some literature data obtained by mass spectrometry. 
More data (the level of fucose or bisecting N-acetylglucosamine) will be obtained using 
other lectins. Such research can be significant because N-glycosylation of the IgG Fc 
moiety influences its biological activity by modulating the interaction with Fc 
receptors. 
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Estrogens are steroid hormones which, beside reproductive organs, influence other 
physiological systems i.e. cardiovascular system, skeleton, cognition, etc. Their effects 
are achieved via estrogen receptors (ER) - α and β - both being polymorphic. 
Previously, a possible association was assessed between variants of ERα gene and 
antiphospholipid syndrome (APS), an autoimmune condition, predisposing to acute 
myocardial infarction (AMI). Lupus anticoagulant (LA) are one of the most frequently 
found antibodies in APS and fibrinogen level can be considered as an indicator of 
inflammation accompanying AMI. Our objective was to examine the influence of ERα 
c.454-397T>C variant on results of LA screening and fibrinogen measurement in 
patients with AMI. Study involved 120 patients (54 males and 66 females) with AMI. 
Commercially available tests were employed for LA screening and fibrinogen 
measurement. ERα genotyping performed using PCR-RFLP analysis. Results were 
analyzed using Student's t-test. On average, higher results of LA1 test were encountered 
in patients who were homozygote for Erα c. 454-397C allele (46.4±16.07 s vs 
39.9±6.41 s; P=0.008). LA2 results in patients with Erα c. 454-397CC genotype 
(51.8±13.82 s) were significantly above (P=0.018) values in patients with other 
genotypes (39.9±6.43). Higher fibrinogen concentrations were measured in carriers of 
Erα c. 454-397C allele (5.4±1.34 g/L vs 6.3±1.90 g/L; P=0.007). Also, homozygosity 
for Erα c. 454-397C allele was associated with difference in certain demographic 
characteristics i.e. higher body mass (82.7±16.38 kg vs 74.8±14.75 kg; P= 0.030) and 
height (175±7.8 cm vs 168±9.4 cm; P=0.002). Gender related differences were not 
present for either of the reported parameters. Our pilot results indicate higher values of 
LA screening tests and fibrinogen measurement in the presence of the ERα c. 454-397C 
allele. Further studies are necessary to comprehensively evaluate the causes and 
significance of these associations. 
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Collagen-induced arthritis (CIA) is a well-established experimental model mimicking 
many immunopathogenic and clinical aspects of rheumatoid arthritis (RA), including 
sexual dimorphism in the clinical presentation. Our previous study showed that a more 
severe disease in female compared with male rats correlated with more robust Th17 
response reflecting sexual dimorphism in Th17/Treg axis plasticity. Given that 
autoantibodies play a significant role in the immunopathogenesis of RA and CIA, in 
the present study the germinal center (GC) reaction in the lymph nodes draining 
inflamed joints and adjacent tissue (dLNs) was examined for putative sexual 
dimorphism. Female rats mounted greater serum collagen II-specific IgG response than 
their male counterparts. This dimorphism correlated with the higher frequency of GC 
B cells in female compared with male dLNs. Consistently, the frequency of 
activated/proliferating Ki67+ cells among dLN B cells was higher in females than in 
males. This was associated with the shift in dLN T follicular regulatory (Tfr)/T 
follicular helper (Tfh) cell ratio towards Tfh cells in females, and greater densities of 
CD40L and CD40 on their dLN T and B cells, respectively. The higher Tfh cell 
frequency in females was consistent with the greater dLN expression of mRNA for IL-
21/27, the key cytokines involved in Tfh cell generation and help to B cells. 
Additionally, in collagen II-stimulated female rat dLN cell cultures, IFN-γ/IL-4 ratio 
was shifted towards IFN-γ. Consistently, serum ratio between pathogenic IgG2a and 
protective IgG1 collagen II-specific antibodies was shifted towards the former in 
females. Thus, the study suggests that targeting T/B cell interactions should be 
considered in further translation research aimed to design sex-specific therapies for RA. 
(This work was supported by the grant 175050 from MPNTR RS). 
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Rheumatoid arthritis (RA) with a frequency of 0.5% to 1% in the general population is 
the most common systemic autoimmune disease associated with chronic inflammation 
and joint destruction. Sometimes it is difficult to differentiate RA from other forms of 
arthritis in the onset of the disease, so early diagnosis can be quite difficult. 
Autoantibodies found in RA can be present and detected years before the development 
of clinical symptoms. Due to toxic drugs that can cause very dangerous side effects, a 
highly specific marker is needed to identify patients with RA before joint damage 
occurs. The most significant feature of RA is the presence of specific antibodies. The 
IgM  Rheumatoid factor (RF) is detected with a sensitivity of 60-70% and a specificity 
of 80-90%. However, antibodies to cyclic citrulline peptide (CCP antibodies) have a 
higher specificity of up to 98%, and similar sensitivity of 68-80%. Anti-CCP antibodies 
are a potentially significant marker for the diagnosis and prognosis of RA because they 
are: sensitive and specific more than IgM RF in both early disease development and 
fully developed clinical features, they can predict eventual development in RA from 
undifferentiated arthritis, they are marker of disease erosivity, they can be detected in 
healthy people years before the clinical development of RA. The aim of this study is to 
compare the results of anti-CCP antibodies in patients with differentially diagnosed 
RA, with the results of anti-CCP antibodies after Methotrexate therapy.This study 
enrolled 30 patients with the ACR criteria for RA, who had elevated anti-CCP 
antibodies at the outset of the disease. After Metotrexat therapy no significant changes 
of anti-CCP levels were evaluated. We detected that anti-CCP antibodies were positive 
in 90% of RA patients at the early onset of the disease and after Metotrexat therapy we 
measured approximately the same value. 
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Sjögren’s syndrome (SS) is a complex autoimmune disease, characterized by a 
progressive hypofunction and inflammation of salivary and lachrymal glands. 
Diagnosis of SS is problematic, because it often relies on nonspecific signs and 
symptoms with no specific biomarker(s). Since saliva directly reflects salivary 
gland inflammation and damage, this body fluid appeared as useful tool for new 
biomarker research. In the last few years, salivary proteomic studies were 
conducted providing considerable contribution in the search of  SS biomarkers. 
As a body fluid, saliva contain a number of glycosylated proteins, including 
heavily glycosylated carcinoembryonic antigen (CEA), decsribed as 
inflammatory protein. This study aimed to investigate salivary proteome and 
CEA as a potential salivary biomarker in Sjogren’s syndrome patients. 
Quantitative salivary research was conducted on saliva samples collected from 
healthy women and SS female patients. The protein concentration was 
determined by using BCA protein assay kit (ThermoScientific), while proteome 
was analysed using electrophoretic techniques. The levels of CEA were 
measured using immunoradiometric assay IRMA CEA (INEP).The results 
showed altered salivary proteome of SS pateints compared to healthy subjects, 
especially in the area of smaller molecular masses. Beyond the proteome, CEA 
analysis showed that SS is associated with significantly increased CEA level in 
SS patients. The obtained results indicate that salivary CEA could be a 
potentially useful diagnostic and follow-up SS biomarker. Even more, due to 
many indicated roles of CEA family members, CEA presence could be 
functionally relevant in the pathogenesis of disease. 
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The ability to target DNA specifically at any given position within the genome allows many 
intriguing possibilities and has inspired scientists for decades. Early gene targeting approaches 
exploited chemicals or DNA oligonucleotides to interfere with the DNA at a given locus in order 
to inactivate a gene or correct mutations. In addition to the promise of gene correction, scientists 
soon realized that genes could be silenced and even re-activated without inducing potentially 
harmful DNA damage, by targeting transcriptional modulators to a particular gene.1 These first 
generation programmable DNA binding domains (polyamides, triplex forming oligonucleotides), 
however, proved difficult to fuse protein effector domains to.2 The engineering of gene-targeting 
proteins (ZFPs, TALEs) circumvented this problem, but required new protein fusions for each 
locus. The more recent introduction of CRISPR/Cas offers a flexible approach to target fusion 
dCas-proteins to the locus of interest using cheap designer RNA molecules. Many research 
groups now exploit this platform and the first human clinical trials have been initiated: 
CRISPR/Cas has kicked off a new era of gene targeting and is revolutionizing biomedical 
sciences. Following the increasing awareness of frequent epigenetic dysregulations in human 
diseases, and the success of clinically approved epigenetic drugs, the gene targeting platforms 
have been repurposed to edit epigenetic signatures at any given locus.3 Currently, this approach 
has convincingly demonstrated causality of various epigenetic modifications in instructing gene 
expression and has provided exciting indications supporting the promise to interfere with disease-
associated gene expression dysregulations. Some reports indicate the feasibility of long-term 
gene repression as well as re-expression,3 but solid guidelines on how to stably interfere with 
epigenetic gene regulation in any given chromatin environment are largely lacking. The expected 
progress in this aspect, together with developments in safe delivery methods, open novel 
therapeutic avenues and editing epigenetic signatures might realize the “curable epigenome” 
concept for currently untreatable diseases.  Financial support includes an EU SNN grant and an 
H2020 ITN grant (www.EpiPredict.eu). Networking activities are supported by EU COST 
CM1406 (www.EpiChemBio.eu) 
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Tomasz P Jurkowski 
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Epigenetic memory in the form of cytosine methylation is essential for 
vertebrate development and the formation of cellular identity (Lee, Hore and 
Reik, 2014). Active removal of DNA methylation by the action of the TET 
hydroxylase family is crucial for assisting cells to gain developmental potency, 
both in vivo and in culture, through the creation of induced pluripotent stem 
cells (Costa et al., 2014; Hore et al., 2016). Despite this, little is known about 
the molecular mechanisms that target the TET proteins to their site of action, 
and currently, it is assumed that all sites demethylate with equal efficiency. We 
report that mammalian TET enzymes show strong preference (>500 fold) for 
oxidation of a subset of CG containing hexamers (in vitro and in cultured cells). 
These preferred sequences constitute binding sites for developmental 
transcription factors whose DNA binding activity is regulated by DNA 
methylation. X-ray structural analysis and molecular dynamics simulations 
suggest that TET use indirect readout to sense the sequence context flanking 
CG sites. These results are significant for understanding epigenetic 
reprogramming during development and have implications for synthetic 
biology and epigenetic editing. 
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Myotonic dystrophy type 1 (DM1) is phenotypically one of the most variable 
monogenic diseases. It is caused by an expansion of CTG repeats in the DMPK gene. 
The number of CTG repeats is the main factor influencing disease severity. However, 
the effect of the causing mutation can be modified by different factors. An example of 
genetic factors are variant repeats (CCG, CTC, GGC or CAG) scattered among CTG 
repeats and found in about 5% of DM1 patients. We previously showed that variant 
repeats delay age at onset in DM1 patients by stabilizing DMPK expansions in somatic 
cells. Since our patients had various patterns of CCG repeats, we assumed that CCG 
repeats might be methylated themselves, similarly to CGG and G4C2 repeats in the 
expansions associated with Fragile X syndrome and Amyotrophic lateral 
sclerosis/Frontotemporal dementia, respectively. Therefore, our aim was to investigate 
whether CCG variant repeats in DMPK expansions were associated with changes in 
epigenetic marks both in the repeat region itself and in the surrounding CpG sites within 
a large CpG island, in which the DMPK repeat region is embedded. By using two 
originally designed methods: methyl-specific RP-PCR on a bisulfite-converted 
genomic DNA and classical RP-PCR on genomic DNA digested by SsiI enzyme. We 
discovered that variant CCG repeats were heterogeneously methylated within DMPK 
expansions. Targeted bisulfite sequencing revealed heterogenic methylation of CpG 
islands upstream and downstream of repeat tract. Based on the observation that the 
relative degree of methylation of CCG repeats and CpG islands depends on quantity 
and patterns of CCG repeats, it is hypothesized that methylation is initiated on CCG 
repeats and spreads locally on the surrounding CpG islands. The discovery of 
methylation of CCG repeats in DMPK expansions opens questions about the role of 
epigenetic mechanisms in the stabilization of DMPK locus.  
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Oral cancer arises in oral cavity and is the most common type of head and neck cancers. 
Epidemiology of oral cancer is worrisome, due to increased incidence worldwide, 
especially among younger people. Exposure to risk factors, such as smoking, alcohol 
consumption and infection with human papilloma virus, significantly increase risk to 
oral cancer susceptibility. In addition, accumulation of genetic and epigenetic changes 
leads to carcinogenesis of oral epithelial cells. The first line of oral cancer treatment is 
surgical resection. Despite successful removal of cancerous tissue, approximately 20% 
of patients will develop recurrence. As oral cancer is still challenging contemporary 
medical practice and patients’ outcome, revealing molecular complexity of this cancer 
type is needed. That is why scientific efforts are put into identification of more sensitive 
and novel molecular biomarkers for discrimination of oral cancer and surrounding non-
cancerous tissue as well as prognostic biomarkers.  
A class of small non coding RNA molecules, micro RNAs (miRNAs) is nominated as 
potential molecular biomarkers due to its stability in tissues. Using methodology of 
high-throughput platforms, numerous studies identified deregulated miRNAs in oral 
cancer compared to adjacent non-cancerous tissue, but obtained data are highly 
inconsistent. In order to find the most commonly deregulated miRNAs characteristic 
for oral cancer, we conducted the meta-analysis of previously published data. The list 
consisted of twenty commonly deregulated miRNAs in oral cancer compared to 
adjacent non-cancerous tissue. The biological meaning of miRNAs meta-list in oral 
cancer was characterized by bioinformatics enrichment analysis. Validation of 
identified miRNAs in an independent set of oral cancer clinical specimens by more 
sensitive methods, such as quantitative Real Time PCR is warranted. Based on our 
obtained results so far, it will be illustrated why it is important to continue studying 
miRNAs in oral cancer. 
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Tumors evolve through acquisition of genetic and epigenetic alterations that lead to 
diversification of tumor subclonal populations. One consequence of clonal evolution is 
phenotypic tumor heterogeneity manifested by spatial and temporal differences in gene 
and surface marker expression, aggressiveness, and response to therapy. Genetic 
mutations may activate oncogenes or abrogate function of tumor suppressor genes, but 
also give rise to modified proteins - neoantigens that can be recognized by the immune 
system to trigger adaptive response. Yet, cancer cells have evolved several mechanisms 
to avoid recognition by the immune cells or halt their response. Similarly, human 
tumors contain large numbers of epigenetic changes affecting gene expression and 
chromosomal stability. However, the extent of epigenetic alterations, both between and 
within spatially separated tumour regions, and their impact on tumor evolution is not 
yet understood. DNA methylation is one of the most studied epigenetic marks, 
frequently deregulated in cancer. Here we will show an application of reduced-
representation bisulfite sequencing (RRBS) for the study of DNA methylation on a 
cohort of 36 non-small cell lung cancer (NSCLC) patients. Leveraging clinically and 
multi-omics fully annotated multiregional cohort of NSCLC patients from the 
TRACERx trial, we have previously identified a novel epigenetic mechanism 
underlying immune evasion in cancer, through DNA methylation mediated silencing 
of neoantigens.  Here we use new algorithms to deconvolute pure tumor methylomes 
and evaluate the degree of both inter- and intra-tumour epigenetic heterogeneity to 
inform on the relationship between genetic and epigenetic tumour evolution, tumor 
phenotype and clinical outcomes. 
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Neoplastic transformation of human cells is in part attributed to a summation of genetic 
and epigenetic modifications. Most commonly, epigenetic control of gene expression 
is achieved via DNA methylation, histone modification and/or regulation by small non-
coding RNAs. Tumor suppressor gene (TSG) promoter hypermethylation represents a 
powerful mechanism of transcription silencing and the INK4a-ARF locus, encoding 
two tumor suppressors, p16INK4a and p14ARF, is one of the alteration hotspots in 
human neoplasms.  
Our research group has determined the methylation status of p14ARF and p16INK4a 
in a series of head and neck tumors. Benign (pleomorphic adenomas) and malignant 
salivary gland tumors (carcinoma ex pleomorphic adenomas and mucoepidermoid 
carcinomas), as well as oral squamous cell carcinomas (OSCC) have been analyzed 
using methylation specific PCR. Hypermethylation of p16INK4a and p14ARF appears 
to be a quite frequent event in all investigated pathologies; namely, the frequency 
ranged from 60 up to 100 %, depending on tumor type. The most remarkable finding 
was that all of the analyzed mucoepidermoid carcinoma samples exhibited p14ARF 
promoter hypermethylation. On the other hand, only 20% of the analyzed normal 
salivary glands exhibited this epigenetic modification. Interestingly, it seems that 
p16INK4a hypermethylation and p14ARF hypermethylation are unrelated events. In 
OSCC patients three types of samples were analyzed (tumors, tumor-free surgical 
margins and unaffected oral mucosa) for the simultaneous occurrence of these 
alterations and p14ARF was methylated in all three samples from 62% of patients, and 
p16INK4a in 35% of patients.  
p14ARF and p16INK4a promoter hypermethylation do not appear to be significantly 
related to tumor phenotype, i.e. to clinicopathological parameters in any of the 
examined neoplasms. However, their high frequency points to the importance of this 
epigenetic event in head and neck carcinogenesis and should be further analyzed in a 
larger cohort. 
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Epigenetic alterations represent one of the key mechanisms which drive development 
of diffuse gliomas. Among various alterations that occur as a result of disruption of 
DNA methylation patterns during diffuse glioma carcinogenesis, the methylation of the 
promoter of the O6-methylguanine-DNA methyltransferase (MGMT) gene was found 
to be prognostic and predictive epigenetic biomarker with a recognized clinical value. 
MGMT is DNA-repair enzyme which induces chemoresistance due to its ability to 
counteract with cytotoxic effect of alkylating agents such as Temozolomide (TMZ). 
Epigenetic silencing of MGMT through methylation of cytidine-phosphate-guanosine 
dinucleotides (CpG) in promoter region can lead to a more favorable outcome and 
treatment response. The goal of our study was to screen Serbian diffuse glioma patients 
for a methylation status of MGMT promoter and to estimate its impact on overall 
survival. Our cohort of samples included 33 diffuse glioma patients (21 male and 12 
female). Positive methylation status was detected in 17 patients (51.5%) by 
methylation-specific polymerase chain reaction. Preliminary results obtained in our 
study suggest that hypermethylation of MGMT promoter was not found to correlate 
with overall survival. Significantly higher overall survival was associated with younger 
patients in comparison with the patients older than 50 years (19 months – 7 months 
median survival). It was also recorded that greater extent of tumor resection influences 
overall survival in patients with diffuse gliomas. 
For more accurate evaluation, further evaluation of MGMT promoter methylation 
status on larger sample study is planned. 
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Chronic hepatitis C virus infection is characterized by progressive fibrosis of variable 
degrees and long-term progression to cirrhosis and hepatocellular carcinoma. 
Prevention of chronic hepatitis C and its complications is based on antiviral therapy 
and early detection of reliable molecular markers in persons under the risk. This study 
was designed to describe the relationship between host and viral factors and their 
impact on response to therapy with pegylated interferon/ribavirin (PEG-IFN/RBV) in 
patients with chronic hepatitis C (HCV) infection with genotype 1b. Also, we 
investigated how IL28B single nucleotide polymorphism (SNP) rs12979860 and 
aberrant methylation of RASSF1A gene may have an impact on therapy response and 
stage of liver fibrosis individually and simultaneously.  Samples were collected from a 
total 47 patients with chronic hepatitis C genotype 1b, before the start of PEG-
IFN/RBV therapy. The SNP rs12979860 were determined by TaqMan assay. 
Methylation status of RASS1A gene were determined by chemical bisulfite 
modification of DNA and subsequent PCR, using primers specific for either methylated 
or unmethylated DNA. Methylated RASSF1A was found in 34% (16 of 47) samples. 
Among 26 patients with CC genotype of IL28B, RASSF1A methylation was detected 
in 50% (13 of 26) of samples, while among 21 patients with CT/TT genotype, 
RASSF1A methylation was detected in 14,3% (3/21) of samples. Observed differences 
was statistically significant (p=0.024). We also found significant association between 
response to therapy and rs12979860 genotypes (p= < 0.001). Thus, patients with CC 
genotype of IL28B rs12979860 were significantly more frequent in sustained virologic 
response (SVR) group than in non-response (NR) group. There was no correlation 
between rs12979860 genotypes, methylation status of RASSF1A and stage of liver 
fibrosis individually and simultaneously. Our results suggest that combined analysis of 
RASSF1A gene methylation status and IL28B rs1297860 polymorphism could help in 
prediction of therapy response. 
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Thyroglobulin is a large glycoprotein which contains neutral sugars, sialic acid and 
iodine. In cow and pig, it also contains an α-gal epitope, which has been pinpointed as 
an epitope responsible for delayed immediate‐type hypersensitivity to red meat.  
The goal of this study was to test the reactivity of human serum IgE to unmodified 
commercial bovine and porcine thyroglobulin in ELISA. Two groups of subjects were 
tested; the people who were suspected to be atopic by general practitioners and 
professional athletes who declared themselves as not being atopic. Thyroglobulin 
specific IgE, IgG and IgG subclasses were tested in ELISA. IgE to commercial meat 
extract was also assessed in ELISA. Porcine thyroglobulin was separated according to 
charge on a DEAE matrix. The fractions were dot blotted and analyzed for IgE 
reactivity. 
Among 229 suspected atopic subjects 27 (11.8%) had high IgE level and 41 (17.9%) 
had moderate level of thyroglobulin specific IgE. The situation was similar with 
professional athletes (n=38) 15,8% high and 23.7% moderate. The suspected atopic 
subjects who had high IgE level to thyroglobulin also had statistically higher meat 
extract specific IgE, but were not significantly different in any other antibody 
class/subclass tested. The IgG subclasses present, specific for thyroglobulin were IgG2 
and IgG4.  
Subjects who had detectable IgE levels were significantly younger (Hi: intermediary: 
low= 13: 13: 27 years; p<0.0002; Kruskal-Wallis). The IgE reactivity to porcine 
thyroglobulin is dependent on charge. The reactivity to α-Gal epitope cannot be 
assessed by using unmodified commercial bovine or porcine thyroglobulin in ELISA. 
The function of the detected anti-thyroglobulin IgE antibodies is unknown, but 
considering their preferential distribution in the younger age group they might come 
from the pool of natural IgE antibodies.
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Background. Asthma is a chronic inflammatory airway disease. Many factors have been 
reported to aggravate asthma symptoms including respiratory infections (RIs). These 
latter may cause asthma exacerbations and may lead to emergency room visits and 
hospital admission. Objectives. i) To investigate respiratory infections in asthmatic 
adults from Tizi-Ouzou city. ii) To determine antibiotic sensitivity of isolated germs. 
Methods. Asthmatic patients were recruited from the pulmonary department of the 
Mohamed Nedir university hospital after completing an asthma questionnaire. Sputum 
samples from 13 adult asthmatics without apparent symptoms for RIs and 5 healthy 
subjects were collected and sputum cytology and culture (bacterial and fungal 
infection) were performed. All identified bacteria were tested for antibiotic sensitivity 
to 16 antibiotics. Results. Sputum cytological analysis showed the presence of 
leucocytes cells including eosinophils in 7 samples (> 53%) from asthmatic patients. 
Epithelial cells were detected in 9 asthmatic samples (> 69%). Bacterial germs were 
found in 5 (> 38%) asthmatic samples including Staphylococcus aureus, Klebsiella 
pneumonia, and Citrobacter freundii. However, Candida albicans was the only fungal 
germ found in 6 (> 46%) asthmatic samples. Interestingly, bacterial infection was found 
to be associated with high sputum total leukocyte values and high annual rate of asthma 
hospitalizations. No germs were found in non-asthmatic samples. Among tested 
antibiotics, only second generation cephalosporins (cefoxitin), aminoglycosides 
(gentamycin) and tetracyclines were effectives on all isolated bacteria.  Conclusion. 
Our results show the presence of germs in the sputum of adult asthmatics without RIs 
symptoms. Moreover, RIs in adult asthmatics are associated with asthma 
hospitalization. Antibiotics may be a beneficial therapy to reduce asthma exacerbation 
and hospitalization. Sputum analysis and culture as a routine test in pulmonary 
department may help health professional to reduce asthma exacerbation. 
 
Sunday, December 8th Session: CANCER 
119 
 
Poster presentation 
TARGETING OF INFLAMMATION-CONNECTED TUMORS BY CARBORANE-
CONJUGATED ROFECOXIB ANALOGS 
Blagoje Murganić1, Antonio Buzharevski2, Svetlana Paskaš1, Menyhárt-Botond 
Sárosi2, Markus Laube3, Peter Lönnecke2, Wilma Neumann2, Sanja Mijatović1, Jens 
Pietzsch3,4, Evamarie Hey-Hawkins2, Danijelа Maksimović-Ivanić1 
1Institute for Biological Research "Siniša Stanković"- National Institute of Republic of 
Serbia, University of Belgrade, Serbia; 2Institut für Anorganische Chemie, 
Universität Leipzig, Germany. 3Helmholtz-Zentrum Dresden-Rossendorf, Institute of 
Radiopharmaceutical Cancer Research, Department of Radiopharmaceutical and 
Chemical Biology, Dresden, Germany; 4Technische Universität Dresden, Faculty of 
Chemistry and Food Chemistry, Dresden, Germany 
Connection between inflammation and tumorigenesis is very well described in the 
literature. Inducible cyclooxygenase-2 (COX-2), due to its important function in 
inflammation and tumor initiation/progression, is one of the potential targets in the 
treatment of inflammation-associated tumors. However, the application of both 
nonselective and selective COX-2 inhibitors revealed serious life threatening adverse 
effects. Recently, it was found that introduction of a carborane moiety into COX 
inhibitors significantly improved their potency against different cell lines. The aim of 
this study was to evaluate the efficacy of carborane-containing analogs of rofecoxib on 
a panel of melanoma and colon cancer cell lines. Novel carborane-containing analogs 
of rofecoxib significantly diminished the viability of tumor but not healthy mouse 
macrophages. Among them, the most efficient is a nitric oxide (NO) modified 
carborane-containing analog of rofecoxib. This compound strongly suppressed the 
proliferation of A375 cells without significant contribution of apoptotic cell death. The 
increase of both NO and reactive oxygen/nitrogen species was observed upon the 
treatment of A375 cells with this compound explaining its cytostatic potential. 
Moreover, the release of NO was not detected in culture medium and conditioned 
culture medium, indicating that this compound does not behave as exogenous donor. 
Since this carborane-containing analog of rofecoxib did not inhibit the COX-2 activity, 
its tumoricidal potential can be ascribed to a COX-independent action.  In summary, 
the obtained results represent an excellent basis for further investigations of the 
antitumor potential of new classes of nonsteroidal anti-inflammatory drugs based on 
carborane-containing analogs of COX inhibitors in the treatment of inflammation-
associated tumors. 
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C60 molecule - third allotropic form of elemental carbon in nature known as fullerene 
is the only molecule of a single element able to form a spherical cage. Inspired by the 
extraordinary optical properties of that molecule, new form of light defined by fullerene 
icosahedral symmetry is created using fullerene nanophotonic filter (Zepter). It is 
confirmed that hyperpolarized light (HPL) promotes micro-circulation and body’s 
defense system. Additionally, the discovery of hydroxylated fullerenes, fullerol 
(3HFWC), with significantly improved solubility and, accordingly availability to 
biological systems, brought new possibility in the treatment of different pathologies. 
The aim of this study is to evaluate the influence of 3HFWC (Zepter) on highly 
invasive, anaplastic iNOS+ human melanoma cells, A375, alone or in the combination 
with short, 15 min pulse of HPL. A375 cells were exposed to 3HFWC for 48h in wide 
spectrum of doses.  Viability assessment, as well as microscopic evaluation, revealed 
significant decrease in the number of viable cells. Short term exposure to HPL 
remarkably potentiated effect of 3HFWC, while HPL alone didn’t affect cell viability 
in the same setting.  Determination of cell division rate in cultures exposed to IC50 dose 
indicated strong blockage in proliferation, while massive presence of enlarged, floating 
cells suggested that the nano substance provoked specific type of cell death, anoikis. 
The expression of β galactosidase indicated that A375 cells obtained senescent 
phenotype. All these effects were accompanied with inhibited ROS/RNS production, 
while, interestingly, NO was significantly potentiated and probably responsible for the 
mentioned effects. Importantly, while the viability of primary peritoneal exudate cells 
was not disturbed by 3HFWC and 15 min long HPL exposure, combined treatment 
stimulated the proliferation of lymphocytes.  Taken together, 3HFWC in combination 
with HPL might have beneficial effects on both tumor cells and immune system. 
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Introduction: The hemocyanins (Hcs) are oligomeric copper-containing glycoproteins 
that function as oxygen carriers in the hemolymph of several molluscs and arthropods. 
Molluscan Hcs have been studied intensively for many years as very promising class 
of anti-cancer therapeutic, generating strong humoral and cellular immune response. A 
possible mechanism for their antitumor effect is the presence of cross-reactive epitopes 
between the carbohydrate content of the hemocyanin molecule and tumor-associated 
carbohydrate antigens, which are characteristic for different types of cancer. Aim: The 
aim of the present work was to develop an experimental murine model of colon 
carcinoma and to investigate the anti-tumor activity of RtH and HpH. Materials and 
Methods:  The Hcs were isolated from marine snail Rapana thomasiana (RtH) and the 
terrestrial snail Helix pomatia (HpH). Murine colon carcinoma cell line C-26 was used 
for animal administration and solid tumor establishment. Flow cytometry was 
performed for phenotyping of spleen and tumor suspensions and an apoptosis assay. 
The levels of cytokines and anti-C-26 antibodies were quantified by ELISA. Results: 
The Hcs exhibited strong in vivo anti-cancer and anti-proliferative effects in the 
developed murine model of colon carcinoma. We observed a significant increase of the 
spleens in non-treated C-26-bearing mice compared to Hcs treated. The immunization 
with RtH and HpH prolonged the survival of treated animals, improve humoral anti-
cancer response and moderate the manifestation of C-26 carcinoma symptoms as tumor 
growth, splenomegaly and lung metastasis appearance. Conclusions: Hemocyanins are 
used so far for therapy of superficial bladder cancer and murine melanoma models. Our 
findings demonstrate a potential anti-cancer effect of hemocyanins on a murine model 
of colon carcinoma suggesting their use for immunotherapy of different types of cancer. 
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P-glycoprotein (P-gp) is an ATP-binding cassette (ABC) transporter whose 
overexpression in cancer cells is one of the main causes of multidrug resistance (MDR). 
P-gp overexpression is responsible for reduced intracellular accumulation and efficacy 
of both targeted therapies and classic chemotherapeutics. Therefore, P-gp has an 
important role in "absorption, distribution, metabolism, and excretion" – ADME 
studies. It is also considered as the first cellular defense line and a part of so-called 
“cellular immunity’. Tyrosine kinase inhibitors (TKIs) have been reported to interact 
with ABC transporters, and in some cases increase the susceptibility of cancer cells to 
chemotherapy. We have investigated the anticancer potential of novel tyrosine kinase 
inhibitors pyrazolo[3,4-d] pyrimidines and their prodrugs against two pairs of sensitive 
and MDR cancer cell lines with P-gp overexpression: non-small cell lung carcinoma 
(NCI-H460 and NCI-H460/R) and colorectal carcinoma (DLD1 and DLD1-TxR). The 
tested compounds displayed significant cell growth inhibition and enhanced the 
efficacy of doxorubicin and paclitaxel in MDR cancer cells. Some of the TKIs directly 
interacted with P-gp and inhibited its ATPase activity. A kinetics study showed that the 
compounds increased the intracellular accumulation of the P-gp substrate rhodamine 
123 in a time-dependent manner.  Treatment with the compounds did not increase the 
mRNA expression level of P-gp in resistant cancer cells. The investigated pyrazolo[3,4-
d] pyrimidines showed significant potential for reversing P-gp-mediated MDR even in 
prolonged treatment, making them good candidates for further development regarding 
treatment of resistant cancers. 
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Cadmium (Cd) is one of the most cytotoxic agents and environmental contaminants, 
which can cause serial health problems in various organs such as liver, kidney, testis, 
bone, nervous tissue and immune system. Furthermore, Cd is classified as a human and 
animal carcinogen agent. Despite the fact that Cd accumulates in the skin, there is a 
lack of evidence about its involvement in skin cancer biology. Skin cancer is one of the 
most common cancers worldwide, with melanoma as the most lethal type. Based on 
that, we set up the study to examine the effect of cadmium on the B16 melanoma cell 
line, measuring viability by MTT and crystal violet (CV) tests, proliferation rate 
(CFSE), ROS production (DHR), migration (scratch test) and adhesion on matrigel. 
The results showed that non-cytotoxic doses of cadmium (ranging from 0,3-2,5µM) 
increased viability, proliferation, and migration of B16 cells, while at the same time 
slightly promoted ROS production. Otherwise, pronounced oxidative stress induced by 
higher doses (ranging from 5-20µM) led to cell death. Summary, these results showed 
that low doses of cadmium could upregulate B16 melanoma cell line growth and 
migration probably through moderate ROS/RNS generation and thus their ability to 
modulate relevant signaling pathways involved in cancer progression. Considering that, 
underlying mechanisms of Cd impact on melanoma cell lines proliferation, migration 
and invasiveness needs to be clarified in vitro, as well as its relevance for in vivo system. 
The work is supported by the Ministry of Education, Science and Technological 
Development of the Republic of Serbia, Grant #173013 and #173039 
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Thanks to their unique cage-like structure and electron-deficiency, carbon 
nanomaterials fullerenes are in the focus of research in many fields, including medicine. 
An important task for the application of fullerenes in therapy of different pathologies, 
including cancer, is to achieve their water solubility. By addition of hydroxyl groups, a 
Hyper-harmonized Fullerene Water Complex (3HFWC, Zepter) with significantly 
improved solubility and bioavailability was patented. The fullerene-based 
nanotechnology was recently applied in light therapy, by the application of fullerene 
nanophotonic filter in BIOPTRON® device (Zepter), thus changing the properties of 
light and converting it to hyperpolarized light (HPL). The beneficial effects of HPL on 
micro-circulation, wound healing and immune system is already confirmed. The aim 
of this study was to investigate the antitumor activity of 3HFWC on melanoma cells in 
vitro, alone or in the combination with HPL. For this purpose, B16-F10 mouse 
melanoma cells were exposed to 3HFWC for 48h (IC50 dose - 50 µg/ml). In order to 
evaluate HPL effects, single, short term irradiation of cells with HPL was applied. Our 
results on determination of cell division rate as well as microscopic analysis, clearly 
demonstrated inhibition of proliferation, without significant increase of cell death. 
Although HPL alone did not affect significantly proliferation rate of melanoma cells, 
our study showed that it potentiated 3HFWC effects. Additionally, senescent phenotype 
was stimulated during these treatments, as confirmed by β galactosidase expression, 
the appearance of giant mitochondrial and accumulation of lipid bodies. Additional 
ultrastructural study demonstrated internalization of 3HFWC aggregates by 
endocytosis. In conclusion, our results clearly demonstrate antitumor effects of 
3HFWC on B16-F10 melanoma cells, which is stimulated by HPL. Thus, their 
combination presents potentially promising strategy in cancer therapy. 
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Aim: We investigated the mechanism and the role of autophagy in phorbol myristate acetate 
(PMA)-induced myeloid differentiation of human acute myeloid leukemia HL-60 cells. Methods: 
The mRNA levels of myeloid differentiation markers colony stimulating factor 1 receptor 
(CSF1R), early growth response protein 1 (EGR1), and interleukin 8 (IL-8), were assessed by 
real-time RT-PCR. Cell cycle arrest and the expression of surface myeloid marker CD11b and 
CD45 were analyzed by flow cytometry. Autophagy was monitored by acridine orange staining, 
RT-PCR analysis of autophagy-related (ATG) gene expression, immunoblot analysis of LC3-
II/p62, Beclin-1/Bcl-2 interaction, nuclear translocation of transcription factor EB (TFEB) and 
Foxo3. The activation of MAP kinases extracellular signal-regulated kinase (ERK) and c-Jun-N 
terminal kinase (JNK) was assessed by immunoblotting. Pharmacological inhibition and RNA 
interference (RNAi) were used to determine the role of MAP kinases in autophagy and HL60 
cell differentiation, while the role of autophagy in HL60 differentiation was analyzed using 
RNAi-mediated knockdown of ATG5 and p62. Results: PMA-induced differentiation of HL-60 
cells into macrophage-like cells was confirmed by cell-cycle arrest accompanied by elevated 
expression of p21, CD11b, CD45, CSF1R, EGR1, and IL-8. The induction of autophagy was 
demonstrated by accumulation of LC3-II, the increase in autophagic flux, the increase in 
expression of ATG genes, nuclear translocation of TFEB and Foxo3 and dissociation of 
Beclin1from Bcl-2. The suppression of autophagy by RNAi–mediated knockdown of ATG5 or 
p62 counteracted myeloid differentiation of HL60 cells. Both ERK and JNK were activated by 
PMA, and their pharmacological and genetic inhibition decreased PMA-induced autophagy and 
differentiation of HL60 cells. Conclusion: Our study revealed the involvement of JNK and ERK 
in autophagy-dependent differentiation of HL60 cells into macrophage-like cells, indicating 
MAP kinase-mediated autophagy as a possible target for the treatment of acute myeloid 
leukemia.  
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Changes in morphology and organization of extracellular matrix (ECM) in cancer, 
itself, are the subject of numerous studies, while it is far less known about the changes 
in the uninvolved mucosa away from cancer. The aim of our study was to analyse 
changes in morphology and organization of ECM components in the uninvolved 
colonic mucosa 10 cm and 20 cm away from the cancer, in comparison with healthy 
subjects.Tissue samples 10 cm and 20 cm away from the colon cancer, were obtained 
during colonoscopy from 25 patients and 30 healthy controls at the University Hospital 
Center "Dr Dragiša Mišovic-Dedinje". For collagen fiber visualization and analysis 
nonlinear laser scanning microscopy with SHG detection was used. CT-FIRE and 
CURVE-ALIGN were used to assessed individual collagen fibers and calculate length, 
straightness, width and alignment. The anisotropy parameter β was calculated on the 
same microscope with addition of polarizer. For analysis of reticular fibers Gomori's 
silver impregnation technique was used. For visualization of periostin and hyaluronic 
acid immunohistochemical staining with anti-periostin and anti-HABP antibody was 
used. In the Fiji and Icy softwares we calculated representation of extracellular matrix 
components and diameter of spaces between them. At the distance 10 cm and 20 cm 
away from the cancer, representation of ECM components was significantly decreased, 
compared with healthy mucosa. The diameter of spaces between ECM components 
were significantly increased. Also, we detected increase in length, width, straightness 
and alignment of collagen fibers at the distance 10 cm and 20 cm away from the cancer 
compared with healthy colon lamina propria. Using different, complementary 
approaches we detected changes in morphology and organization of ECM components 
at the distance 10 cm and 20 cm away from colon cancer, compared with healthy 
subjects. 
 
Sunday, December 8th Session: CANCER 
127 
 
Poster presentation 
EFFECTS OF PACLITAXEL ON TGF-β-INDUCED UROKINASE-TYPE 
PLASMINOGEN ACTIVATOR EXPRESSION AND MIGRATION OF RAW 264.7 
MACROPHAGES 
Sonja Mojsilović1, Slavko Mojsilović2, Milica Tošić3, Marija Živanović3, Sunčica 
Bjelica3, Tatjana Srdić-Rajić4, Juan F. Santibañez3,5 
1Laboratory for Immunochemistry, Institute for Medical Research, University of Belgrade, 
Serbia; 2Laboratory for Experimental Hematology and Stem cells, Institute for Medical 
Research, University of Belgrade, Serbia; 3Group for Molecular Oncology, Institute for Medical 
Research, University of Belgrade, Serbia; 4Department of Experimental Oncology, National 
Cancer Research Center, Belgrade, Serbia; 5Integrative Center of Biology and Applied 
Chemistry (CIBQA), Bernardo O'Higgins University, Santiago, Chile;  
 
Paclitaxel (PTx), a natural diterpene alkaloid, is a widely used anticancer drug with immune-
activating properties. It irreversibly enhances polymerization of microtubules (MT), disrupting 
tubulin cytoskeleton dynamics, leading to cell migration inhibition, cell cycle arrest, and cell 
death. It was shown that PTx reduce macrophage (Mφ) tumor infiltration and induce Mφ M1 
polarization. On the other hand, transforming growth factor-β (TGF-β) is highly abundant in 
tumor in tumor microenvironment plays a profound role in regulating Mφ function and tumor 
growth. It induces alternative Mφ activation that favors immunosuppression and tumor 
progression. TGF-β also increases macrophage recruitment to tumor stroma by mechanisms that 
include enhancement of cell motility and extracellular matrix degradation. MT integrity is crucial 
for TGF-β intracellular signaling, which suggests that PTx may be useful for targeting MT 
cytoskeleton and regulating signaling and functions of TGF-β in Mφ. 
In this study we used mouse macrophage RAW 264.7 cells treated with combinations of PTx and 
TGF-β. Proliferation was analyzed by MTT assay and cell cycle analysis. Immunofluorescence 
was performed to determine tubulin cytoskeleton and Smad3 nuclear localization. Western blot 
and transcriptional luciferase reporters were used to measure signal transduction activation. 
Migration was determined by wound-healing assay. uPA activity was determined by zymography 
assay. We found that PTx decreased RAW 264.7 cell proliferation by inducing G2/M cell cycle 
arrest and profoundly modified the tubulin cytoskeleton. Also, PTx inhibited TGF-β-induced 
Smad3 activation. Furthermore, PTx decreased cell migration and uPA expression stimulated by 
TGF-β. Remarkably, p38 MAPK mediated PTx inhibition of uPA activity induced by TGF-β, 
but it was not implicated in cell migration inhibition. In conclusion, PTx inhibits TGF-β induction 
of mouse Mφ migration and uPA expression, suggesting that PTx, as TGF-β targeting therapy, 
may enhance Mφ anticancer action within tumors. *Mojsilovic S, Tosic M, Mojsilovic S, 
Zivanovic M, Bjelica S, Srdic-Rajic T, Santibanez JF. Paclitaxel inhibits transforming growth 
factor-β-increased urokinase-type plasminogen activator expression trough p38 MAPK and 
RAW 264.7 macrophage migration. J BUON (in press) 
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Omega class glutathione transferases, GSTO1-1 and GSTO2-2, exhibit a distinctive range of 
different activities involved in regulation of inflammation, apoptosis and cellular redox 
homeostasis. Significant changes in those cellular processes occur in clear cell renal cell 
carcinoma (ccRCC). We aimed to determine the potential effect of GSTO1*C419A (rs4925), 
GSTO2*A424G (rs156697) and GSTO2*A183G (rs2297235) polymorphisms on postoperative 
prognosis in ccRCC patients. Furthermore, in non-tumor and tumor ccRCC tissue GSTO1-1 and 
GSTO2-2 expression, as well as, phosphorylation status of PI3K/Akt/mTOR and Raf/MEK/ERK 
signaling pathways was assessed. Considering the role of GSTO1 in IL1-β posttranslational 
processing, pro-IL-1β and IL-1β levels in ccRCC tissue samples were determined. Additionally, 
we investigated possible association of GSTO1 with signaling molecules known to be regulated 
by glutathionylation. GSTO1 (rs4925) and GSTO2 (rs156697, rs2297235) genotyping was 
performed in 239 ccRCC patients, while ccRCC tumor and non-tumor specimens were used for 
immunoprecipitation and immunoblot using anti-GSTO1, Akt, phospho-Akt (pT308), β-actin 
antibodies and Akt/MAPK signaling pathway antibody cocktail. Pro-IL-1β and IL-1β levels in 
tumor ccRCC tissue samples were determined by ELISA. We showed that GSTO1*CC (rs4925) 
genotype, exhibiting higher deglutathionylase activity, predicts shorter survival among male 
patients (p=0.049). Additionally, male carriers of GSTO1*CC (rs4925) genotype had 
significantly increased mortality risk compared to the carriers of GSTO1*A allele (p=0.037). 
Higher protein expression of GSTO1-1 and GSTO2-2 has been shown in tumor ccRCC compared 
to their respective non-tumor specimens (p=0.002, p=0.007, respectively). Expression of 
phosphorylated proteins of Akt/MAPK signaling pathway (p90RSK1 (pS380), Akt (pS473) and 
ERK1/2 (pY204/187)) was increased in ccRCC tumor compared to corresponding non-tumor 
specimens. Furthermore, immunoprecipitation has shown an association of GSTO1 with Akt, 
phospho-Akt, p90RSK1 (pS380) and RPS6 (pS235/236). Weak positive correlation was found 
between GSTO1 protein expression and IL-1β/ pro-IL-1β ratio (r=0.260, p=0.350). In conclusion 
GSTO1*CC genotype might be determinant of postoperative prognosis among male ccRCC 
patients. 
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The dehydrogenate polymer from coniferyl alcohol (DHP; a lignin model compound) 
in alginate hydrogel (ALG) has been shown to exert a strong antibacterial activity. To 
broadens a spectrum of potential DHP/ALG application, we aimed this study to 
evaluate the immunomodulatory activity of DHP/ALG. DHP and ALG were tested 
separately and in mixture (1:2 w/w) for their impact on in vitro production of cytokines 
(IL-6, IL-12, and IL-10) and reactive oxygen (ROS) and nitrogen (RNS) species by 
resident (RMs) and thioglycolate-elicited (TGMs) peritoneal macrophages of BALB/c 
mice. RMs and TGMs were stimulated (48h) with ALG and DHP in concentrations 
previously shown to be non-cytotoxic (up to 50 and 25 µg/ml, respectively). DHP/ALG 
promotes simultaneous production of inflammatory (IL-6, IL-12) and regulatory 
cytokines by RMs in a positive dose-dependent manner. Production of inflammatory 
cytokines was stimulated by ALG, while an increase in IL-10 production positively 
correlated to the concentration of DHP. ALG also stimulated the production of IL-12 
by TGMs, which was mirrored in the outcome of ALG/DHP stimulation. The 
significant increase in the activity of myeloperoxidase (MPO) due to DHP and/or ALG 
stimulation was recorded in TGMs, while a slight increase in MPO activity in RMs was 
recorded only upon stimulation with the higher amount of ALG. ALG in a positive 
dose-dependent manner stimulated the production of ROS and RNS by both RMS and 
TGMs. In all cases, except ROS production by RMs, the impact of ALG stimulation 
was mirrored in the outcome of ALG/DHP stimulation. Our results suggest that 
DHP/ALG exerts an immunomodulatory activity that could complement already 
reported antimicrobial activity and warrants further investigation on the use of 
DHP/ALG in the treatment of infectious diseases. (Supported by Ministry of Education, 
Science and Technological Development Republic of Serbia, grants 172049 and 
173017) 
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Many plant extracts are well known for their anti-oxidant, anti-bacterial and anti-
inflammatory activities including Aronia berry-derived juices and powders. In 
comparison to other black berries, Aronia berries have a greater content of phenolic 
constituents such as procyanidins, anthocyanins and phenolic acids with antioxidative 
and anti-inflammatory properties. However, the effects of aronia berries extract on the 
immune response parameters have been only sporadically assessed. When administered 
orally to healthy C57BL/6 mice (50 mg/kg body weight), aronia extract exerted 
immunomodulatory effects as evidenced by decreased proportion of F4/80+ 
macrophages, CD11c+ dendritic cells, CD4+ T helper cells, CD8+ T cytotoxic 
lymphocytes and CD4+CD25- activated lymphocytes within the gut-associated 
lymphoid tissue. Surprisingly, oral consumption of chokeberry extract in doses of either 
200 mg/kg bw or 50 mg/kg bw in mice with multiple low dose streptozotocin-induced 
type 1 diabetes resulted in the increase of blood glucose levels. Further, our study shows 
that this detrimental effect on type 1 diabetes pathogenesis may be a consequence of 
the pro-inflammatory nature of the extract. This is based on the evident stimulation of 
macrophages and dendritic cells by the extract through up-regulation of pro-
inflammatory mediators such as nitric oxide, IL-12, IL-6 and TNF in vitro. Also, this 
extract augmented differentiation of IFN-γ-producing T helper 1 cells in vitro. 
Collectively, the obtained results imply that our particular aronia berries fruit extract 
displays pro-inflammatory characteristics and that care should be taken when these 
berries are to be included in the human diet. 
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Cucurbiturils (CB[n]) are nanoscale macrocyclic compounds capable of 
encapsulating a molecule or a fragment of the molecule drug compounds by 
forming host-guest complexes. Integration of drugs with cucurbituril used for 
the following purposes: to control clearance, protection of the drug from the 
biodegradation of targeted delivery to specific organs, tissues or cells, reduce 
toxicity, improve the solubility, etc. However, one of the major problems 
encountered in the application of new drug delivery systems is the study of their 
biological properties. Today it is known that CB[n], unlike many other often 
toxic nanoparticles, have extremely low toxicity in high doses. However, many 
aspects of the biological actions of these nanoscale cavitands, including 
immunotropic properties remain unclear. The aim of this study was to 
investigate immunotoxicity and immunomodulation properties of CB[7]. It was 
found that CB[7] did not decrease of viability of PBMCs in all used 
concentrations from 0.1 to 1 mM.  In addition, 0,5 mM concentration of CB[7]  
increase the number of T-helpers,but decrease in the expression of activation 
markers (CD69, HLA-DR) on T cells. Overall, results indicate 
immunomodulatory effect of high concentrations of CB[7]. The reported study 
was funded by Russian Science Foundation according to the research project 
?19-15-00192.  
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Aging differently affects the expression of estrogen receptors alpha and beta 
(ERα and ERβ) and Toll-like receptors (TLR4) on peritoneal cavity cells of 
male and female rats. We explored the involvement of ERα and ERβ in the in 
vitro treatment of LPS-stimulated peritoneal macrophages with 17β-estradiol 
(which stimulates both receptors) or genistein (which is predominantly an ERβ 
agonist) on inflammatory cytokine secretion from young (3 months old) and 
middle-aged (16 months old) female and male AO rats. Aging diminished the 
proportion of TLR4+ cells and secretion of IL-1β and IL-6 in macrophages 
from female rats while the effect on male rat macrophages was opposite. 17β-
estradiol increased IL-1β secretion by middle-aged females’ macrophages via 
ERα, and suppressed it in cells from young females via ERβ. Genistein-induced 
decrease of IL-1β in macrophages from all experimental groups was probably 
mediated by ERβ. 17β-estradiol augmented IL-6 secretion by cells from all 
experimental groups via ERα while genistein diminished it in all females’ and 
in middle-aged male rats’ macrophages by activating ERβ. However, genistein 
increased IL-6 secretion from macrophages of young male rats via ERα. 
Although 17β-estradiol and genistein stimulated secretion of macrophage 
inflammatory cytokines via ERα and suppressed it probably via ERβ, their 
modulatory actions were determined by aging-induced changes in macrophage 
ERs expression and possible ERα / ERβ interactions (Supported by Ministry of 
Education, Science and Technological development, Republic of Serbia, Grant 
No 175050). 
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Korean red ginseng (KRG) has long been used as a traditional herbal medicine 
with various pharmacological effects. In this study, KRG was shown to reduce 
lipoteichoic acid (LTA)-induced nitric oxide (NO) secretion and inducible 
nitric oxide synthase (iNOS) expression in BV-2 microglial cells without 
cytotoxicity. And it also suppressed nuclear translocation of NF-κB p65 and 
degradation of IκB-α. Furthermore, heme oxygenase-1 (HO-1) protein was 
dose-dependently increased by KRG and this induced HO-1 suppressed iNOS 
expression. In addition, KRG-mediated HO-1 expression was suppressed by 
the inhibitors of phosphoinositide-3-kinase (PI-3K) and mitogen-activated 
protein kinases (MAPKs), and KRG induced the phosphorylation of these 
kinases. Thus, these results suggest that KRG might be very useful treatment 
for Gram-positive bacteria-induced neuroinflammation and also have 
therapeutic potential for various neuro-inflammatory diseases. 
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Alphaketoglutarate (aKG) is a key intermediate in cell metabolism. Exogenous 
aKG was shown to extend the lifespan by regulating the cellular response to 
callory restriction (CR). However, it is not known how the exogenous aKG 
affects immune responses, particularly those mediated by key 
immunoregulatory cells, dendritic cells (DC). Using a model of human 
monocyte-derived DC, we found that exogenous aKG (10mM or 50mM) does 
not induce autophagy in DC (according to LC3II expression), but impairs the 
differentiation of DC from monocytes (acording to CD1a and CD14 co-
expression). Additionally, aKG inhibited LPS/IFN-γ-induced upregulation of 
NLRP-3, IL-1β, HLA-DR, CD83, CD86, CD40, CCR7, CD209, IL-33, IL-10 
and IL-12p70 expression in DC, but potentiated the capacity of these cells to 
express TGF-β, CD73, and IL-23 in a dose-dependent manner. Although aKG-
treated DC, displayed a lower capacity to stimulate proliferation of alloreactive 
T cells compared to control mature DC, the normalized number of 
CD4+RORγt+IL17+ (Th17) and CD4+GATA3+IL-4+ (Th2) cells was higher, and 
the number of CD4+T-bet+IFN-γ+ (Th1) and CD8+IFN-γ+GranzA+Perf+ (CTL) 
was lower in co-cultures with aKG-treated DC, compared to corresponding 
control DC. Morover, aKG increased significantly the capacity of DC to induce 
CD4+CD25hiCD127-FoxP3+ Tregs in a dose dependent manner. These results 
suggested that, while exogenous aKG could have beneficial effects on lifespan, 
the quality of life might be compromized due to its immunomodulatory effects 
related to reduction of Th1 mediated immune responses.  
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Cellulose nanocrystals (CNC) are attractive nanomaterials with large surface area 
suitable for development of drug delivery and diagnostics systems. However, the 
biocompatibility and immunomodulatory properties of CNC have not been studied so 
far. Here we used wood-based native (n)CNC, TEMPO-oxidized (o)CNC and 
phosphonated (p)CNC, to assess their toxicity and immunomodulatory potential on 
human monocyte derived dendritic cells (MoDC) in vitro. We found that non-toxic 
concentrations CNC impair the differentiation of MoDC, according to CD14/CD1a co-
expression analysis. oCNC displayed the strongest inhibitory effect on MoDC 
differentiation, followed by nCNC and pCNC, respectively. These results correlated 
with the weakest maturation capacity of oCNC-treated MoDC upon stimulation with 
LPS/IFN-γ. Additionally, nCNC- and oCNC-treated MoDC expressed higher levels of 
PD1-L, TGF-β and ILT-4 compared to control MoDC, whereas pCNC-treated MoDC 
showed no such phenotypic properties. The capacity of MoDC to produce higher levels 
of IL-12p70, IL-1β, IL-23, and low levels of IL-10, were impaired by nCNC and oCNC, 
but not by pCNC. In line with this, nCNC- and oCNC-treated MoDC displayed an 
increased capacity to induce alloreactive Th2 cells, and TGF-β-producing 
CD4+CD25hiFoxP3+ Treg cells, and a decreased capacity to induce IFN-γ-producing 
Th1 cells in co-culture. Cumulatively, these results suggest that CNC may induce 
tolerogenic properties in MoDC, whereas phosphonation of CNC prevents such an 
effect, thus restoring the immunogenic potential of MoDC. 
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1Institute for the Application of Nuclear Energy—INEP, University of 
Belgrade, Belgrade, Serbia; 2Institute of Pathology, Medical Faculty, 
University of Belgrade, Belgrade, Serbia 
Papillary thyroid carcinoma (PTC) is the most common malignant tumor of the 
endocrine system. However, little is known about the genetic mechanisms underlying 
the development of PTC. BRAFV600E is the most common somatic mutation found in 
PTC that confers constitutive activation of the MAPK/ERK pathway. BRAF-activated 
long non-coding RNA (BANCR) is a novel and potential regulator of cancer cell 
proliferation and survival. But, findings concerning BANCR expression and its 
function in thyroid carcinomas are controversial. The aim of the present study was to 
explore the possible influence of the BRAFV600E mutation on BANCR level of 
expression in PTC. The level of expression of BANCR in PTC and matched 
nonmalignant thyroid epithelial tissues from 54 patients was determined using 
quantitative RT-PCR. Mutant allele-specific PCR was used for the detection of the 
BRAFV600E mutation presence. In the total sample, there is noticeable decrease of 
BANCR expression in PTC vs. adjacent nonmalignant thyroid tissue, but the down-
regulation is not statistically significant. Conversely, the relative level of expression of 
BANCR in PTC depends on the presence of the BRAFV600E mutation, so the presence 
of the BRAFV600E mutation associates with lower relative BANCR expression in PTC 
(p=0.011). Furthermore, the fold change of BANCR expression in PTC vs. matched 
nonmalignant thyroid epithelial tissues depends on the presence of the BRAFV600E 
mutation (p=0.003). In the BRAFV600E positive PTC, the level of expression of 
BANCR decreases significantly compared to its levels in adjacent nonmalignant 
thyroid tissue, while in the BRAFV600E negative PTC, the relative level of expression 
of BANCR is unchanged or higher compared to the value for paired nonmalignant 
thyroid tissue. This implies that further research on the role of BANCR in the 
pathogenesis of PTC should include the BRAFV600E mutation status. 

 
 
 
 
 
 
 
 
 
CIP - Каталогизација у публикацији 
Народна библиотека Србије, Београд 
 
616.9:612.017(048) 
 
    IMMUNOLOGY at the Confluence of Multidisciplinary Approaches : 
abstract book / [editors Tamara Saksida, Suzana Stanisavljević, Đorđe 
Miljković]. - Belgrade : Institute for Biological Research "Siniša Stanković", 
University of Belgrade : 
Immunological Society of Serbia, 2019 (Kragujevac : Interprint). - 136 str. ; 21 
cm 
 
Tiraž 200. 
 
ISBN 978-86-80335-12-4 (IBRSS) 
 
a) Имунологија -- Апстракти 
 
COBISS.SR-ID 281009420 
 
 
 

  
 
 
 
 
 
 
 
 
 
